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Résumé 
La leptine circule en proportion de la masse graisseuse du corps et la transduction de son 
signal à travers la forme longue de son récepteur via un certain nombre de voies neurales , y 
compris MAPK, PI3-K ,AMPK et JAK2 - STAT3 . Il faut noter que STAT3 constitue une 
voie clée au récepteur de la leptine par laquelle la leptine module l'expression des gènes 
impliqués dans la régulation du bilan énergétique. 
La plupart des recherches ont porté sur la fonction du récepteur de la leptine au sein de l' 
hypothalamus, en particulier la fonction du récepteur de la leptine dans le noyau arqué. 
Toutefois, les récepteurs de la leptine sont également exprimés sur les neurones 
dopaminergiques de l'aire tégmentale ventrale et la leptine agit sur cette région du cerveau 
pour influencer la prise alimentaire, la motivation, la locomotion, l'anxiété et la transmission 
de la dopamine. De plus, la leptine active la STAT3 dans les dopaminergiques et 
GABAergiques populations neuronales. Bien que ces résultats contribuent à notre 
compréhension des multiples actions de la leptine dans le système nerveux central, il reste à 
résoudre les cellules et la signalisation du récepteur de la leptine qui sont responsables des 
effets neurocomportementaux de la leptine dans le mésencéphale. 
Visant à déterminer la contribution de la voie de signalisation STAT3 dans les neurones 
dopaminergiques du mésencéphale, nous avons généré une lignée de souris knockout 
conditionnel dans lequel l'activation du gène de STAT3 sur son résidu tyrosine 705 ( Tyr 705 ) 
est absent spécifiquement dans les neurones dopaminergiques. Avec l'utilisation de ce modèle 
de souris génétique, nous avons évalué l'impact de l'ablation de la signalisation STAT3 dans 
les neurones dopaminergiques sur un certain nombre de fonctions liées à la dopamine, y 
compris l'alimentation, la locomotion, les comportements liés à la récompense, l'émotion et la 
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libération de dopamine dans le noyau accumbens. Fait intéressant, nous avons observé un 
dimorphisme sexuel dans le phénotype des souris STAT3DAT-KO. L'activation de la voie de 
signalisation STAT3 dans les neurones dopaminergiques est responsable de l'action de la 
leptine dans la réduction de la locomotion, récompense liée à l'activité physique, et de 
l'augmentation de la libération et de la disponibilité de la dopamine chez les souris mâles. 
Cependant, il ne module pas le comportement émotionnel. D'autre part, les souris femelles 
STAT3DAT-KO augmentent les niveaux d'anxiété et les niveaux plasmatiques de corticostérone, 
sans provoquer de changements de la dépression. Cependant, la perte d'activation de STAT3 
dans les neurones dopaminergiques ne module pas le comportement locomoteur chez les 
souris femelles. Notamment, les actions de la leptine dans le mésencéphale pour influencer le 
comportement alimentaire ne sont pas médiées par l'activation de STAT3 dans les neurones 
dopaminergiques, considérant que les souris mâles et femelles ont un comportement 
alimentaire normal. 
Nos résultats démontrent que la voie de signalisation STAT3 dans les neurones 
dopaminergiques est responsable des effets anxiolytiques de la leptine, et soutient l'hypothèse 
que la leptine communique l'état d'énergie du corps (i.e. la relation entre la dépense et les 
apports énergétiques) pour les régions mésolimbiques pour atténuer les effets de motivation et 
de récompense de plusieurs comportements qui servent à réhabiliter ou à épuiser les réserves 
d'énergie. En outre, ce travail souligne l'importance d'étudier la modulation de la signalisation 
de la leptine dans différente types de cellules, afin d'identifier les voies de signalisation et les 
mécanismes cellulaires impliqués dans les différentes fonctions neuro-comportementales de la 
leptine. 
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Abstract 
The adipocyte-derived hormone leptin circulates in proportion to the body fat content and 
transduces its signal through the long form of its receptor via a number of neural pathways, 
including MAPK, PI3-K, AMPK and JAK2-STAT3. Of note, STAT3 constitutes a key 
pathway downstream to the leptin receptor by which leptin modulates the expression of genes 
involved in energy balance. 
Most research has focused on leptin receptor function within the hypothalamus, in particular 
leptin receptor function within the arcuate nucleus. However, leptin receptors are also 
expressed on dopaminergic neurons of the ventral tegmental area, and leptin has been shown 
to target this brain region to influence feeding, motivation, locomotion, anxiety and dopamine 
tone. Moreover, leptin activates STAT3 in both dopaminergic and GABAergic neuronal 
populations. Although these findings contribute to our understanding of the multiple actions of 
leptin in the central nervous system, it remains to be resolved which cells and leptin receptor 
signaling pathway mediates the neurobehavioral effects of leptin in the midbrain. 
Aiming at determining the contribution of STAT3 signaling in midbrain DA neurons, we 
generated a line of conditional knockout mice in which the main activation site of STAT3 
gene (tyr 705) is absent specifically in dopaminergic neurons (STAT3DAT-KO mice). Using this 
genetic mouse model, we assessed the impact of ablation of STAT3 signaling in dopaminergic 
neurons on a number of dopamine-related functions, including feeding, locomotion, reward-
related behaviors, emotion and nucleus accumbens dopamine release. Interestingly, we 
observed a sexual dimorphism in the phenotype of STAT3DAT-KO mice. STAT3 signaling in 
DA neurons mediates the actions of leptin in the midbrain to decrease locomotion and running 
reward, and to increase dopamine release and availability in male mice. However, it does not 
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modulate emotional behavior. On the other hand, STAT3DAT-KO female mice exhibited 
increased anxiety-like behavior accompanied by increased plasma corticosterone levels, 
without changes in behavioral despair relative to littermate controls. However, loss of STAT3 
activation in dopaminergic neurons does not modulate locomotor behavior in female mice. 
Notably, the actions of leptin in the midbrain to influence feeding behavior are not mediated 
by STAT3 signaling in dopaminergic neurons, as both male and female STAT3DAT-KO mice 
have normal feeding behavior as compared to littermate controls. 
Our results demonstrate that STAT3 signaling in dopaminergic neurons mediates the 
anxiolytic actions of leptin, and support the hypothesis that leptin communicates body energy 
status (defined as a relationship between energy intake and energy expenditure) to mesolimbic 
regions to adjust the motivational and rewarding effects of multiple behaviors that serve to 
either restore or deplete energy stores. In addition, this work highlight the importance of 
studying cell-type specific modulation of leptin signaling molecules to tease apart pathways 
and the mechanisms involved in the different neurobehavioral functions of this adipocyte-
derived hormone. 
 
Keywords: leptin, STAT3; dopamine, midbrain, running reward, anxiety, behavior. 
viii 
 
Index 
 
Resume ......................................................................................................................................iii 
Abstract ......................................................................................................................................vi 
Index ........................................................................................................................................viii 
List of Figures .............................................................................................................................x 
List of Abbreviations ................................................................................................................xv 
Dedication ..............................................................................................................................xviii 
Acknowledgements ..................................................................................................................xix 
 
Chapter I ....................................................................................................................................1 
1. General introduction ............................................................................................................2 
1.1. Central regulation of energy balance................................................................................2 
1.2. Ingestive behavior: appetitive versus consummatory behavior......................................3 
1.3. Feeding behavior.................................................................................................................5 
1.4. Locomotion: ambulatory activity and voluntary exercise..............................................6 
2. Leptin overview......................................................................................................................9 
2.1. Leptin discovery and physiological actions......................................................................9 
2.2. Leptin receptor signaling.................................................................................................12 
2.3. Leptin activates STAT3 signaling in the hypothalamus................................................17 
3. The mesolimbic and nigrostriatal dopamine systems.......................................................19 
3.1. The ventral tegmental area (VTA) and substantia nigra (SN): receptors and 
neurotransmitters....................................................................................................................19 
3.2. The dopaminergic reward circuit, feeding and running behavior...............................24 
4. Leptin signaling in the mesolimbic dopamine system......................................................30 
4.1. Leptin activates STAT3 signaling in extra-hypothalamic brain regions.....................30 
4.2. Leptin and locomotion......................................................................................................33 
4.3. The effect of leptin on reward..........................................................................................34 
5. Leptin's role in emotion and mood.....................................................................................37 
 
Chapter II ................................................................................................................................40 
6. Objectives .............................................................................................................................41 
6.1. First objective ....................................................................................................................41 
6.2. Second objective ................................................................................................................41 
7. General Methods....................................................................................................................42 
 
Chapter III ...............................................................................................................................46 
8. Articles ..................................................................................................................................47 
8.1. Leptin suppresses the rewarding effects of running via STAT3 signaling in dopamine 
neurons.....................................................................................................................................48 
8.2. Deletion of STAT3 in midbrain dopamine neurons increases anxiety-like behavior in 
female mice...............................................................................................................................91 
 
Chapter IV .............................................................................................................................120 
9. General discussion ..............................................................................................................121 
ix 
 
9.1. Role for STAT3 signaling in DA neurons in locomotion and running 
reward.....................................................................................................................................121 
9.2. Loss of STAT3 signaling in DA neurons induces an anxiogenic phenotype in female 
mice..........................................................................................................................................130 
 
10. General limitations...........................................................................................................136 
 
11. Perspectives......................................................................................................................137 
 
12. Conclusion........................................................................................................................140 
 
13. Appendices .......................................................................................................................141 
13.1. Appendix I: Unpublished results on the role for STAT3 signaling in DA neurons in 
the modulation of feeding behavior in male mice...............................................................142 
13.2. Appendix II: Unpublished results on the role for STAT3 signaling in DA neurons in 
the modulation of feeding behavior and learning in female mice.....................................152 
 
14. References.........................................................................................................................164 
 
x 
 
List of Figures 
 
Chapter I 
Figure 1. Leptin receptor signaling pathways schematics....................................................16 
 
Figure 2. Schematic representation of mesocorticolimbic and nigrostriatal systems........23 
 
Figure 3. Schematic representation of leptin receptor signaling in dopaminergic neurons 
of the midbrain.........................................................................................................................32 
 
Chapter II 
Figure 4. Breeding strategy to obtain STAT3DAT-KO mice....................................................44 
 
Chapter III 
Article #1 
Figure 1. STAT3 in DA neurons regulates body weight, locomotor activity and voluntary 
wheel running. (A) Body weights of control (n=7) and STAT3DAT KO mice (n= 8). Inset: 
Weaning weight (n=20/group) (B) Total lean and fat mass of control (n=7) and STAT3DAT KO 
(n=8) mice at 23 weeks of age. (C) Caloric intake (chow) normalized by body weight in 
control (n=7) and STAT3DAT KO (n=8) mice (D) Metabolic efficiency (total intake divided by 
weight gain) of control (n=7) and STAT3DAT KO (n=8) mice. (E) 24h ambulatory activity in 
control and STAT3DAT KO mice (n=9/group). (F) Dark phase locomotor activity is elevated in 
STAT3DAT KO mice relative to controls (n=9/group) (G) Ad libitum voluntary wheel running is 
increased in STAT3DAT KO (n=12) as compared to controls (n=7) (H) STAT3DAT KO (n=12) 
mice run much longer distances each day relative to controls (n=7). Mean±SEM; *p≤.05; ** 
p≤.01; ***p<0.001.....................................................................................................................85 
 
Figure 2. STAT3 in dopamine neurons does not mediate the anorectic effects of central 
leptin and hedonic feeding but impairs food-motivated operant learning (A) Food intake 
of control and STAT3DAT KO mice receiving an intra-VTA injection of leptin 
(200ng/500μl/side) or vehicle (n=7-11/group) (B) Food intake of control and STAT3DAT KO 
mice receiving an ICV injection of leptin (1μg/1μl) or vehicle (n=4/group) (C) Lever press 
responses on a fixed-ratio (FR)-1 operant conditioning task in control and STAT3DAT KO mice 
(n= 9/group; main effect of genotype). (D) Percentage of correct and incorrect responses by 
Day 8 of testing (n= 9/group) (E) Layout of the hedonic feeding test where mice learn to 
consume their daily chow ration in a 4-h time window (F) Test day intake of chow and 
sweetened high-fat diet (“dessert”) in control and STAT3DAT KO mice (n= 7/group). 
Mean±SEM; *p≤.05; ** p≤.01; ***p<0.001..........................................................................86 
 
Figure 3. The rewarding effects of running are increased in STAT3DAT KO mice and are 
inhibited by leptin in the VTA. (A) Schema demonstrating the conditioned-place preference 
(CPP) task used to measure running reward. Alternating conditioning trials  (paired one day, 
unpaired next) lasted 14 days (B) Control (n=16) and STAT3DAT KO (n=12) mice show 
significant preference for the “paired” side of the chamber associated with wheel running. (C). 
Preference for the paired side of the chamber is enhanced in STAT3DAT KO mice (n=12) 
relative to controls (n=16). (D) In a separate cohort, running CPP was assessed 1 hour after 
xi 
 
intra-VTA injection of vehicle in control (n=9) and STAT3DAT KO (n=8) mice. As in B, 
STAT3DAT KO mice show increases running CPP relative to controls (E) Intra-VTA leptin 
blocked the rewarding effects of running in control mice (n=14) but not in STAT3DAT KO 
(n=16) mice. Running CPP was tested one hour after intra-VTA leptin (200ng, 500μl/side) 
injection. Mean±SEM; *p≤.05; ** p≤.01; ***p<0.001............................................................87 
 
Figure 4. Lack of STAT3 in DA neurons decreases DA overflow in the NAc core and 
blocks amphetamine locomotor sensitization. (A) Illustration of brain slice preparation with 
placement of carbon fibre recording and stimulating electrodes for measurement of DA 
overflow using fast-scan cyclic voltammetry. (B) Representative current-time plot showing 
subsecond stimulation-evoked DA release and reuptake in a control and STAT3DAT KO mouse. 
Background current waveforms obtained immediately before the stimulation were subtracted 
from current waveforms obtained after stimulation to generate DA cyclic voltammograms. 
Oxidation current peaks for DA were obtained at potentials of -300 to -500 mV (versus 
Ag/AgCl) corresponding to 3.5–4.5 ms in the voltage waveform. The peak oxidation currents 
derived from voltammograms were converted to concentration by electrode calibration and 
used to generate current-time plots (C) DA overflow (mean of peak values from current-time 
plots) is reduced in STAT3DAT KO mice (n=6;3) relative to controls (n=6;3). (D) TH and D1 
receptor protein expression is lower in in the NAc of STAT3DAT KO mice as compared to 
controls (n=5-10/group). Protein quantifications were normalized to GAPDH values. (E) 
AMPH locomotor sensitization: Locomotor activity over time following the first dose of 
AMPH. (F). Locomotor activity over time following the second dose of AMPH. (G). Area 
under the curve (AUC) locomotor activity data for control mice treated with leptin (n=9) or 
vehicle (n=9). Locomotor activity was increased following the second injection of AMPH in 
both groups of control mice, indicative of sensitization. (H) Area under the curve (AUC) 
locomotor activity data for STAT3DAT KO mice treated with leptin (n=6) or vehicle (n=7). 
STAT3DAT KO mice treated with vehicle failed to sensitize to repeat AMPH whereas leptin 
treatment to these mice restored AMPH sensitization. Mean±SEM; *p≤.05; ** p≤.01...........88 
 
Supplemental Figure 1. Cre mediated STAT3 recombination. (A) PCR detection of STAT3 
gene recombination. The recombined STAT3 gene (∆STAT3) was observed only in 
tissues/nuclei of STAT3DAT KO mice in which DAT is expressed. (B) Double 
immunohistochemistry for TH (VIP, purple) and pSTAT3(tyr705) (ni-DAB, black) from 
leptin treated STAT3DAT KO mice (n=4/group) reveals the absence of pSTAT3 from TH+ 
(dopamine) neurons (open arrows) and the presence of pSTAT3 in TH- cells (closed arrows) 
of the VTA, SN and MBH of STAT3DAT KO mice. CX: cortex; HPC: hippocampus; Liv: liver; 
MBH: mediobasal hypothalamus; Pan: pancreas; OB: olfactory bulb; VTA: ventral tegmental 
area; SN: substantia nigra..........................................................................................................89 
 
Supplemental Figure 2, related to Figure 1. Similar wheel running activity between DAT::Cre 
and wildtype littermates. (n=4-5/group)....................................................................................90 
 
Supplementary Figure S3, related to Figure 1. Comparable anxiety-like behavior in STAT3DAT 
KO mice and controls. (A) Heat maps showing locomotor activity in the EPM in a STAT3DAT 
KO mouse and control. (B,C) Anxiety-like behavior as measured in the EPM was similar 
between STAT3DAT KO mice and controls (n=11-12/group). Percentage of open arm and open 
xii 
 
arm time were not different between genotypes (C) No differences were observed in anxiety-
like behavior in the open field test. Exploratory activity (distance travelled) was comparable 
between STAT3DAT KO mice and controls (n= 5-6/group).........................................................89 
 
 
Article #2 
Figure 1: Absence of STAT3 signaling in dopamine neurons enhances CORT levels and 
anxiety-like behavior. (A) Basal plasma corticosterone levels (ng/ml, ± SEM) is increased in 
STAT3DAT-KO mice (n=4) as compared to controls (n=4). ***p< 0.001. (B) 30’ restraint stress-
induced plasma corticosterone levels (ng/ml, ± SEM)  is significantly increased in STAT3DAT-
KO mice (n=6) as compared to littermate controls (n=6). ***p< 0.001 (C) Significant decrease 
in percentage of time spent in the centre of an open field arena in STAT3DAT-KO mice (n=10) 
as compared with the control group (n=8). ***p< 0.001. (D) Percentage time spent in the 
periphery of an open field arena is increased in STAT3DAT-KO mice (n=10) as compared to 
littermate controls (n=8). ***p< 0.001. (E) Percentage of open arm time and open arm entries 
is decreased in STAT3DAT-KO mice (n=7) as compared to littermate controls (n=8). ** p≤0.01, 
percentage open arm time; ** p<0.01.....................................................................................115 
 
Figure 2. STAT3DAT-KO  mice display normal locomotor activity, body weight and food 
intake. (A) 24h-locomotor activity, expressed as total distance travelled during the test in 
STAT3DAT-KO mice and respective controls (n=7-9). (B) Dark (active) phase locomotor 
activity in STAT3DAT-KO mice and respective controls (n=7-9). (C) Average caloric intake 
normalized by body weight of STAT3DAT-KO female mice and littermate controls on a regular 
chow diet (n=8-9).....................................................................................................................116 
 
Figure 3: Lack of STAT3 in dopamine neurons does not affect depressive-like behavior. 
(A) Total immobility time in the forced swim test is similar between STAT3DAT-KO (n=6) and 
control mice (n=4). (B) Immobility time of STAT3DAT-KO (n=4) mice was comparable to 
controls (n=4) in the tail suspension test. ...............................................................................117 
 
Figure 4: Lack of STAT3 in DA neurons alters the expression of DA-related proteins in 
the CeA. TH and DAT protein levels in CeA of STAT3DAT-KO mice (n=5-7) were reduced as 
compared to controls (n=4). ***p< 0.001. Phosphorylation of DARPP32 at Thr 34 was 
increased in STAT3DAT-KO mice (n=4) relative to controls (n=4). *p< 0.05...........................118 
 
Figure 5: D1R antagonist (SCH23390) administration in the CeA reverses the anxiogenic 
phenotype of STAT3DAT KO mice. (A) Schema illustrating the placement of cannulae in the 
CeA (B) Percentage of time spent in the open arm of an EPM is comparable between 
STAT3DAT KO (n=5) and control mice (n=5) treated with SCH23390 (0.3 µg per mouse). 
Percentage of time spent in the open arm of an EPM is decreased in saline-treated STAT3DAT 
KO mice (n=5) as compared to saline-treated controls (n=5). * p< 0.05. Similar proportion of 
time spent in the open arm time in saline- (n=5) versus SCH23390-treated (n=5) control mice. 
Increased percentage of time spent in open arm in SCH23390-treated STAT3DAT KO mice 
(n=5) as compared to saline-treated STAT3DAT KO mice (n=5). **p<0.01. (C) Percentage of 
entries made to the open arm of an EPM is similar between STAT3DAT KO (n=5) and control 
mice (n=5) treated with SCH23390. Percentage of entries to the open arm of an EPM is 
xiii 
 
decreased in saline-treated STAT3DAT KO mice (n=5) as compared to saline-treated controls 
(n=5). *p< 0.05. Comparable percentage of open arm entries in saline- (n=5) and SCH23390-
treated (n=5) control mice. Increased percentage of open arm entries in SCH23390-treated 
STAT3DAT KO mice (n=5) as compared to saline-treated STAT3DAT KO mice (n=5). *p< 
0.05..........................................................................................................................................119 
 
Chapter IV 
General discussion 
Figure 5. The anxiolytic actions of leptin in female mice are mediated by increased 
LepRb-STAT3 signaling in midbrain DA neurons that target the CeA to decrease D1R 
signaling, perhaps via increased DA reuptake....................................................................135 
 
Appendices 
Appendix I 
Figure 6. Long-term high-fat(HF) diet intake and body weight is not different between 
STAT3DAT-KO and control mice. (A) Cumulative HF caloric intake of STAT3DAT-KO and 
control mice. n= 8-11/group. (B) Long-term body weight in STAT3DAT-KO and control mice. 
n= 8-11/group..........................................................................................................................148 
 
Figure 7. Food anticipatory activity (FAA) is not different between STAT3DAT-KO male 
mice and littermate controls. (A) 4h-locomotor activity prior to food access is not different 
in control and STAT3DAT-KO mice. n= 5/group. (B) Locomotor activity is not different between 
control and STAT3DAT-KO mice 60 minutes prior to access of food 
(n=5/group)..............................................................................................................................149 
 
Figure 8. Food restriction-induced feeding is not different between STAT3DAT-KO male 
mice and littermate controls. (A) Protocol schematics. (B) Free-access to food after three 
days of 50% food restriction did not alter significantly regular chow consumption between 
genotypes. n=7/group................................................................................................................150 
 
Figure 9: Food preference in STAT3DAT-KO mice. HF- versus LF-diet preference is similar 
between STAT3DAT-KO and littermate controls. n=10-14/group. ............................................151 
 
Appendix II 
Figure 10. Caloric intake, body weight, and food preference is not different in STAT3DAT-
KO female mice as compared to controls. (A) Average long-term caloric intake and body 
weight of STAT3DAT-KO female mice and littermate controls on regular chow diet. n=8-
9/group. (B) Food-preference test in STAT3DAT-KO and control mice. n=11-12/group.  (C) 
Average long-term high-fat caloric intake of STAT3DAT-KO female mice and littermate 
controls. n=12-13/group. .......................................................................................................160 
 
Figure 11. Locomotor activity and voluntary exercise is not different in STAT3DAT-KO 
female mice as compared to controls. (A) Dark (active) phase locomotor activity expressed 
as total distance travelled during the test in STAT3DAT-KO female mice as compared to 
xiv 
 
controls. n=7-9/group. (B) Voluntary wheel running exercise in female mice, expressed as 
average number of wheel revolutions per week. n=10 mice/group.........................................161 
 
Figure 12. Operant conditioning task and D1R protein expression in STAT3DAT-KO and 
control mice. (A) Total lever press. n= 8-10/group ***p<0.001 (B) Percentage of correct over 
incorrect responses by day 10. n= 8-10/group. **p<0.01 (C) Significant decrease in D1R 
protein levels in the dorsolateral striatum (DLS) of STAT3DAT-KO mice as compared to 
controls. n=4-7/group. **p<0.01.............................................................................................162 
 
Figure 13. STAT3DAT-KO female mice acquired CPP for a sweetened high-fat food. (A) 
CPP protocol schematics (B) Preference for the food-paired side of the CPP apparatus after 
minus before the CPP test. n=11/group..................................................................................163 
xv 
 
List of Abbreviations 
 
5-HT: serotonin 
6-OHDA: 6-hydroxydopamine 
AAV: adeno-associated virus 
ABA: activity-based anorexia 
AgRP: agouti related protein 
AMPH: amphetamine 
AMPK: 5′adenosine monophosphate-activated protein kinase 
ARC: hypothalamic arcuate nucleus 
BBB: blood–brain barrier 
BDNF: brain derived neurotrophic factor 
BMR: basal metabolic rate 
BNST: basal nucleus of the stria terminalis 
BSR: brain-stimulation-reward 
cAMP: cyclic adenosine monophosphate 
CART: cocaine- and amphetamine-regulated transcript 
CCK: cholecystokinin 
CeA: central nucleus of the amygdala 
CLi: caudal linear nucleus 
CNS: central nervous system 
CNTF: ciliary neurotrophic factor 
CPP: conditioned place-preference 
D1R: dopamine 1-like receptor 
D2R: dopamine 2-like receptor 
DA: dopamine 
DARPP: dopamine- and cAMP-regulated phosphoprotein 
DAT: dopamine transporter 
db: diabetes gene 
DIO: diet-induced obesity 
DLS: dorsolateral striatum 
DNA: deoxyribonucleic acid 
DRN: dorsal raphe nucleus 
ECBs: endocannabinoids 
EGF: epidermal growth factor 
EPM: elevated-plus maze 
ER: estrogen receptor 
ERK 1/2: extracellular signal-regulated kinase 1/2 
FAA: food anticipatory activity 
fMRI: functional magnetic resonance imaging 
FR1: fixed ratio 1 
FST: forced-swim test 
GABA: γ-aminobutyric acid 
G-CSF: granulocyte-colony stimulating factor 
HF: high-fat 
HPA: hypothalamic-pituitary axis 
xvi 
 
ICV: intracerebroventricular 
IFN: interferon 
IGF-1: insulin-like growth factor-1 
IL: interleukin 
IRS: insulin receptor substrate 
JAK2: janus tyrosine kinase 2 
KO: knockout 
LepR: leptin receptor 
LepRa: short-isoform of the leptin receptor 
LepRb: long-isoform of the leptin receptor 
LF: low fat 
LH: lateral hypothalamus 
LHA: lateral hypothalamic area 
LPOA: lateral preoptic area 
MAPK: mitogen-activated protein kinase 
MHb: medial habenular nucleus 
mTOR: mammalian target of rapamycin 
NAc: nucleus accumbens 
NE: norepinephine 
NMDA: N-methyl-D-aspartate 
NPY: neuropeptide Y 
NT: neurotensin 
NTS: nucleus of the solitary tract 
ob: obese gene 
OFT: open field test 
OT: tuberculum olfactorium 
PAG: periaqueductal gray 
PFC: prefrontal cortex 
PI3-K: phosphatidylinositol-4,5-bisphosphate 3-kinase 
PKA: cAMP-dependent protein kinase 
PMT: pontomesencephalic tegmentum 
POMC: proopiomelanocortin 
PTP1B: protein-tyrosine phosphatase 1B 
PVN: paraventricular hypothalamic nuclei 
RLi: rostral linear nucleus 
RRF: retrorubral field 
RRF: retrorubral field 
SH2: Src homology 2 domain containing proteins 
SHP2: protein tyrosine phosphatase 2 
SN: substantia nigra 
SNc: substantia nigra pars compacta 
SNr: substantia nigra pars reticulada 
SOCS 3: suppressor of cytokine signaling 3 
STAT: signal transducer and activator of transcription 
STAT3DAT-KO: dopamine-specific STAT3 knockout mice 
STAT3 N-/- : neural STAT3 mutant mice 
xvii 
 
TH: tyrosine hydroxylase 
TST: tail suspension test 
Tyr: tyrosine 
VMH: ventromedial hypothalamus 
VTA: ventral tegmental area 
xviii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This thesis is dedicated to my parents Maria Amelia Fernandes and Manoel Fernandes. All I 
have and will accomplish are only possible due to their endless love and sacrifices. 
xix 
 
Acknowledgements 
I would like to acknowledge my research director, Dr. Stephanie Fulton, for welcoming me as 
her first grad student and for giving me the precious opportunity to work and learn in her 
laboratory. I am deeply thankful for all her time, her mentoring and willingness to keep me 
focused and motivated. I will never forget and cannot thank her enough for her enormous 
support, especially when I was going through a really tough time in my personal life...Many 
thanks for teaching me the importance of doing good science and, above of all, for inspiring 
me to become a better scientist. 
 
I also have to express my sincere gratitude to Dr. Thierry Alquier and Dr. Pierrette Gaudreau 
for their time and insightful ideas into this project over the years, as well as their help, 
encouragement and support. 
 
I warmly thank everyone in the Fulton lab, specially Sandeep Sharma, Cecile Hryhorczuk and 
Stephanie Auguste, who were part of the "first generation" of the lab, for the great working 
environment. 
 
Sandeep Sharma and Cecile Hryhorczuk, your friendship and support has made all the 
difference during this long journey! A huge thanks for the encouragement, for always being 
willing to lend a helping hand with my experiments, for telling me to stand up for myself and 
for keeping me sane in the lab... All our scientific and non-scientific conversations will be 
missed dearly. I will always hold you both close to my heart. 
 
xx 
 
I am also very grateful to Shangang Zhao and Bouchra Taib, for always putting a smile on my 
face and for being so kind to me. Big thanks to Demetra Rodaros (Demi) for her assistance, 
friendship and for the laughing time. 
 
I especially need to thank my dear family back in Brazil. I thank my mother, Maria Amelia, 
and my father, Manoel, for all the love, unconditional support and for their understanding 
when I was moving away... Without you none of this would be possible! To my sister Andrea, 
thank you for being the best sister ever and for taking such good care of mom and dad. I miss 
you all every single day, and love you deeply! 
 
I want to thank my beloved husband Vincent for his infinite love, patience, constant support, 
understanding and for being there for me through the rough and busy times during grad 
school. There are no words to describe how much I love you. 
 
Finally, I thank the Faculty of Graduate Studies (FESP/ Université de Montréal) and the 
Canadian Diabetes Association (CDA) for providing doctoral fellowships. 
 
1 
 
 
 
 
 
 
 
 
Chapter I 
 
Introduction and Literature Review 
 
2 
 
 
1. General Introduction 
1.1. Central regulation of energy balance 
In order to maintain an ideal body weight, an organism must balance energy intake with energy 
expenditure. Under normal "steady-state" conditions, daily caloric requirements are estimated 
based on a balance between energy expenditure and energy needs, to maintain normal growth, 
thermogenesis, locomotion and reproduction (Bouchard and Perusse 1993, Wynne et al. 2005, 
Lenard and Berthoud 2008). Energy balance regulation depends on a complex interaction 
between central and peripheral signals to influence food intake and energy expenditure (Kalra et 
al. 1999, Wynne et al. 2005, Matsuda et al. 2011). Excessive caloric intake in relation to 
metabolic needs can lead to positive energy balance and, as a consequence, weight gain (Wynne 
et al. 2005). 
In modern societies, it is very common to eat beyond need, given that food consumption is also a 
gratification for the palate (Cota et al. 2006). Along with overfeeding, sedentary life style greatly 
contribute to an imbalance in total daily energy expenditure, resulting in body fat gain (Levine et 
al. 1999), which will eventually cause obesity. On the other hand, body energy stores can be 
depleted when daily energy expenditure exceeds caloric consumption. The major components of 
total daily energy expenditure are: 1) caloric needs; 2) thermic effect of food; 3) locomotion-
induced thermogenesis (D'Alessio et al. 1988, Levine 2004). Of note, in most cases, these 
homeostatic mechanisms matching energy expenditure to energy intake, regulates body weight 
tightly, aiming to maintain body weight over a long period of time. However, this is not always 
the case as in modern societies, it is very common to eat beyond physiological or nutritional 
needs. 
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To preserve energy homeostasis, peripheral signal informs the brain about the body energy stores 
through either the autonomic nervous system, or via central actions of nutrients, hormones and 
metabolites (Lenard and Berthoud 2008). Within the central nervous system (CNS), there are 
several structures involved in energy homeostasis, including the brainstem, parts of the cortex 
and limbic system, and the hypothalamus (Lenard and Berthoud 2008). In fact, the hypothalamus 
has been implicated in the control of food intake and body weight since a long ago, when 
experiments demonstrated that lesions of this brain structure lead to a dysregulation of food 
consumption (Brobeck 1946, Anand and Brobeck 1951). Within the hypothalamus, there are two 
primary populations of neurons located in the arcuate nucleus (ARC) which are responsible for 
the integration of peripheral signals of nutritional status (Cone et al. 2001): 1) the anorexigenic 
proopiomelanocortin (POMC)- and cocaine- and amphetamine-regulated transcript (CART)-
containing neurons (Elias et al. 1998, Kristensen et al. 1998); 2) the orexigenic neurons 
coexpressing neuropeptide Y (NPY) and agouti related protein (AgRP) (Broberger et al. 1998, 
Hahn et al. 1998). These ARC neuronal populations form complex neural circuits with 
hypothalamic second-order neurons to modulate energy homeostasis (Lopaschuk et al. 2010). 
Thus, the above mentioned hypothalamic pathways allow transduction of peripheral signals into 
behavioral and metabolic responses aiming at maintaining body energy stores at a constant level. 
 
1.2. Ingestive behavior: appetitive versus consummatory behavior 
Given the ever-increasing rise in obesity in our society, mostly due to energy intake chronically 
exceeding energy output (Ogden et al. 2006), it remains very important to identify the 
mechanisms underlying ingestive and locomotor behavior. In fact, ingestive behavior 
encompasses all drinking and eating behaviors, and is thought to be comprised of two main 
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phases that contribute to the overall energy intake of animals: the appetitive and consummatory 
phases (Kearney 2010, Keen-Rhinehart et al. 2013). The appetitive phase is characterized by 
foraging behavior, when animal acquire and transport food, along with hoarding behavior, when 
the animal stores the food; the consummatory phase is the phase that follows, when the food is 
consumed, and involves basic motor movements that control chewing, swallowing, etc, as well 
as central mechanisms responsible for food consumption (Foltin 2001, Bartness et al. 2011). 
Both appetitive and consummatory behaviors can increase in conditions where energy reserves 
are further challenged, such as during pregnancy/lactation, exposure to cold temperatures, hunger 
and food cravings (the desire to immediately consume food and to replenish the energy stores) 
(Day and Bartness 2003). Although both consummatory and ingestive behaviors involve 
motivation, reward-related pleasure and locomotion, the important distinction between these two 
phases of ingestive behavior lies in the fact that consummatory behaviors also reflects the ability 
to perform motor actions; while appetitive behaviors reflects willingness to aquire fuels either for 
eating or for storage (Keen-Rhinehart et al. 2013). Despite the importance of appetitive behavior 
to the etiology of obesity and related diseases, more focus has been given to the neuroendocrine 
mechanisms underlying consummatory behavior (Kalra et al. 1999, Abizaid and Horvath 2012, 
Kageyama et al. 2012). 
Appetitive ingestive behavior is a motivated behavior which aims to ensure that sufficient energy 
will be available to fulfill the energy needs of the body (Everitt et al. 1984). Therefore, this phase 
of ingestive behavior is greatly influenced by the dopaminergic reward circuit, which will be 
discussed in more detail later in this thesis. For now, it is sufficient to mention that food hoarding 
increases the activation of tyrosine hydroxylase (TH) (a rate limiting enzyme for the synthesis of 
dopamine) within dopaminergic neurons in the mesolimbic reward circuitry (Yang et al. 2011, 
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Zhang et al. 2011), suggesting that the act of hoard food can be naturally rewarding and 
reinforcing for animals which engage in such behavior. 
 
1.3. Feeding behavior 
Feeding is a physiological process required for survival (Blundell and Tremblay 1995). There are 
multiple and complex factors involved in feeding behavior, which are characterized by 
interactions between peripheral and central mechanisms that sense and respond to environmental 
changes, such as nutrient supply, temperature and plasma glucose, among others, to adjust 
energy intake (Stubbs 1999). In fact, the composition and amount of ingested food is variable 
between individuals, and as mentioned previously in this thesis, is not well correlated with daily 
energy expenditure (Edholm 1977, de Castro 1998). Thus, chronic consumption of excessive 
calories coupled with physical inactivity often observed nowadays, will eventually cause obesity. 
The "thrifty genotype" theory (Neel 1962) can serve as a possible explanation on how alterations 
in feeding behavior throughout time are contributing to the increased rates of overweight and 
obesity. According to this theory, for thousands of years our ancestors lived by hunting, farming 
and fishing to obtain food. However, these people experienced alternating periods of food 
abundance and starvation. Thus, to adapt to these extreme changes in caloric needs, our ancestors 
developed a thrifty genotype that allowed them to eat in abundance and store fat during times of 
plenty, so that they would not starve during times of famine (Neel 1962). With today's 
obesogenic environment, including less physical activity coupled to high availability of caloric 
foods, the "thrifty genotype" is no longer adaptive. In fact, the biological mechanisms stemming 
from this began to work against us by continuing to store calories in preparation for famine, by 
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promoting increased food seeking and ingestion, and thus contributing to increased body fat 
stores. 
The decision whether or not to eat a palatable food depends on how the CNS processes and 
integrates information about different aspects of eating behavior with hormonal signals related to 
hunger and satiety to promote energy balance (Smith and Campfield 1993, Morton et al. 2006). 
Thus, nutrient sensing, absorption and repletion of the body energy stores regulates the 
expression and release of several metabolic hormones that play a fundamental role in the control 
of energy homeostasis by the CNS (Fernandes et al. 2013). So, when energy stores are depleted, 
the brain intercommunicates with peripheral signals to provide the energetic needs to the body, 
making sure that adequate amounts of calories are available to tissues via the circulation 
(Figlewicz et al. 1995, Riedy et al. 1995, Barrachina et al. 1997, Woods et al. 2000). Actually, 
under usual circumstances, blood energy supply does not necessarily decrease below the 
threshold to trigger a feeding episode - it is very common that animals initiate meals even though 
the body energy stores are full, suggesting that timing and frequency of meals are not always 
driven by energy needs (Woods et al. 2000). In the last decade, great progress has been made in 
the identification of these peripheral signals which affects food intake and energy balance by 
communicating metabolic information to the brain. Moreover, the realization that specific genes 
have a profound influence on food intake and body weight, played a pivotal role in generating 
new targets for drug development in the treatment of obesity and related disorders. 
 
1.4. Locomotion: ambulatory activity and voluntary exercise 
As previously mentioned, there are three main components of energy expenditure: 1) basal 
metabolic rate (BMR); 2) thermic effect of food; 3) activity-induced thermogenesis, including 
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both voluntary exercise and spontaneous locomotor activity, or "non-exercise activity 
thermogenesis" (Levine 2004). By definition, voluntary exercise can be seen as a purposeful 
activity and/or movement that expends a significant amount of energy (Knab and Lightfoot 
2010); while ambulatory activity represents the energy expenditure associated with all activities 
we undertake, including those associated with mating, predator avoidance, food- and shelter-
seeking (Garland et al. 2011). These processes can be very different among species and 
individuals, resulting in a large variation in daily energy expenditure and efficiency of energy 
stored. Efficient energy storage, calculated by dividing the excess calories stored by the excess 
calories consumed, is beneficial because it allows longer survival during periods of scarcity of 
food (Levine et al. 1999). However, as discussed in Section 1.3, in the obesogenic environment 
of modern societies where locomotion necessary for daily activities has diminished and high-
density food supply has become abundant, efficient energy storage leads to energy imbalance 
and predisposes to obesity (Levine et al. 1999, Garland et al. 2011). This energetic efficiency 
with which non-exercise activities are performed is one of the major determinants of how much 
energy an individual will spend performing daily trivial activities. The link between non-exercise 
ambulatory activity and eating is highlighted in studies showing that severe underfeeding or food 
deprivation triggers substantial increases in locomotor activity, possibly due to an increase in 
motivation for foraging behavior in rodents (Overton and Williams 2004, Adan et al. 2011). 
Similarly, voluntary exercise is important to human health for many reasons, including the 
prevention of obesity (Schrauwen and Westerterp 2000, Connelly et al. 2007). It is well known 
that insufficient physical activity disturbs energy balance, and thus contributes to increased 
overweight, obesity and associated comorbidities (Dishman et al. 2006). Conversely, exercise 
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reduces body weight and body fat mass in obese compared to lean rodents (Mayer et al. 1954), 
and is associated with increased BMR (Hill et al. 1983). 
Peripheral and central metabolic mechanisms greatly influence physical activity behavior and in 
turn, physical activity affect the CNS. Exercise was shown to induce changes in central 
neuropeptide systems involved in the regulation of energy homeostasis (Levin and Dunn-
Meynell 2004). Furthermore, regular physical activity protects the brain against the deleterious 
effects of poor lifestyle (including those elicited by consumption of a high-saturated fat diet) 
possibly by modulating molecular signaling pathways, known to be disrupted by the intake of 
junk food (Molteni et al. 2004, Wu et al. 2004). 
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2. Leptin overview 
2.1. Leptin discovery and physiological actions 
According to Kennedy's "lipostatic theory", the amount of food ingested is determined by a 
circulating "limiting factor" produced by the adipose tissue and sensed by the CNS, so that the 
brain monitors this blood metabolite to adjust the body fat stores accordingly (Kennedy 1953). In 
the late 50's, Hervey's parabiosis experiment (Hervey 1959), aiming at a better understanding of 
the mechanisms involved in the central regulation of food intake, strongly supported the 
lipostatic theory of body weight control. This parabiosis study of Hervey involved surgically 
connecting the circulatory system of two animals: lean and obese ventromedial hypothalamus 
(VMH)-lesioned rat, to produce a common blood supply. Hervey observed that the parabiosis 
significantly reduced both food intake and body fat mass of the parabiotic partners of obese 
VMH-lesioned rats, as compared to parabiotic partners of lean rats. This result suggested that a 
circulating humoral factor was produced in excess by the lesioned parabiont as body fat 
accumulated, and this factor was responsible for the reduced food intake and body weight 
observed in the non-lesioned parabiont (Hervey 1959). A couple of decades later, parabiotic 
experiments performed among wild-type and two different strains of mice with unknown genetic 
mutations, ob/ob and db/db, demonstrated that the obese gene (ob) mutation lacked the 
production of a circulating anorexic factor, whereas the diabetes gene (db) mutation impaired the 
response to this factor (Coleman 1973). This circulating factor was later identified by Jeffrey 
Friedman's laboratory and named leptin (from the Greek leptos, meaning thin) (Zhang et al. 
1994). Therefore, leptin was the circulating satiety factor working as a negative feedback signal 
to control energy balance. However, it must be taken into consideration that both human and 
animals will eat beyond need should the opportunity arise. Thus, an important limitation to the 
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above-described studies is that a "circulating limiting factor" cannot be the only determinant of 
the amount of food consumed. 
Leptin, a 16-kDa protein, is a hormone synthesized mainly by the adipose tissue that circulates in 
proportion to body fat mass and informs the CNS about the status of the body's energy stores, as 
well as acute changes in caloric intake (Zhang et al. 1994, Boden et al. 1996, Considine et al. 
1996, Schwartz and Seeley 1997, Chan and Mantzoros 2005). It is secreted in a pulsatile fashion 
and has a significant diurnal variation with higher levels in late evening and early morning hours, 
possibly aiming to suppress appetite during the night while sleeping. (Sinha et al. 1996, Licinio 
et al. 1997). Leptin can be transported across the blood–brain barrier (BBB) to enter the brain, 
where it binds to specific leptin receptors (LepR), expressed throughout the body, to modulate a 
number of biological functions (Seeley and Woods 2003). 
Early in the 90's it was observed that leptin injections reversed the obese phenotype of the leptin-
deficient ob/ob mouse and also restored fertility to female ob/ob mice (Campfield et al. 1995, 
Halaas et al. 1995, Pelleymounter et al. 1995, Chehab et al. 1996). Importantly, additional 
studies determined that the db mutation resides in the gene encoding the leptin receptor (Chua et 
al. 1996, Lee et al. 1996) and that leptin administration to db/db mouse does not reduce food 
ingestion or body weight (Halaas et al. 1995). In summary, overfeeding will lead to increased 
body fat stores and consequently increased leptin levels. Increased plasma leptin will then 
activate LepR signaling within the brain, which will in turn, decrease food intake and body 
weight by stimulating energy expenditure. 
Leptin has a number of other biological actions, including regulation of neuroendocrine function. 
It was previously reported that when starvation induces a fall in leptin, this acute energy 
deprivation will trigger a series of neuroendocrine responses, including decreases in reproductive 
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hormone levels in order to prevent energy-requiring processes, such as pregnancy; reductions in 
the metabolic rate by decreasing thyroid hormone levels; increases in growth hormone levels, 
that may mobilize energy stores; and reductions in growth-related processes by modulating 
insulin-like growth factor-1 (IGF-1) levels (Ahima et al. 1996, Cunningham et al. 1999, 
Amstalden et al. 2000, Chan et al. 2003, Chan et al. 2008). Other situations of extreme energy 
deprivation, such as eating disorders (i.e.: bulimia, anorexia nervosa), cachexia and exercise-
induced amenorrhea are also associated with hypoleptinemia (Mantzoros et al. 1997, Audi et al. 
1998, Licinio et al. 1998, Miller et al. 1998, Jimerson et al. 2000) and will indeed trigger a 
neuroendocrine dysfunction with subsequent anovulation and osteoporosis, suggesting that leptin 
is required for normal reproductive and neuroendocrine function (Welt et al. 2004). Moreover, 
leptin acts as a permissive signal that allows initiation of puberty, as its administration advances 
sexual maturation in mice (Barash et al. 1996, Ahima et al. 1997). Of note, leptin deficient ob/ob 
mice is sterile and its sterility can be reversed by leptin treatment (Chehab et al. 1996, Mounzih 
et al. 1997). Thus, leptin acts as a signal to the neuroendocrine reproductive system, so that 
under hypoleptinemia conditions, this adipocyte hormone acts as a metabolic gate to inhibit the 
neuroendocrine reproductive axis in males and females (Cunningham et al. 1999). 
Leptin also plays a pivotal role in coupling the immune system and energy balance (Finck et al. 
1998, Fantuzzi 2009, Procaccini et al. 2009), as inflammatory cytokines can influence 
leptinemia, and leptin can also induce the synthesis of inflammatory cytokines (Granowitz 1997, 
Sarraf et al. 1997, Loffreda et al. 1998, Yamaguchi et al. 1998). Other pleiotropic actions of 
leptin include the promotion of linear growth through its influence on energy balance, and the 
stimulation of secretion of pituitary growth hormone (Gat-Yablonski and Phillip 2008). 
Moreover, leptin signaling is critical for neural development, as leptin-deficient ob/ob and leptin 
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receptor-deficient db/db mice have reduced brain weight and DNA content - of note, this 
phenotype can be reversed in ob/ob mice by leptin administration (Steppan and Swick 1999). 
This adipocyte-derived hormone was also shown to promote mitosis in many different brain 
regions (Udagawa et al. 2006, Udagawa et al. 2007) and to stimulate the formation of neuronal 
projections among hypothalamic nuclei, thereby influencing the maturation of the hypothalamic 
feeding control circuitry (Bouret and Simerly 2007). Finally, leptin also plays a role in bone 
development, growth and homeostasis (Steppan et al. 2000, Driessler and Baldock 2010), thyroid 
function (Ghamari-Langroudi et al. 2010) and stress response (Ahima and Osei 2004). 
 
2.2. Leptin receptor signaling 
The LepR is the product of the db gene and belongs to cytokine class I receptor family (Myers 
2004). The full-length receptor has similar signaling capacities as Interleukin 6- (IL6)-type 
receptor and its helical structure resembles the structure of this cytokine (Baumann et al. 1996, 
Tartaglia 1997). It has been shown to be expressed in the anterior pituitary gland, granulosa and 
theca cells of the ovarian follicle, several brain regions and other peripheral tissues (Zachow and 
Magoffin 1997, Finn et al. 1998). 
Alternative splicing generates several isoforms of LepRs - to date, six splice variants of this 
receptor have been identified in several species, all of them capable of binding leptin (Chua et al. 
1997, Tartaglia 1997). The short-isoform of the leptin receptor, LepRa, has a truncated 
intracellular domain and is detected in many organs and apparently lacks signaling capability 
(Campfield et al. 1996, Wang et al. 1997). However, it plays a pivotal role in transporting leptin 
across the BBB (Bjorbaek et al. 1998). Of note, the long isoform, LepRb, has the complete 
intracellular domain, mediates signal transduction and is highly expressed in the hypothalamus 
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(Lee et al. 1996, Elmquist et al. 1998, Chan et al. 2002, Zabeau et al. 2003). Other than the 
hypothalamus, leptin acts via the LepRb in the mesolimbic system, to modulate dopamine (DA)-
related behaviors including food motivation, reward and emotion (Figlewicz 2003, Fulton et al. 
2006, Hommel et al. 2006, Leinninger and Myers 2008, Scott et al. 2009, Leshan et al. 2010) 
and in the nucleus of the solitary tract (NST) of the brainstem to contribute to satiety (Robertson 
et al. 2008). Among other events, LepRb signal transduction is triggered by activation of signal 
transducer and activator of transcription (STAT), a protein key for leptin-induced gene 
transcription (Wang et al. 1997). 
Except for LepRa, all other isoforms contain a conserved intracellular proline-rich box1 domain, 
required for recruiting janus tyrosine kinase 2 (JAK2), a tyrosine kinase associated to the 
receptor, which provides the receptor with the required kinase activity for signal transduction 
(Bjorbaek et al. 1997, Ghilardi and Skoda 1997). Thus, following leptin binding to LepRb, JAK2 
is autophosphorylated and activated, promoting the subsequent phosphorylation of three LepRb 
tyrosine residues (Tyr985, Tyr1077, and Tyr1138). Each LepRb tyrosine phosphorylation site 
serve as docking sites for Src homology 2 (SH2) domain containing proteins, so that: Tyr985 
leads to the recruitment of SH2-containing protein tyrosine phosphatase 2 (SHP2), which will 
trigger the activation of extracellular signal-regulated kinase 1/2 (ERK1/2) (Li and Friedman 
1999, Banks et al. 2000, Bjorbaek et al. 2001, Zhang et al. 2004). Alternatively, LepR Tyr985 was 
shown to recruit suppressor of cytokine signaling 3 (SOCS3), thereby attenuating LepRb 
signaling (Banks et al. 2000, Bjorbak et al. 2000, Bjornholm et al. 2007); Tyr1077 recruits 
STAT5 (Gong et al. 2007); and Tyr1138 specifically binds and activates the latent transcription 
factor STAT3 (Vaisse et al. 1996, Eyckerman et al. 1999, Banks et al. 2000, Villanueva and 
Myers 2008). After binding to the LepRb, STAT3 is phosphorylated on tyrosine residue 705 by 
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JAK2. Once phosphorylated, STAT3 dimerizes and translocates to the nucleus to induce 
transcription of a number of genes, including SOCS3, which will in turn negatively feedback on 
LepRb signaling (Zabeau et al. 2003). Importantly, STAT3 is also activated by a variety of 
cytokines, members of the interferon (IFN) and interleukin (IL) families, including IL-6, IL-10, 
IL-2, by tyrosine kinase receptors, granulocyte-colony stimulating factor (G-CSF), epidermal 
growth factor (EGF), ciliary neurotrophic factor (CNTF), among others (Takeda et al. 1998, 
Akira 1999, Levy and Lee 2002).  
LepRb signals by a number of neural pathways, including JAK2/STAT3 (Tartaglia 1997, Banks 
et al. 2000), phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3-K) (Kellerer et al. 1997, 
Niswender et al. 2001) and other signaling pathways, including mitogen-activated protein kinase 
(MAPK) (Rahmouni et al. 2009, Trinko et al. 2011), 5′adenosine monophosphate-activated 
protein kinase (AMPK), and the mammalian target of rapamycin (mTOR) (Robertson et al. 
2008) (For leptin receptor signaling pathways, see Figure 1). 
With respect to LepRb signaling in the modulation of energy balance, it was reported by Zhang 
and coworkers that conditional deletion of SHP2 in the forebrain, with subsequent impairment in 
ERK1/2 activation by LepR, induces obesity in mice, although the specific role of ERK1/2 in 
mediating the feeding effect of leptin needs further clarification (Zhang et al. 2004). Another 
important signaling pathway mediating leptin's effect on energy balance is PI3-K pathway 
(Niswender et al. 2001, Niswender et al. 2003). It was previously demonstrated that ICV 
administration of LY294002, a potent inhibitor of PI3-K signal transduction, prevented leptin-
induced anorexia in rats (Niswender et al. 2001). In addition, it was suggested that JAK2 
activation induces PI3-K activity through the insulin receptor substrate 2 (IRS-2) in the 
hypothalamus (Niswender et al. 2001). As shown in Figure 1, a key pathway downstream of the 
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LepRb by which leptin regulates gene expression and energy homeostasis, involves the 
activation of LepRb-STAT3 signaling pathway (Bjorbaek et al. 1997, Bates et al. 2003, 
Munzberg et al. 2003, Zabeau et al. 2003, Gao et al. 2004). 
In humans, homozygous mutations of the ob gene leading to complete leptin deficiency and 
severe obesity have been described in extremely rare cases. Most obese humans are characterized 
by high circulating leptin levels (Considine et al. 1996) accompanied by leptin-resistance (El-
Haschimi et al. 2000). Clinically, these patients with congenital leptin deficiency due to 
mutations in the ob gene or leptin resistance due to mutations of the db gene are obese due to 
severe hyperphagia (Strobel et al. 1998, Farooqi et al. 2007). Leptin replacement therapy to these 
patients will normalize body weight and food consumption by altering the rewarding value of the 
food and enhancing the response to satiety signals (Farooqi et al. 1999, Farooqi et al. 2007). Of 
note, for the vast majority of leptin-resistant obese humans leptin replacement is largely 
ineffective, inducing little if any weight loss (Heymsfield et al. 1999, Roth et al. 2008). Thus, 
leptin's anorectic effect is attenuated during conditions of high-fat (HF) feeding and diet-induced 
obesity (DIO) (Myers et al. 2012). Among the hypothalamic mechanisms involved in resistance 
to leptin's effect are: a) defects at/or downstream to the LepRb signaling, including impaired 
STAT3 activation; b) induction of inhibitors of leptin signaling by molecules such as SOCS 3 
(Bjorbaek et al. 1999) and protein-tyrosine phosphatase 1B (PTP1B) (Zabolotny et al. 2002); c) 
alterations in leptin's transport across the BBB (Munzberg 2008, Myers et al. 2008). On the other 
hand, conditions such as dieting, which reduce body fat stores, lower plasma leptin levels and 
therefore disinhibit neural circuits driving feeding. Thus, overall leptin serves as a homeostatic 
regulator for long-term food intake and body weight maintenance (Ahima et al. 1996). 
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Figure 1: Leptin receptor signaling pathways 
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2.3. Leptin activates STAT3 signaling in the hypothalamus 
STATs are a family of cytokine-activated signaling proteins that can directly bind to DNA and 
modulate gene transcription (Gao et al. 2004). These proteins are characterized by a specific 
structure consisting of several highly conserved domains: an N-terminal domain, a helical coil 
domain, the DNA-binding domain, a linker domain, the dimerization domain and a 
transactivation domain (Horvath et al. 1995, Mao et al. 2005). The dimerization domain contains 
a SH2 domain, required for STATs to be recruited to the phosphorylated receptors and for the 
subsequent formation of dimers (Shuai et al. 1994). Thus, after its recruitment to the receptor, 
STATs becomes phosphorylated on a single tyrosine residue by the JAKs. The following events 
are: dimerization by reciprocal interaction between phophotyrosine-SH2 domain and nuclear 
translocation to induce target genes (Levy and Darnell 2002). Of note, all STATs are dimeric 
proteins in the absence of activating tyrosine phosphorylation (Braunstein et al. 2003). 
Different STAT proteins were identified in mammals: STAT1, STAT2, STAT3, STAT4, 
STAT5A, STAT5B, STAT6. However, STAT3 has the most pleiotropic functions, playing an 
important role in embryogenesis, macrophage function, immune regulation, glial and neuron 
differentiation, among others (Bonni et al. 1997, Niwa et al. 1998, Takeda et al. 1999, Takizawa 
et al. 2001, Levy and Lee 2002, Moon et al. 2002, Yoo et al. 2002, Welte et al. 2003). 
Moreover, STAT3 is widely distributed throughout the CNS, and has been well implicated in 
glial and neuronal differentiation (Bonni et al. 1997, Takizawa et al. 2001, Moon et al. 2002) 
and, most importantly, in leptin-mediated energy homeostasis (Bates et al. 2003, Bates et al. 
2004, Gao et al. 2004). STAT3 has a critical tyrosine residue (Tyr 705) in the SH2 region, which 
is essential for its activation (Calo et al. 2003). When phosphorylated/activated, STAT3 induces 
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the transcription of several genes, including SOCS3, which inhibits JAK2/STAT3 signaling and 
triggers central leptin resistance (Bjorbaek et al. 1999, Flier 2004, Howard et al. 2004). 
Of note, STAT3 can be activated by a number of cytokines and stressors, via receptor-associated 
kinases (Akira et al. 1994, Wegenka et al. 1994, Zhong et al. 1994, Vaisse et al. 1996, 
Wishingrad et al. 1997, Peterson et al. 2000). Similarly, leptin can activate a number of STAT 
proteins (i.e.: STAT3, STAT5 and STAT6) (Ghilardi et al. 1996). However, only STAT3 is 
activated in the hypothalamus following leptin administration (Darnell 1996, Vaisse et al. 1996), 
giving strength to the notion that STAT3 plays a pivotal role in leptin's action in the 
hypothalamus to mediate energy balance. 
Consistent with leptin's crucial role in the regulation of energy homeostasis and reproduction, 
neural STAT3 mutant mice (STAT3 N-/-) causes all of the major phenotypes of leptin signaling, 
recapitulating the obese and infertile phenotype of both LepRb deficient db/db mice and leptin 
deficient ob/ob mice (Gao et al. 2004). Of note, STAT3 N-/- are leptin-resistant, have reduced 
energy expenditure, decreased linear growth, increased corticosterone levels, infertility and 
became hypothermic after exposure to fasting or cold stress (Gao et al. 2004). Furthermore, mice 
with LepRb point mutations, that do not bind STAT3, are hyperphagic and obese with reduced 
energy expenditure. However, these mice are less hyperglycaemic as compared to db/db mice, 
and have normal reproductive and growth function (Bates et al. 2003, Bates et al. 2004). 
Importantly, the major role of STAT3 in energy homeostasis is further supported by evidence 
that other cytokines that activate STAT3, such as CNTF and IL-6, also decrease body weight 
(Lambert et al. 2001, Wallenius et al. 2002). 
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3. The mesolimbic and nigrostriatal dopamine systems 
3.1. The ventral tegmental area (VTA) and substantia nigra (SN): receptors and 
neurotransmitters 
In the ventral midbrain, areas containing dopaminergic neurons were classified into three nuclei: 
A8 cells in the retrorubral field (RRF), A9 cells in the SN, and A10 cells in the VTA and related 
nuclei (Oades and Halliday 1987, German and Manaye 1993). Neurons containing TH-positive 
cell bodies are mainly found in all VTA (Swanson 1982) and SN regions (mostly SN pars 
compacta) (Aumann et al. 2011). Of note, TH is the rate limiting enzyme in the synthesis of the 
neurotransmitters DA and norepinephine (NE), whose distribution in the midbrain parallels the 
distribution of DA (Bannon and Roth 1983). Eight major dopaminergic pathways were identified 
by dissecting DA circuits in the brain and the specific locations of the DA receptors in these 
circuits (Björklund et al. 1984). In the present section, I will focus on two of these pathways that 
are especially important: the nigrostriatal and the mesolimbic pathway, described below. 
The nigrostriatal and mesolimbic systems are functionally interconnected (Haber et al. 2000, 
Everitt and Robbins 2005) and play complementary roles in the hedonic regulation of food 
intake, reward, motivation, emotion-related behavior, learning and locomotion (Barbeau 1974, 
McDonald and White 1993, D'Ardenne et al. 2008, Phillips et al. 2008, Smith and Villalba 
2008). The SN lies in the midbrain immediately dorsal to the cerebral peduncles (Frankle et al. 
2006) and consists of two parts with very different connections and functions: the dorsal part of 
the SN, known as SN pars compacta (SNc), contains most of the DA neurons of the A9 area 
(Anden et al. 1964, Dahlstroem and Fuxe 1964) and projects to the striatum; the ventral part, or 
SN pars reticulata (SNr), also contains some DA cells and comprises GABA neurons which 
projects to the thalamus (Deniau et al. 1978, Lynd-Balta and Haber 1994, Yung et al. 1998, Joel 
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and Weiner 2000). The main function of the SNc is motor control (Hodge and Butcher 1980), 
evidenced by the fact that degeneration of SNc DA neurons leads to the muscle tremors of 
Parkinson's disease (Kim et al. 2003, Pioli et al. 2008). However, besides locomotion, SN is also 
implicated in other behaviors such as addiction (See et al. 2007), reward-oriented behaviors 
(Hikosaka et al. 1993, Sato and Hikosaka 2002) and learning (Ljungberg et al. 1992, Da Cunha 
et al. 2003, Da Cunha et al. 2006). The VTA represents a significant portion of the 
extrapyramidal system of the basal ganglia, and is home to one of the major populations of DA 
cells in the brain (Kalivas 1993, Fields et al. 2007). It is located close to the midline on the floor 
of the midbrain, and surrounded by the SN (laterally), mammillary bodies and posterior 
hypothalamus (rostrally), and by the pons and hindbrain (caudally) (Oades and Halliday 1987). 
The VTA is composed by approximately of 55-60% dopaminergic, 5-33% GABAergic and 1-
15% of glutamatergic neurons (Kalivas 1993, Margolis et al. 2006, Yamaguchi et al. 2007, Dobi 
et al. 2010). Of note, there's evidence indicating that some DA neurons may also use glutamate 
as a neurotransmitter (Descarries et al. 2008). Selective stimulation and intracellular recording of 
synaptic responses of VTA DA neurons suggested that both DA and glutamate were coreleased 
by the same cell (Sulzer et al. 1998, Joyce and Rayport 2000). Furthermore, the ability of DA 
neurons to release glutamate was explained by demonstrating that they selectively express 
VGLUT2, one of the three vesicular glutamate transporters (Dal Bo et al. 2004). 
The VTA receives afferents from a numbers of brain regions, such as the amygdala (Wallace et 
al. 1992), the nucleus accumbens (NAc) (Heimer et al. 1991), the prefrontal cortex (PFC) 
(Sesack and Pickel 1992), the dorsal raphe nucleus (DRN) (Gervais and Rouillard 2000), the 
medial habenular nucleus (MHb) (Cuello et al. 1978), the lateral preoptic area (LPOA) and the 
medial hypothalamus (Swanson 1982). The major neuronal efferents of the VTA are divided into 
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mesolimbic and mesocortical projections. Mesolimbic projections include outputs to the NAc, 
tuberculum olfactorium (OT), amygdala, basal nucleus of the stria terminalis (BNST) and lateral 
septum, hippocampus, the medial part of the thalamus and supraoptic nucleus of the 
hypothalamus. Mesocortical projections include outputs to the prefrontal, entorhinal, cingulate 
and occipital cortices, in addition to the periaqueductal gray, parabrachial nucleus, locus 
coeruleus and dorsal and medial raphe nuclei (Swanson 1982, Oades and Halliday 1987, Pierce 
and Kumaresan 2006) (For mesocorticolimbic and nigrostriatal systems, see Figure 2). 
Dopamine's action on neuronal circuits depends on two other neurotransmitters: glutamate and 
GABA (Beaulieu and Gainetdinov 2011). The main inhibitory inputs to the VTA are GABAergic 
and includes local interneurons and projections from the NAc, ventral pallidum and 
pontomesencephalic tegmentum (PMT) (Mao and McGehee 2010). As for the excitatory inputs 
to the VTA, the great majority are glutamatergic projections from the PFC, BNST, amygdala and 
also from the PMT (Mao and McGehee 2010). In fact, projections from the PMT are both 
GABAergic and glutamatergic and play an important role in reward-relevant behavior (Lanca et 
al. 2000, Corrigall et al. 2002). 
Dopamine's physiological actions are mediated by G protein-coupled receptors, which according 
to their structural, pharmacological, and biochemical properties were divided into D1 and D2 
classes of DA receptors (Andersen et al. 1990, Tiberi et al. 1991, Niznik and Van Tol 1992, 
Sokoloff et al. 1992, Civelli et al. 1993, Vallone et al. 2000). Dopamine signals through D1-like 
receptors (D1R) or D2-like receptors (D2R) to stimulate or inhibit, respectively, regional brain 
activity (Girault and Greengard 2004, Volkow et al. 2013). Among D1R are: DA receptors D1 
and D5; among D2R are: DA receptors D2, D3 and D4 (Girault and Greengard 2004). According 
to autoradiography studies, D2R are expressed both post-synaptically on DA target cells and pre-
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synaptically on DA neurons (Bouthenet et al. 1987, Sales et al. 1989, Chen and Pan 2000, Pickel 
et al. 2002, Sokoloff et al. 2006, Rondou et al. 2010). D2R are known to inhibit cyclic adenosine 
monophosphate (cAMP) production from adenylate cyclase. Conversely, the D1R family, 
activates G proteins to stimulate cAMP production from adenylate cyclase. These receptors are 
found post-synaptically on DA-receptive neurons (Beaulieu and Gainetdinov 2011). Moreover, 
D1R has been shown to be involved in the direct membrane depolarization of cholinergic cells 
(Aosaki et al. 1998, Pisani et al. 2000) and fast-spiking GABAergic interneurons (Bracci et al. 
2002). 
Dopamine receptors are highly expressed in the periphery and the CNS. In the brain, D1R is 
mostly expressed in striatal regions, NAc, SN, olfactory bulb, PFC and amygdala (Missale et al. 
1998, Gerfen 2000, Rankin and Sibley 2010). As for the D2R expression, it is mostly expressed 
in the striatum, NAc, olfactory tubercle, SN, VTA, hypothalamus, cortex, hippocampus, septum 
and amygdala (Missale et al. 1998, Gerfen 2000, Vallone et al. 2000). 
Previous neuroanatomical and functional studies have detected the presence of GABAA and 
GABAB receptors in the VTA, densely distributed in the paranigral nucleus (Bayer and Pickel 
1991, Churchill et al. 1992, Ciccarelli et al. 2012). Importantly, a large interconnected network 
of GABAergic neurons in the VTA projects to the PFC and NAc (Van Bockstaele and Pickel 
1995, Carr and Sesack 2000). 
Among other neurotransmitters affecting DA neurotransmission in the midbrain, a subpopulation 
of DA neurons containing neurotensin (NT) and cholecystokinin (CCK) were already described 
in this region (Seroogy et al. 1987, Schalling et al. 1990, Kiyama et al. 1991, Binder et al. 2001). 
Moreover, the presence of nicotinic, endocannabinoid (ECB), serotonin (5-HT), N-methyl-D-
aspartate (NMDA), glutamate and Mu opioid receptors were also detected in the VTA and NAc 
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(Doherty and Pickel 2000, Swanson and Kalivas 2000, Klink et al. 2001, Zheng and Johnson 
2003, Pickel et al. 2004). Of note, 5-HT signaling was previously demonstrated to tightly 
regulate a number of DA-related functions in both inhibitory and excitatory ways (Fletcher et al. 
1999, Fletcher et al. 2012). 
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Figure 2: Schematic representation of mesocorticolimbic and nigrostriatal systems. 
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3.2. The dopaminergic reward circuit, feeding and running behavior 
Rewards are defined as those objects or goals which we will work to acquire despite of time, 
energy or effort; simply because they are highly pleasurable (Schultz 2010). Rewards typically 
serve as reinforcers. By definition, a reinforcer is something that, when presented after a 
behavior, causes the probability of that behavior's occurrence to increase. Importantly however, 
not all rewards are reinforcers and not all reinforcers are rewards. A reward can be defined as a 
reinforcer only if it increases the probability of behaviors that lead to the procurement and/or 
consumption of the reward (Fulton 2010). 
Given the importance of rewards to basic vital functions such as eating, drinking and 
reproduction, it has been proposed that there exists a neural system responsible for the reward 
processing (Shizgal 1997). This neural system was identified as the mesolimbic DA pathway, 
which responds to rewards through the neurotransmitter DA (Arias-Carrion and Poppel 2007, 
Phillips et al. 2008). 
As described in a previous section, the mesolimbic pathway is one of the dopaminergic pathways 
in the brain whose neurons originate in the VTA and connect to the limbic system, including the 
NAc, the amygdala, the hippocampus and the PFC (Goodman 2008). Dopaminergic activity 
within the VTA depends on both inhibitory and excitatory inputs that are critically involved in 
brain mechanisms of reward, reinforcement and emotional arousal (Wise and Rompre 1989). The 
VTA also send dopaminergic projections to several brain areas that are part of the so-called 
"brain reward regions", which are interconnected in a highly complex circuitry allowing 
discerning and reacting to both reward and aversive stimuli in the environment (Russo and 
Nestler 2013). Of note, dopaminergic projections from VTA to the NAc represent the best 
characterized reward circuit in the brain (Koob 1992, Russo and Nestler 2013). The 
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identification of this circuit dates back to 1954, when the Canadian researchers James Olds and 
Peter Milner discovered that rodents will learn to work for direct electrical stimulation of certain 
brain regions, and such stimulation seemed to be highly rewarding (Olds and Milner 1954) - this 
experimental setup is referred to as brain-stimulation-reward (BSR). Similarly, there is data 
showing that brain self-stimulation also exert a powerful feeling of pleasure in humans (Bishop 
et al. 1963). Electrical brain stimulation is considered as one of the most powerful rewards since 
it directly activates the reward circuitry (Wise and Rompre 1989). BSR studies demonstrated that 
electrical stimulation of reward-related areas in the brain was rewarding and reinforcing, and 
thus, it has provided a useful tool for understanding how natural rewards are processed by the 
brain and the anatomical structures and neural mechanisms associated with reward circuitry 
(Rolls 1975, Wise 2002). In addition, BSR experiments provided first evidence that the reward 
circuitry is subdivided along functional and anatomical lines. Of note, besides playing a role in 
recognizing rewards in the environment and initiating their consumption, brain reward circuitry 
also modulates pleasure, motivation, value, and decision making (Koob and Le Moal 2008, 
Pujara and Koenigs 2014). 
The "Dopamine hypothesis" postulates that DA, released in the mesolimbic pathway, promotes 
reward-related activities (Fibiger et al. 1987, Di Chiara and Imperato 1988). An extension of this 
hypothesis is the "Reward Deficiency Syndrome", stating that animals will engage in behaviors 
known to increase DA release solely to maintain high levels of this neurotransmitter (Palmiter 
2007). In fact, there are two hypothesis on how DA and reward sensitivity influences the 
expression of motivated behaviors: 1) The above mentioned "Reward Deficiency Syndrome", 
which hypothesises that individuals with low dopaminergic function seek rewarding substances 
or behaviors to increase endogenous DA levels and improve mood (Blum et al. 2000); 2) 
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Conversely, when reward hypersensitivity is associated with increased dopaminergic 
transmission, individuals may feel more motivated to seek for additional reward stimuli solely 
due to the fact that a specific reward is such a powerful reinforcer (Davis et al. 2008). 
As for the role of DA signaling in the pursuit of natural rewards, such as food, it was previously 
described that DA signaling in the NAc mediates the reinforcing effects of food (Wise 2008). On 
the other hand Baldo and coworkers demonstrated that bilateral injections of either D1R or D2R 
antagonist into the NAc show little effect on ad libitum food intake, although according to the 
authors, an important caveat to this interpretation is that the doses of D1R or D2R antagonist 
used may not have been high enough to completely block the effects of DA in food consumption 
(Baldo et al. 2002), suggesting that higher antagonist doses would have decreased feeding, 
Furthermore, when DA is depleted by intracranial injection of the DA-specific neurotoxin 6-
hydroxydopamine (6-OHDA) rodents develop severe motivational and regulatory deficits in 
feeding and drinking and will die of starvation if DA is not replaced (Ungerstedt 1971, Zigmond 
and Stricker 1972, Marshall et al. 1974). Complementary to these studies are those on DA-
specific deficient mice, suggesting that DA is pivotal for vital functions such as feeding, drinking 
and locomotion, but is not required for the development of neural circuits involved in these 
behaviors (Zhou and Palmiter 1995). In regards to feeding behavior, rodents lacking DA in 
dopaminergic neurons (but retaining noradrenergic neurons) can execute behaviors necessary to 
seek and ingest food, but they do not eat enough to survive (Szczypka et al. 1999). In light of the 
"DA hypothesis", this could be explained by a lack of motivation to respond to the presence of 
food - i.e.: the animal no longer shows goal-directed behavior because it does not anticipate a 
reward. 
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In fact, food has long been known as a powerful behavioral modulator. For example, behaviorist 
Edward Thorndike used food reward to motivate hungry animals learning to escape from early 
operant chamber (Thorndike 1898). Consistent with this, a study using an appetitive operant 
conditioning paradigm demonstrated that dopaminergic transmission within the NAc is required 
for food-seeking behavior through mechanisms related to hedonic value of food, suggesting DA 
as an important component of food motivation (Zhang et al. 2003). Similarly, dopamine 
transporter (DAT) KO mice, that show chronically elevated extracellular DA, display increased 
goal-directed behavior for food reward (Cagniard et al. 2006). Moreover, mesoaccumbens DA 
signaling has been implicated in behavioral responses to cues that predict reward and 
mechanisms involved in addiction (Robinson and Berridge 2003, Vezina 2004, Nicola et al. 
2005, Hyman et al. 2006). Taken together, these studies suggest that DA is important to acquire 
information about cues and stimuli related to food rewards and to the behavioral responses to 
obtain these rewards (goal-directed behavior). However, apparently this neurotransmitter is not 
involved in the events related to food consumption per se. 
Associations between the dopamine reward pathway and physical activity behavior have been 
found both in animal models and in humans. Consistent with that, voluntary wheel running 
exercise has two relevant components: a motor (movement) component and a motivational 
(rewarding) component (Knab and Lightfoot 2010), and has been suggested as a strong natural 
reinforcer and as such, a self-rewarding behavior. Moreover, voluntary exercise is related to 
changes in gene transcription in reward circuitry (Greenwood et al. 2011). Interestingly, a role 
for the DA system on the regulation of motivation for physical activity was previously described 
in studies of addiction and feeding showing that some animals will engage in physical exercise in 
order to obtain food (Pirke et al. 1993, Casper 2006, Palmiter 2007). Likewise, animals will 
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increase drinking and/or eating when these activities were conditioned with the opportunity to 
run on wheels (Premack et al. 1964), demonstrating that voluntary wheel running is a highly 
motivated behavior. 
Notably, goal-oriented behaviors that impose high energy costs, such as running exercise are 
often motivated by psychological changes associated with prolonged physical activity, better 
known as "runner's high" (Panksepp et al. 2002, Dietrich and McDaniel 2004). Humans usually 
report this feeling during or right after long distance running, and it likely plays a major role in 
humans’ motivation to keep running. In addition, rodents will readily begin to run when a wheel 
is introduced (Wagemaker and Goldstein 1980, Partin 1983, Eikelboom and Mills 1988, Looy 
and Eikelboom 1989), will indeed work by lever pressing to gain access to a running wheel 
(Belke 2006, Belke 2006, Belke and Christie-Fougere 2006) and spend more time in a place 
previously associated with the aftereffects of running (Lett et al. 2000, Lett et al. 2001), 
indicating that voluntary wheel running activity is naturally rewarding and reinforcing. 
Interestingly, rats trained to run long distances in a daily basis showed withdrawal signs, such as 
displaced aggression (i.e.: digging and biting in the test cage), when access to the running wheels 
is denied (Hoffmann et al. 1987). In addition, response to short-term wheel running deprivation 
is similar to response to short-term deprivation on other reinforcers (such as food): rodents will 
compensate with an elevation in the behavior when access is restored (Mueller et al. 1999). In 
agreement with this data, other reports demonstrated that a couple of days of running deprivation 
for rats with extensive wheel experience will induce a substantial increase in their subsequent 
daily running (Hill 1956, Hill 1958, Hill 1961, Mueller et al. 1997). Together, these data point to 
the conclusion that voluntary running exercise is a powerful natural reinforcer and shares neural 
reward pathways with other reinforced behaviors such as food (Chaouloff 1989). Consistent with 
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this idea, mice selectively bred for high wheel running exhibited increased running motivation 
mediated by reduced D1R signaling in the midbrain (Rhodes and Garland 2003) and as a result 
of this alteration, high-running mice are more motivated than the respective controls to seek for 
"running reward" (Rhodes et al. 2005). Other studies performed on this same mice suggest that 
selective breeding based on wheel running rates raise reward threshold in high-running mice by 
reducing the reinforcing value of shorter running durations (Belke and Garland 2007). The 
altered DA transmission in mice bred for high wheel running exercise can probably be explained 
by a decrease in DA concentration, decreased dopamine receptor densities, or reduced second-
messenger signaling (Rhodes et al. 2005). 
Besides being rewarding, when taken to extremes, voluntary wheel running activity can develop 
into an addictive-like behavior, as suggested by data obtained from surveys among highly 
committed human runners, reporting: 1) runner's high (a feeling or euphoria after a strenuous 
bout of exercise), 2) tolerance (the need to increase the distance run to achieve feelings of well-
being), 3) addiction (difficulties in job performance and social interactions) 4) symptoms of 
withdrawal, including depression, irritability, and anxiety, when prohibited from running (Rudy 
and Estok 1989, Chapman and De Castro 1990, Furst and Germone 1993) and by the number of 
parallels between wheel running activity and drug-induced reward. For example, rats with a 
tendency toward addiction develop compulsive running, probably due to a downregulation of 
dopamine receptors (Werme et al. 1999). Moreover, similar to drugs of abuse, chronic running is 
related to increased delta FosB expression in the NAc of addiction-prone Lewis rats (Werme et 
al. 2002). Of note, the transcription factor delta FosB has been implicated in the development of 
drug addiction and control of the reward system in the brain (McClung and Nestler 2003, Nestler 
2008). Importantly, there is growing data demonstrating that running and drugs of abuse activate 
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overlapping neural systems (Kanarek et al. 1998, Werme et al. 2000, Ferreira et al. 2006). For 
example, endurance exercise stimulates the release of endogenous opioid peptides in rats and 
humans (Christie and Chesher 1982, Janal et al. 1984, Werme et al. 2000, Angelopoulos 2001) 
and wheel running attenuates the rewarding effects of morphine in a conditioned place 
preference test (Lett et al. 2002).Providing further evidence of the parallel between addiction and 
voluntary exercise, experiments conducted in humans demonstrated that bouts of moderate 
exercise can help attenuate symptoms of daily cannabis use, nicotine and alcohol withdrawal 
(Ussher et al. 2001, Daniel et al. 2004, Ussher et al. 2004, Buchowski et al. 2011). Moreover, 
the beneficial effects of exercise as an adjunct in treatment of drug addiction was previously 
suggested to be related to its ability to facilitate DA transmission, normalize glutamatergic and 
dopaminergic signaling, and reverse drug-induced changes in chromatin via epigenetic 
interactions with BDNF in the reward pathway (Lynch et al. 2013). Thereby, as a natural reward, 
voluntary running exercise modulates the brain reward circuitry and changes the rewarding effect 
of addictive substances, thus contributing to reduce the incidence and severity of drug-addictive 
behavior. 
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4. Leptin signaling in the mesolimbic dopamine system 
4.1. Leptin activates STAT3 signaling in extra-hypothalamic brain regions 
Besides being influenced by satiety factors such as leptin, eating behavior is also modulated by 
dopaminergic neurons of the mesolimbic system (Cota et al. 2006, Fulton 2010, Fernandes et al. 
2013). It is very well appreciated that LepRb activation in hypothalamic regions triggers STAT3 
recruitment, phosphorylation and nuclear translocation to induce specific gene transcription and 
influence energy balance (Li and Friedman 1999). However, leptin also induces STAT3 
phosphorylation at residue Tyr 705 in extra-hypothalamic regions. 
More recently, a number of reports have focused on the role of LepRb signaling in brain sites 
other than the hypothalamus, including the hippocampus and VTA (Fulton et al. 2006, Hommel 
et al. 2006, Harvey 2007, Robertson et al. 2008), where leptin activates LepRb-STAT3 in both 
DA and GABAergic neuronal populations (Fulton et al. 2006). Consistent with this, LepRb 
mRNA was already detected in the VTA, SN, DRN, thalamus, cerebellum, NTS, among other 
areas (Elmquist et al. 1998, Figlewicz et al. 2003, Fulton et al. 2006, Hommel et al. 2006, Myers 
et al. 2009, Scott et al. 2009). Most importantly, colocalization of the LepRb and the 
dopaminergic marker TH was observed in different brain regions, including the hypothalamic 
preoptic nucleus, ARC, paraventricular hypothalamic nuclei (PVN) and caudal linear nucleus 
(Cli) of the midbrain. In addition, a small population of neurons coexpressing LepRb and TH 
was found in the DRN, periaqueductal gray (PAG), rostral linear nucleus (RLi) and retrorubral 
field (RRF) nucleus (Hakansson et al. 1998, Hay-Schmidt et al. 2001, Scott et al. 2009). 
However, not all these LepRb-expressing DA cells can sense peripheral leptin, as observed by 
lack of STAT3 phosphorylation following systemic leptin administration (Scott et al. 2009). In 
fact, besides the VTA/SN area (Figlewicz et al. 2003, Fulton et al. 2006, Hommel et al. 2006), 
LepRb- expressing DA neurons only induces pSTAT3 in the PAG and DRN, suggesting that 
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while many TH neurons express LepRb, very few cells are leptin-responsive (Scott et al. 2009) 
(For LepRb signaling in the midbrain, see Figure 3). 
Interestingly, evidence for the significant role of DA in leptin action, comes from studies 
performed in mice lacking both leptin and DA. Contrary to leptin deficiency alone (ob/ob mice), 
mice lacking both leptin and DA are hypophagic and lean, developing obesity only when treated 
with the DA precursor L-DOPA. These findings are suggestive that dopaminergic 
neurotransmission is required for feeding in ob/ob mice (Szczypka et al. 2000). Moreover, ob/ob 
mice exhibit a substantial reduction in NAc DA release, do not sensitize to the locomotor-
stimulating effects of AMPH (Fulton et al. 2006) and have their obese hyperphagic phenotype 
reversed by peripheral administration of D1R and D2R agonists (Scislowski et al. 1999). 
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Figure 3: Schematic representation of leptin receptor signaling in dopaminergic neurons of 
the midbrain. 
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4.2. Leptin and locomotion 
Other than feeding, leptin influences a wide range of DA-related behaviors, including 
ambulatory activity (Fulton et al. 2006, Hommel et al. 2006) and voluntary wheel-running 
exercise (Bates et al. 2003, Coppari et al. 2005, Shapiro et al. 2011, Verhagen et al. 2011). 
However, there is inconsistency in the literature concerning leptin's effect on locomotion. Leptin-
deficient ob/ob mice have reduced ambulatory activity (Clark and Gay 1972, Dauncey 1986) and 
reduced voluntary wheel running exercise (Jurgens et al. 2006), which can be reversed by leptin 
administration (Pelleymounter et al. 1995, Coppari et al. 2005, Fulton et al. 2006, Huo et al. 
2009, Morton et al. 2011). Similarly, either an ICV leptin treatment (Ainslie et al. 2001, Choi et 
al. 2008) or leptin overexpression in the brain increases voluntary running exercise in rodents, 
while a partial blockade of LepRb diminishes this behavior (Matheny et al. 2009). On the other 
hand, other studies reported that an intraperitoneal leptin treatment in fed C57Bl/6 wild-type  
mice, did not affect either ambulatory activity or voluntary exercise (Pelleymounter et al. 1995, 
Morton et al. 2011). In contrast, leptin administration reduces hyperactivity in rodents (Exner et 
al. 2000, Morton et al. 2011, Verhagen et al. 2011) and lack of LepRb signaling in the VTA 
increases locomotion in male rats (Hommel et al. 2006). 
Several factors may contribute to these inconsistent reports, including animal's physiological 
variation in leptin levels (Morton et al. 2011). Interestingly, fasting, a condition characterized by 
reduced leptinemia, is known to increase locomotor activity and voluntary exercise in rodents 
(Sakkou et al. 2007, Morton et al. 2011). Consistent with these findings, leptin was shown to 
abolish hyperactivity triggered by severe caloric restriction in both rodents and humans (Exner et 
al. 2000, Hebebrand et al. 2003). 
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The mechanisms involved in fasting-induced hyperactivity remain poorly elucidated and may 
represent a manifestation of increased food seeking behavior, driven by a reduced leptin 
signaling (Overton and Williams 2004, Williams et al. 2004). Alternatively, it may also involve 
increased hyperactivity-induced DA transmission in the reward circuitry (Mathes et al. 2010). 
However the specific role of leptin in the modulation of ambulatory activity and voluntary 
running exercise as well as the downstream signaling mechanisms needs to be further clarified. 
 
4.3. The effect of leptin on reward 
Observations that LepRb is expressed in the brain reward circuitry (Elmquist et al. 1998, 
Figlewicz et al. 2003) strongly suggest that there is a crosstalk between energy regulatory signals 
and the mesolimbic system. 
Consistent with the notion that leptin influences the activity on neural circuits controlling food 
intake to impair the perception of food rewards, animal studies using the palatable food self-
administration paradigm demonstrated that leptin inhibits motivated behavior for palatable food 
(Figlewicz 2003) and decreases operant responding for sucrose (Figlewicz et al. 2006, Davis et 
al. 2008). Furthermore, leptin reverses CPP for both sucrose and HF diet (Figlewicz et al. 2001, 
Figlewicz et al. 2004) and rodents fed a HF diet showed reduced CPP for AMPH (Davis et al. 
2008). Notably, a human study using functional magnetic resonance imaging (fMRI) 
demonstrated that leptin administration to patients with congenital leptin deficiency increases the 
ability to discriminate between the rewarding properties of food (Farooqi et al. 2007), further 
highlighting the notion that leptin markedly affects food reward. 
With respect to leptin's role in rewards other than food, it was previously reported that leptin 
decreases rewarding electrical brain stimulation (Fulton et al. 2000, Fulton et al. 2004), evoked 
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DA release in the NAc (Krugel et al. 2003) and inhibits DA neuronal firing (Hommel et al. 
2006). In addition, leptin influences sexual motivation (Wade et al. 1997, Schneider 2006, 
Schneider et al. 2007) and drug self-administration. For example, this adipocyte hormone was 
shown to attenuate the effect of food restriction to cause heroin relapse (Shalev et al. 2001) and 
increased response to psychostimulant drugs, such as AMPH (Hao et al. 2004, Fulton et al. 
2006), suggesting an excitatory role of leptin on reward pathways. Moreover, obese individuals 
self-administer drugs of abuse less often than lean individuals (Davis et al. 2010), suggesting a 
potential role for leptin in drug reward. 
As previously mentioned in this thesis, voluntary wheel running exercise is a naturally rewarding 
and reinforcing behavior and shares similar neurobehavioral characteristics with either drugs or 
foods as reinforcers (Pierce et al. 1986, de Visser et al. 2007). Although a role for leptin in the 
modulation of running reward has yet to be described, Girard and coworkers reported that mice 
selectively bred for high wheel running activity have reduced plasma leptin levels which 
correlates with increased running speed and distance (Girard et al. 2007), suggesting enhanced 
motivation for foraging behavior (Exner et al. 2000). Alternatively, the low body fat and 
hypoleptinemia observed in high-runner rodents could be explained by "reward substitution", 
meaning that for these rodents, the rewarding value of running became much greater than the 
rewarding value of food (Meek et al. 2012). This "reward substitution" was also observed in 
studies conducted by Scarpace and co-workers, demonstrating that wheel running activity 
reduces the preference of rodents for a HF diet and modulates LepRb-STAT3 signaling in the 
brain reward circuitry (Scarpace et al. 2010). Thus, it is possible that, in the case of high-runner 
rodents, voluntary running is a highly valued reward, which can be even greater than food 
reward and is also modulated by leptin. Important to remember that mice bred for high rates of 
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running wheel activity have dysregulation of DA system in the brain, which is linked to a 
number of aberrant behaviors, such as addiction, hyperphagia and compulsive exercise (Mathes 
et al. 2010) 
Leptin's ability to reduce reward-related behaviors occurs via an interaction with midbrain DA 
signaling pathways (Carr 2002). However, the specific cells and signaling pathways mediating 
the actions of leptin in the mesolimbic DA reward circuit remain to be better characterized. 
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5. Leptin's role in emotion and mood 
The localization of the LepRb in limbic structures implicated in the control of mood and 
emotion, such as the hippocampus, cortex and amygdala, suggests a potential role for leptin in 
emotional behavior (Mercer et al. 1996, Elmquist et al. 1998, Leshan et al. 2006, Scott et al. 
2009). Consistent with that, there is data showing that this adipocyte-derived hormone affects 
emotional behavior via its action in limbic regions (Harvey 2007). Moreover, analyses of leptin-
induced c-fos mRNA expression revealed a link between behavioral actions of leptin and 
neuronal activity of specific limbic areas, particularly the hippocampus (Lu et al. 2006). 
Providing a connection between mood disorders and adiposity signals, many reports suggested 
that leptin has antidepressant-like properties (Charnay et al. 2000, Lu et al. 2006, Lu 2007, Garza 
et al. 2012, Guo et al. 2012, Milaneschi et al. 2012, Guo et al. 2013). Leptin administration 
reduces behavioral despair in rats via its action in the hippocampus (Sahay and Hen 2007) and 
stimulates hippocampal neurogenesis - a feature shared by antidepressants (Santarelli et al. 
2003). In addition, ob/ob mice exhibited a depressive-like behavior in the forced-swim test 
(FST), as compared to their lean littermates (Collin et al. 2000), and peripheral leptin 
administration improved behavioral despair in rats (Lu et al. 2006). Briefly, FST or Porsolt test 
is a well characterized model used to screen depression-like behavior in rodents (Porsolt et al. 
1978). 
Chronic stress is a well known trigger for depression in humans (Lu 2007). In agreement, rodents 
exposed to chronic unpredictable stress or chronic social defeat stress showed decreased plasma 
leptin levels and increased despair, which was reversed by systemic leptin administration (Lu et 
al. 2006). In a more recent study, Yamada and coworkers demonstrated that peripheral leptin 
administration reduces depressive-like behavior in lean mice via an upregulation of brain derived 
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neurotrophic factor (BDNF) in the hippocampus (Yamada et al. 2011). Importantly, BDNF 
signaling in the hippocampus has been strongly implicated in the control of depression 
(Shirayama et al. 2002, Karege et al. 2005). Similarly, lack of LepRb signaling in the dorsal 
cerebral cortex and in the dentate gyrus in the hippocampus, also increases behavioral despair in 
mice (Guo et al. 2012). Furthermore, plasma leptin levels are reduced either in humans with 
major depression or in rodents with depression-like behavior, and both peripheral and 
hippocampal administration of this adipocyte hormone improved symptoms (Kraus et al. 2001, 
Atmaca et al. 2002, Westling et al. 2004, Jow et al. 2006, Lu et al. 2006). Consistent with these 
findings, post-mortem studies of depressed patients who committed suicide revealed a 
downregulation of leptin receptors in the frontal cortex (Lalovic et al. 2010). 
Depressive disorder can often coexist with other mood disorders, such as anxiety (Sartorius et al. 
1996). Providing another means of influencing the mesolimbic DA system, Liu and coworkers 
demonstrated that leptin has anxiolytic properties such that lack of LepRb signaling specifically 
in DA neurons induces an anxiogenic phenotype and increases burst firing of DA and D1R 
signaling in the central amygdala (CeA) (Liu et al. 2010, Liu et al. 2011). In agreement with that, 
both leptin receptor- (db/db) and leptin-deficient (ob/ob) mice displayed an anxiogenic 
phenotype (Finger et al. 2010, Dinel et al. 2011), which, in the case of the ob/ob mice, can be 
ameliorated by systemic leptin treatment (Asakawa et al. 2003). Providing further evidence of 
leptin as a neurotrophic hormone with anxiolytic and antidepressant properties, there is literature 
showing that depression and anxiety are common illnesses in patients with disorders 
characterized by hypoleptinemia, such as anorexia nervosa (Braun et al. 1994, Grinspoon et al. 
1996, Pollice et al. 1997, Holtkamp et al. 2004, Hebebrand et al. 2007) and functional 
hypothalamic amenorrhoea (Fava et al. 1984, Warren et al. 1999). Furthermore, Lawson and 
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coworkers observed that low leptin levels are associated with increased symptoms of anxiety in 
women, independently of total body fat mass (Lawson et al. 2012). 
In spite of all these findings, the neural pathways as well as the specific functional role of leptin 
receptor signaling in midbrain DA neurons in the regulation of emotional behavior needs further 
clarification. 
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6. Objectives 
6.1. First Objective 
Our first objective was to investigate whether STAT3 signaling in DA neurons could modulate 
the impact of leptin on feeding, food-motivated behavior, locomotion and NAc DA release. 
Moreover, we sought to determine if leptin influences running reward and if it depends on 
STAT3 signaling in midbrain DA neurons. This was accomplished by generation and phenotypic 
characterization of conditional KO mice lacking the main phosphorylation site (tyr705) of the 
STAT3 gene specifically in DA neurons, hereafter referred to as STAT3DAT-KO mice. This work 
constitutes the first article given in Chapter III: "Leptin suppresses the rewarding effects of 
running via STAT3 signaling in dopamine neurons" by Fernandes, M.F.; Sharma, S.; Mogra, S. 
and Fulton, S. 
 
6.2. Second Objective 
This study was undertaken to assess the contribution of STAT3 signaling in DA neurons on 
emotion-related behaviors. To address this question we generated DA-specific STAT3 KO mice 
(STAT3DAT-KO) by crossing dopamine transporter DATCre mice with STAT3lox/lox mice. Then, we 
studied the behavioral phenotype of STAT3DAT-KO female mice in anxiety and depression-like 
behaviors. Pharmacological and molecular approaches were used to shed light on the potential 
signaling mechanisms underlying the anxiogenic behavior observed in STAT3DAT-KO female 
mice. This study constitutes the second article given in Chapter III: "Deletion of STAT3 in 
midbrain dopamine neurons increases anxiety-like behavior in female mice" by Fernandes, M.F.; 
Sharma, S. and Fulton, S. 
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7. General methods 
The Cre-loxP system overview and STAT3DAT-KO mice generation 
The Cre-loxP system is a special type of site-specific recombination which allows for 
conditional mutagenesis of a gene of interest, thus representing a powerful tool in making 
alterations to the mouse genome (Nagy 2000, Novak et al. 2000). This technology allows the 
investigation of the role of specific genes in different regions or cell types, without confounding 
effects caused by systemic influences. It was first described in bacteriophage P1 and consists of a 
sequence-specific DNA recombinase (Cre) and a DNA sequence flanked by loxP sites, which is 
recognized by the Cre-recombinase (Zou et al. 1994). Because both Cre gene and loxP sites are 
not native to the mouse genome, they must be introduced by transgenic technology (Nagy 2000). 
Thus, when the enzyme Cre-recombinase is introduced to a system expressing loxP sites in the 
genome, it will catalyse a recombination event between the two loxP sites. Of note, the results of 
the recombination depend on the orientation of the loxP sites: 1) if both loxP-sites have the same 
orientation on a chromosome segment, the loxP-flanked DNA will be excised and eliminated; 2) 
if the loxP sites are oriented in opposite directions, Cre recombinase mediates the inversion of 
the floxed segment; 3) if the loxP sites are located on different chromosomes, Cre recombinase 
mediates a chromosomal translocation (Nagy 2000). 
On the present work, Cre and loxP mice colonies were developed separately and crossed to 
produce a Cre-lox strain. More specifically, we generated STAT3DAT-KO mice, whereby 
dopamine transporter-Cre (DATIresCre) mice were crossed with STAT3lox/lox mice (obtained from 
Dr. Shizuo Akira, Osaka, Japan) in which loxP sites flank exon 22 of the STAT3 gene, encoding 
the tyrosine residue 705 (For breeding schematics, see Figure 4). Of note, DATIresCre (or DAT 
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knock-in) have Cre recombinase expression directed to DA neurons, without disrupting 
endogenous DAT expression (Backman et al. 2006, The Jackson Laboratory 2014). 
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Figure 4. Breeding strategy to obtain STAT3DAT-KO mice: 1) First step: to obtain male 
heterozygous Cre mice. Thus male heterozygous Cre were bred with female homozygous Cre 
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mice, to generate male heterozygous Cre mice; 2) Second step: to obtain male heterozygous Cre 
/ heterozygous Lox mice. Thus, male heterozygous Cre / homozygous Lox were bred with female 
homozygous Cre / homozygous Lox (STAT3lox/lox), to generate male heterozygous Cre / 
heterozygous Lox mice; 3) Third step: to obtain the heterozygous Cre / homozygous Lox mice 
(STAT3DAT-KO mice). Thus, male heterozygous Cre / heterozygous Lox were bred with female 
homozygous Cre / homozygous Lox, to generate STAT3DAT-KO and respective control mice. 
48 
 
 
 
 
 
 
 
 
 
Chapter III 
 
Articles 
49 
 
 
8. Articles 
8.1 Article #1 
Contributions: 
Maria Fernanda A. Fernandes, contributed by performing most of the experiments (95%), except 
for the qPCR to detect the disrupted STAT3 gene (performed by Shabana Mogra) and the fast-
scan cyclic voltammetry (performed by Dr. Stephanie Fulton). Sandeep Sharma contributed for 
the setting up of the behavioral experiments. Maria Fernanda A. Fernandes also created the 
graphics and wrote the manuscript. Dr. Stephanie Fulton also contributed in the results 
discussion, redaction and correction of the manuscript. 
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Summary 
Dopaminergic (DA) neurons of the midbrain are part of a neural circuit involved in reward and 
motivation. To determine the role of the Signal Transducer and Activator of Transcription 3 
(STAT3) in this circuitry, we inactivated STAT3 signaling in DA neurons of mice (STAT3DAT-
KO mice). Lack of STAT3 in DA neurons resulted in no changes in feeding, while it increased 
locomotion, running wheel exercise and running reward. Moreover, STAT3 DAT-KO mice 
exhibited impairments in learning an appetitive operant conditioning task and reduced NAc DA 
release. Taken together, these results suggest that STAT3 mediates the action of leptin in the 
midbrain to decrease locomotor behavior and to increase DA tone, while it does not affect food 
intake, implying that different LepRb signaling molecules regulate distinct behavioral and 
biochemical actions of midbrain leptin. Additionally, STAT3 signaling in DA neurons enhances 
the rewarding value of running and facilitates instrumental learning. The findings described here 
shed light on the cells and neural pathways mediating the actions of leptin in the midbrain. 
 
 
 
 
 
Highlights 
► STAT3 signaling in midbrain dopamine neurons is a key modulator of spontaneous and 
voluntary physical activity ► Leptin in the ventral tegmental area abolishes the rewarding 
effects of running in a manner that depends on STAT3 in dopamine neurons ► Loss of STAT3 
in dopamine neurons blunts DA overflow in the nucleus accumbens 
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Introduction 
Behavior is a central component of energy balance and all behavior entails energy expenditure in 
the form of physical activity. Activity that increases the likelihood that a physiological need will 
be met is referred to as appetitive, and appetitive behaviors are crucial to the fulfillment of 
energy demands. Food-directed appetitive behaviors such as foraging, scavenging and hunting 
may benefit from increased physical activity and endurance (Bramble and Lieberman, 2004). 
The capacity for endurance running in cursorial mammals, particularly humans, is considered to 
have evolved as a means to increase the payoff of food-directed behaviors targeting distant or 
shifting food sources (Bramble and Lieberman, 2004; Carrier, 1984).  
Physical activity is strongly influenced by the metabolic state of the organism. The adipocyte-
derived hormone leptin is a critical signal controlling feeding and energy expenditure and a fall 
in leptin levels is a major component of the physiological response to fasting (Ahima et al., 
1996). The influence of leptin on energy expenditure includes its ability to alter spontaneous 
locomotor activity and voluntary running in a manner that largely depends on food availability. 
Leptin increases locomotor activity and/or voluntary running during fed states in leptin-deficient 
humans (Farooqi et al., 1999; Licinio et al., 2004), ob/ob mice (Ahima et al., 1999; Morton et al., 
2011; Pelleymounter et al., 1995), lean mice (Morton et al., 2011) and rats (Choi et al., 2008; 
Meek et al., 2012; Morton et al., 2011), or has no effect on running in fed wildtype mice (Morton 
et al., 2011; Pelleymounter et al., 1995). In contrast, leptin decreases locomotor activity and 
voluntary wheel running when food is restricted in ob/ob and lean mice (Morton et al., 2011) and 
rats (Exner et al., 2000; Verhagen et al., 2011). Physical activity escalates with food restriction, a 
phenomenon viewed as an expression of increased food acquisition behaviors (Bartness et al., 
2011; Overton and Williams, 2004; Sakkou et al., 2007). That leptin could be involved in this 
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process is supported by evidence that circulating concentrations are inversely related to physical 
activity or voluntary running in humans (Franks et al., 2003; Hebebrand et al., 2003), rats (Exner 
et al., 2000; Hebebrand et al., 2003), wildtype mice (Morton et al., 2011; Thorburn et al., 2000) 
and in mice selectively bred for high running capacity (Girard et al., 2007). Furthermore, plasma 
leptin levels correlate negatively with marathon run-time independent of BMI (Bobbert et al., 
2012) and with run speed and duration in high-running mice (Girard et al., 2007), suggesting that 
leptin could impact the motivational and rewarding effects of running. Indeed, endurance 
running is rewarding in humans (“runners high”) (Morgan, 1985; Partin, 1983; Wagemaker and 
Goldstein, 1980) and rodents (Belke and Wagner, 2005; Collier and Hirsch, 1971; Kagan and 
Berkun, 1954; Novak et al., 2012), yet little is known about the neural pathways and signaling 
mechanisms involved. 
Leptin modulates multiple components of brain reward circuitry (Fulton et al., 2000) and inhibits 
the rewarding effects of food (Figlewicz et al., 2004; Figlewicz et al., 2006). DA neurons of the 
midbrain ventral tegmental area (VTA) that project to limbic and cortical sites are essential for 
the control of appetitive and reward-relevant behaviors (Salamone and Correa, 2012; Schultz, 
2013). Leptin receptors (LepR) are expressed on midbrain DA neurons (Figlewicz et al., 2003; 
Scott et al., 2009), and functional LepR signaling in DA neurons of the VTA is well-documented 
(Domingos et al., 2011; Fulton et al., 2006; Hommel et al., 2006; Liu et al., 2011). Leptin has 
anorectic actions in the VTA (Bruijnzeel et al., 2011; Hommel et al., 2006; Trinko et al., 2011) 
whereas LepR knockdown in the VTA increases food intake, spontaneous locomotor activity 
(Hommel et al., 2006) and food-motivated behavior (Davis et al., 2011). LepR signaling involves 
the activation of signal transducer and activator of transcription 3 (STAT3) (Banks et al., 2000; 
Tartaglia, 1997). Leptin phosphorylates STAT3 in DA and GABA neurons of the midbrain 
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(Fulton et al., 2006; Hommel et al., 2006), however leptin-induced pSTAT3 is observed only in a 
subset of LepR-positive DA neurons (Scott et al., 2009) suggesting that DA neurons responsive 
to leptin are heterogeneous and that LepR-STAT3 signaling may have unique neurobehavioral 
actions. 
Few studies have investigated the mechanisms underlying the effects of leptin on locomotor 
activity. The hypoactivity of obese, leptin receptor deficient mice is corrected by restoration of 
LepR to the mediobasal hypothalamus (Coppari et al., 2005) or proopiomelanocortin (POMC) 
neurons (Huo et al., 2009) underscoring the role of the hypothalamus in leptin control of 
locomotor behavior. However, the divergent effects of leptin on physical activity in conditions 
where food is limited versus freely available suggest that separate neural processes are involved. 
We sought to investigate the absence of STAT3 in DA neurons in the control of physical 
activity, feeding and DA tone and to determine if leptin impacts the rewarding effects of running 
via STAT3 signaling in VTA DA neurons. 
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Experimental procedures 
Animals 
All experiments were carried out in accordance with the guidelines and approval of the 
Institutional Animal Care Committee of the CHUM Research Center. Floxed STAT3 mice 
(C57Bl6 background) in which loxP sites flank exon 22 of the STAT3 gene that encodes a 
tyrosine residue (tyr705) essential for STAT3 activation were graciously provided by Dr. Shizuo 
Akira (Osaka, Japan) (Takeda et al., 1998). Female mice homozygous for the floxed STAT3 
allele were crossed with male mice heterozygous for the floxed STAT3 allele and heterozygous 
for the DAT::Cre transgene (B6.SJL-Slc6a3tm1.1(cre)Bkmn/J) (Backman et al., 2006) to generate 
DATCre;STAT3fl/fl mice and littermate controls (STAT3fl/fl or STAT3fl). In addition to littermate 
controls, DAT::Cre mice were used as secondary controls for wheel running experiments. Male 
mice were weaned at P28 and housed in a temperature and humidity controlled room that was 
maintained on a 12:12 hour reverse light/dark cycle. All experiments were conducted in the dark 
phase of the cycle.  
Metabolic assessments 
Mice were individually housed with free access to standard chow and water. Food intake and 
body weight was measured 3 times per week. Lean and fat mass were determined at 23 weeks of 
age using an Echo MRI quantitative nuclear magnetic resonance system (Echo Medical Systems, 
Houston, TX, USA).  Metabolic efficiency (inverse of feed efficiency) was calculated for each 
subject by dividing energy intake (Kcal) over the 12-week period by body weight gain in grams. 
Following two days of habituation to cages, spontaneous locomotor activity was measured for 24 
hours in mice (11-12 weeks of age) using automated metabolic cages (Accuscan Instruments 
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Inc., Columbus, OH, USA) consisting of 16 light beam arrays in x, y and z axes. Distance 
travelled (horizontal activity) was measured by computer-controlled software. 
Voluntary wheel running 
Voluntary wheel running was assessed in a separate cohort of individually-housed mice with 
continuous access to a low profile wireless running wheel in the cage (Med Associates, Inc., VT, 
USA).  Wheel revolutions were constantly monitored via transmitters and recorded by data 
acquisition software (Med Associates Inc., St. Albans, VT, USA) on a nearby computer. Each 
full wheel revolution is equivalent 36.9 cm distance travelled. Mice had free access to food and 
water throughout and were not used for any other experiment. 
Intra-cerebral cannulations and food intake 
Anesthetised mice were placed in an ultraprecise mouse stereotaxic frame (Kopf; Tujunga, CA, 
USA) and maintained on Isoflurane (1.5%+oxygen). VTA cannula implantation: With bregma 
and lambda in the same horizontal plane, a bilateral guide cannula (26 gauge; 0.8mm distance 
between cannulae; Plastics One, Roanoke, VA, USA) was lowered in the VTA (AP, –3.4 mm; 
ML, ± 0.4 mm; DV, −4.7 mm). Intracerebroventricular (ICV) cannula implantation: A single 
guide cannula (26 gauge; Plastics One, Roanoke, VA, USA) was lowered into the right lateral 
ventricle (AP, –0.5 mm; ML, ± 1 mm; DV, −2 mm). Cannulae were anchored to the skull surface 
with dental cement and occluded with metal obturators of the same length. Following recovery 
and weight regain, ICV cannula placements were assessed by verifying the drinking response to 
injection of angiotensin II (10ng/1µl). Mice were habituated to a powder chow diet for 3 days for 
food intake measures. Powder food was placed in food cups that were fixed to the bottom of a 
larger container to catch spillage. Following an overnight fast, separate groups of mice received a 
bilateral VTA injection of leptin (200ng/500nl/side) or vehicle (PBS) or an ICV injection of 
57 
 
 
leptin (1ug/1ul; recombinant mouse leptin from Dr. A.F. Parlow, NIDDK) or vehicle  right 
before dark cycle onset using internal cannulas (Plastics One) attached to 1µl Hamilton 
microsyringe.  
Operant responding for food rewards 
Mice were trained to press a lever for sucrose pellets according to published procedures (Sharma 
et al., 2012). Briefly, mice were trained in operant chambers, house in sound-attenuating boxes, 
equipped with two retractable levers (Med Associates Inc., St. Albans, VT, USA) and a pellet 
dispenser delivering 20mg sucrose pellets (Bio-Serv, Frenchtown, NJ, USA) to a receptacle 
positioned between the levers. One lever was designated active (triggers reward delivery) and 
other as inactive (no reward) in a counterbalanced manner. Operant training on a fixed ratio-1 
(FR1) schedule of reinforcement (1 lever press = 1 sucrose pellet) was carried out for 8 days and 
the number of lever presses on each lever and rewards earned calculated by computer-controlled 
software (Med Associates Inc.) 
Hedonic feeding – “Dessert test” 
We utilized a paradigm in which sated rodents voluntarily over consume a palatable test diet 
(Choi et al., 2010). First, mice were entrained over 19 consecutive days to consume standard 
chow in a 4-hour window in the first half of dark cycle (Fig. 2E). Prior to test day (Day 20) mice 
were exposed to a small amount of high-fat/sugar food (D12231; Research Diets, Inc., New 
Brunswick, NJ) to prevent neophobia. On the day of testing, chow intake was measured each 
hour during 4 hours. Following the fourth hour of chow access, a separate set of food cups 
containing high-fat/sugar food were placed in each cage and weighed one hour later. 
Running reward  
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A new cohort of singly-housed mice (11-14 weeks of age) had free access to homecage running 
wheels for 3 weeks. Mice were then subjected to a conditioned place preference (CPP) task using 
a three-compartment, automated mouse CPP apparatus (Fig. 3A; Med Associates Inc., St. 
Albans, VT, USA). Pre-test: Mice were confined to both the black and white compartments of 
the CPP apparatus for 5-min to permit habituation to each compartment. Mice were then allowed 
to move freely in the apparatus for 15-min during which the amount of time spent in each 
compartment was recorded. Conditioning trials: Mice had 2-hour access either to a running 
wheel (paired trial) or a locked running wheel (unpaired trail) and were then confined to either 
the black or white compartment for 30 min. Paired and unpaired conditioning trials took place in 
opposite compartments (counterbalanced across mice) on alternating days, thus each mouse ran 
every-other day (Fig. 3A). Post-test: Following the last day of conditioning (Day 14), mice were 
placed back in the open CPP apparatus for 15 min. The amount of time spent in each 
compartment was once again recorded and the proportion of time spent in the paired side was 
compared to that obtained during the pre-test. 
Fast scan cyclic voltammetry 
Carbon-fibre electrodes were constructed and prepared according to Kawagoe et al. (Kawagoe et 
al., 1993). Electrodes were calibrated in vitro using known concentrations of DA (1µM 
dopamine HCL; Sigma). Mice (6-7 weeks of age) were anesthetised with Isoflurane prior to 
decapitation. Of note, at high clinical concentrations (<0.7 mM), Isoflurane was shown to inhibit 
the release of glutamate without significantly affect dopamine release  (Westphalen et al. 2013). 
Coronal slices (300μm) were cut using a vibratome at the level of the nucleus accumbens (NAc) 
(+0.90 to +1.30 mm from Bregma) in ice-cold, carbogenated ACSF containing 125 mM NaCl, 
26 mM NaHCO3, 2.5 mM KCl, 2.4 mM CaCl2, 1.3 mM MgSO4, 0.3 mM KH2PO4 and 10 mM 
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D-Glucose. Fast-scan cyclic voltammetry was used to measure electrically-evoked DA release 
according to published procedures (Fulton et al., 2011). Briefly, DA release in the NAc core 
(Fig. 4A) was evoked at 5-min intervals by a single 400μA, 1.2 ms, rectangular electrical pulse 
delivered by an S-900 stimulator (Dagan Corporation, Minneapolis, MN) and a bipolar 
stimulating electrode (Plastics One, Roanoke, VI) placed ~200µm away from the carbon fibre 
electrode. The carbon fibre electrode potential was linearly scanned from -0.4 to +1.2 V and back 
to -0.4 V versus Ag/AgCl using a 400V/s scan rate controlled by an Axopatch 200B amplifier 
connected to a computer and pClamp 10 software through a DigiData 1200B analog to digital 
interface (Molecular Devices). One recording and stimulation site was tested per slice. DA 
overflow was evoked 5 to 8 times per slice, until recordings were stable. The mean values of the 
last three recordings from each slice were used for statistical comparisons. The sample size is 
indicated as n=(x;y), x referring to the number of slices and y the number of mice.  
Western immunoblotting 
Mice were decapitated under Isoflurane anaesthesia, brains rapidly dissected and immersed in  
-10oC isopentane and then stored at -80oC. Frozen brains were sliced into 0.5mm coronal 
sections using an aluminum brain matrix. Coronal sections were mounted onto slides and 
maintained on dry ice. Nuclei were micro-dissected using brain tissue punches (Stoelting Inc., 
Wood Dale, IL). Bilateral punches of 0.75mm diameter were obtained from the VTA and 1.0mm 
diameter punches from the NAc. Micro-dissected tissues were homogenized on ice in 100 ml of 
cell lysis buffer (100mM Tris, pH 7.5; 750mM NaCl; 5mM Na2EDTA; 5mM EGTA, pH 7.5; 5% 
Triton x-100; 12.5mM sodium pyrophosphate; 5mM beta-glycerophosphate; 1mM, 5mM 
Na3VO4; 5µg/ml leupeptin) with added protease (PMSF 1mM) and phosphatase inhibitors 
(Sigma cocktails I and II) in 1.5 ml tubes using a motorized pestle. Tubes were centrifuged for 
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15 min at 14000 g. Protein concentrations were measured using BCA protein assay (Pierce 
Biotechnology, IL, USA). Protein samples were separated by electrophoresis on a 10-12% 
polyacrylamide gel and electro transferred to a nitrocellulose membrane (EMD Millipore 
Corporation, Billerica, MA, USA). Non-specific binding sites were blocked in TBS 5% low-fat 
milk and 0.1% Tween-20 or 5% BSA. Membranes were rinsed in buffer (0.1% Tween-20 in 
TBS) and then incubated with anti-DAT (1:1000; Millipore, EMD Millipore Corporation, 
Billerica, MA, USA), anti-DA D1A receptor (1:1000; Millipore, EMD Millipore Corporation, 
Billerica, MA, USA), anti-D2 receptor (1:1000; Millipore, EMD Millipore Corporation, 
Billerica, MA, USA), anti-TH (1:500; Millipore, EMD Millipore Corporation, Billerica, MA, 
USA) or anti-GAPDH (1:1000) followed by anti-rabbit, anti-rat or anti-mouse IgG horseradish 
peroxidase-conjugate (1:5000). After rinsing with buffer, immunocomplexes were visualized by 
chemiluminescence using the western lighting plus ECL kit (PerkinElmer, Waltham, MA, USA). 
Protein size was assessed using precision plus protein ladder (Bio-Rad, Bedford, MA, USA). The 
film signals were digitally scanned and then density quantified using ImageJ software. GAPDH 
(1:10000, Cell Signaling, Cell Signaling Technology, Inc., Danvers, MA, USA) was used as an 
internal control, such that data were standardized according to GAPDH values. 
Amphetamine locomotor sensitization 
This experiment was performed as described previously (Fulton et al., 2006). A Comprehensive 
Lab Animal Monitoring System (CLAMS; Columbus Instruments) was used for automated 
measurement of locomotor activity following amphetamine treatment. Following a 2-day 
habituation period to CLAMS cages, mice were implanted with a 14-day osmotic mini-pump 
(Alzet model 1002, DURECT Corporation, Cupertino, CA, USA) into the intrascapular region 
under Isoflurane anaesthesia. Pumps delivered leptin (500 ng/hr; 12 g/day) or vehicle (PBS) for 
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the duration of the experiment. Beginning the following day, each mouse received three IP 
injections, each separated by 2 days, in the following order: (1) 1 mg/kg amphetamine (low 
dose), (2) 4 mg/kg amphetamine (high dose), (3) 1 mg/kg amphetamine (repeat low dose). 
Locomotor activity was recorded for 2 hours following injections. D-amphetamine (Sigma-
Aldrich, Dorset, UK) was dissolved in 0.9 % saline. 
Statistical analyses 
Data were analyzed using GraphPad 5 and are presented as mean±standard error of the mean 
(SEM). A two-way ANOVA with Bonferonni post-hoc tests was used to compare control and 
KO mice with regards to body weight, food intake, hedonic feeding, food-motivated operant 
responding, spontaneous locomotor activity and voluntary running. Unpaired t-tests were used 
for comparisons of body composition, metabolic efficiency, 24h-food intake following acute 
leptin injection, locomotor activity during the dark cycle, total running distance (12 weeks), 
running reward, electrochemistry and immunoblotting experiments. Area under the curve (AUC) 
was calculated for dark cycle spontaneous locomotor activity and amphetamine-induced 
locomotor sensitization and compared via unpaired t-tests. AMPH-induced locomotor 
sensitization to the second low-dose of amphetamine was assessed using a one-way ANOVA 
that compared activity counts between the first and second AMPH treatment for each treatment 
group. Criterion for significance was set to p≤0.05 for all comparisons. 
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Results and Discussion 
Ablation of STAT3 in dopamine neurons 
To remove STAT3 function in midbrain DA neurons we bred STAT3 mice in which loxP sites 
flank exon 22 of the STAT3 gene which encodes tyrosine residue 705 that is essential for LepR-
STAT3 activation (Takeda et al., 1998) with heterozygous knock-in mice that express Cre 
recombinase under the control of the regulatory sequence of the dopamine transporter (DAT) 
(Backman et al., 2006). STAT3fl/fl;DATCre knockout mice (hereafter referred to as STAT3DAT KO) 
are born at expected frequencies, are of normal size and appearance and have similar weaning 
weights (Fig. 1A, inset). A PCR product corresponding to the recombined STAT3 gene 
(∆STAT3) was observed in brain nuclei of STAT3DAT KO mice in which DAT is expressed, but 
was absent from control nuclei and tissues (Fig. S1A). Double immunohistochemistry for 
phospho-STAT3 (pSTAT3) and tyrosine hydroxylase (TH) in slices from leptin-treated mice 
confirmed that Cre recombination was specific to DA neurons (Fig. S1B). pSTAT3 nuclear 
staining was absent from DA (TH+) neurons of the VTA and substantia nigra (SN) of STAT3DAT 
KO mice, yet was apparent in non-dopaminergic (TH-) cells of the midbrain and throughout the 
mediobasal hypothalamus (MBH) (Fig. S1B). The number of pSTAT3-postive cells in the VTA 
and substantia nigra (SN) was reduced by 66.46±4.37% (n=4/group) relative to controls as 
determined by counts in a separate series of immunolabelled slices. 
 
STAT3 in dopamine neurons controls body weight and composition  
To determine the contribution of STAT3 signaling in DA neurons in the regulation of body 
composition and feeding, we measured body weight, fat and lean mass and food intake in chow 
fed mice (Fig. 1A-D). As of 19 weeks of age, STAT3DAT KO mice weighed significantly less than 
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controls (Fig. 1A), a difference associated with a reduction in total fat mass (Fig. 1B). Caloric 
intake normalized to body weight values was comparable between STAT3DAT KO mice and 
controls (Figure 1C). As shown in Figure 1D, metabolic efficiency (total caloric intake divided 
by body weight gain) was increased in STAT3DAT KO mice relative to controls indicating that 
STAT3DAT KO mice utilize more energy per input unit. These findings suggest that reduced body 
weight and fat composition of STAT3DAT KO mice is due to elevations in energy expenditure. 
 
STAT3 in dopamine neurons controls spontaneous and voluntary physical activity 
As midbrain DA neurons are strongly implicated in the control of locomotion, we next 
set out to determine if spontaneous locomotor activity is increased in STAT3DAT KO mice. 
Significant increases in horizontal movement (Fig. 1E) and total distance travelled (Fig. 1F) in 
the dark cycle demonstrate that nocturnal activity is elevated in STAT3DAT KO mice relative to 
controls. Previous work of Hommel et al. established that viral-mediated knockdown of LepR in 
the VTA increases both food intake and locomotor activity without affecting body weight 
(Hommel et al., 2006). Thus, findings here suggest that inhibition of locomotor activity by VTA 
leptin involves STAT3 signaling in DA neurons. Reduced leptin signaling is also linked with 
heightened voluntary running or exercise: Hypoleptinemia is associated with increased exercise 
(Franks et al., 2003) and faster marathon run-times (Bobbert et al., 2012) in men independent of 
BMI, with hyperactivity in individuals with anorexia (Hebebrand et al., 2003; Holtkamp et al., 
2003) and increased wheel running in wildtype mice (Thorburn et al., 2000) and mice bred for 
high-running capacity (Girard et al., 2007; Vaanholt et al., 2008). In view of these findings, we 
next measured voluntary wheel running in a separate cohort of mice with free access to a home 
cage running wheel. STAT3DAT KO mice ran substantially more than controls as evidenced by an 
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increased number of wheel revolutions (Figure 1G). Remarkably, STAT3DAT KO mice ran ~11 
km/day as compared to the ~6 km/day run by controls (Figure 1H). Similar wheel running 
activity between DAT::Cre mice and wildtype littermates confirmed that increased running 
activity of STAT3DAT KO mice is not attributable to the Cre transgene alone (Fig. S2).  
We next sought to determine if hyperactivity of STAT3DAT KO mice is an expression of 
increased anxiety-like behavior in view of findings implicating LepR signaling in DA neurons in 
the anxiolytic actions of leptin (Liu et al., 2011). Using the elevated-plus maze (EPM), the most 
commonly used rodent test of anxiety, we found that proportion of time spent and entries made 
in the open arm was similar between STAT3DAT KO and controls (Fig. S3A-C). To confirm this 
result, we also used an open field (OF) test whereby reduced exploration in a novel, open arena 
reflects increased anxiety. Exploration in the OF was comparable between STAT3DAT KO and 
controls (Fig. S3D). Together, these findings demonstrate that loss of STAT3 in DA neurons 
increasing spontaneous locomotor activity and endurance running capacity in a manner unrelated 
to anxiety. These results are in accordance with observations that VTA leptin administration 
inhibits wheel running activity in a rat model of anorexia-induced hyperactivity (Verhagen et al., 
2011). Hyperactivity is a detrimental clinical feature of 30-80% of patients with anorexia nervosa 
that can propagate negative energy balance (Davis et al., 1994). As anorexia-induced 
hyperactivity is tied to hypoleptinemia, findings here may also have implications for increased 
physical activity and motor restlessness in individuals with anorexia. 
 
STAT3 in dopamine neurons does not mediate the anorectic effects of central leptin 
Leptin has central actions to inhibit food intake when administered into the cerebral 
ventricles and into select brain nuclei such as the VTA. To ascertain if STAT3 signaling in DA 
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neurons mediates the anorectic effects of central leptin, we measured food intake following intra-
VTA and ICV injection of leptin. Intra-VTA leptin attenuated chow intake relative to vehicle-
injected controls to a comparable extent in STAT3DAT KO mice and control mice (Fig. 2A).  Thus, 
similar to what has been reported in rats (Bruijnzeel et al., 2011; Hommel et al., 2006; Trinko et 
al., 2011) leptin has anorectic effects when injected into the VTA of mice. Similarly, reductions 
in food intake following ICV injection of leptin were not different between STAT3DAT KO mice 
and controls (Figure 2B). These data suggest that LepR-Stat3 signaling in DA neurons does not 
mediate the anorectic actions of leptin. LepR signal transduction also involves 
phosphatidylinositol 3-OH-kinase (PI3K) (Kellerer et al., 1997; Niswender et al., 2001) and 
extracellular signal-regulated kinase (ERK) signaling pathways (Rahmouni et al., 2009). Leptin 
not only activates Erk1/2 signaling in the VTA but pharmacological inhibition of Erk1/2 
phosphorylation was shown to block the anorectic action of VTA leptin (Trinko et al., 2011). It 
remains to be determined if Erk1/2 signaling in DA and/or GABA neurons is involved in the 
effects of VTA leptin on feeding.  
Absence of STAT3 dampens instrumental learning but does not affect hedonic feeding  
Mesolimbic and nigrostriatal DA neurons are key modulators of ingestive behavior, and 
specifically the appetitive, conditioned and rewarding aspects of feeding (Fulton, 2010; Palmiter, 
2007). Leptin decreases the rewarding effects of food (Figlewicz et al., 2004; Figlewicz et al., 
2006) whereas viral-mediated knockdown of LepR in the midbrain increases food-motivated 
instrumental responding (Davis et al., 2011). To determine the role of STAT3 signaling in DA 
neurons in food reward, we used an effort-based, operant conditioning task whereby mice learn 
to press a lever in order to receive a sucrose pellet (Sharma et al., 2012). Mice were trained to 
respond on a fixed-ratio 1 (FR1) schedule of reinforcement such that each lever press was 
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reinforced with a 20mg sugar pellet. Training could not progress towards more complex 
schedules of reinforcement (e.g., progressive ratio) since STAT3DAT KO mice exhibited 
significant response impairments on the FR1 schedule as evidenced by a reduced number of 
lever presses (Fig. 2C) and decreased percentage of correct (active lever) responses (Fig. 2D) 
relative to controls. Numerous reports have tied diminished performance specifically in operant 
conditioning tasks to DA signaling deficits in the nucleus accumbens (NAc) (Nowend et al., 
2001; Smith-Roe and Kelley, 2000; Steinberg et al., 2014), and thus STAT3DAT KO mice may 
have impaired NAc DA signaling. As an alternate method to investigate changes in food reward, 
we employed a hedonic feeding test whereby sated mice voluntarily overeat palatable food, also 
known as the dessert test (Fig. 2E) (Choi et al., 2010). As shown in Figure 2F, all mice 
consumed around 50% of their daily caloric intake within the 1st hour of exposure to the chow 
diet on the test day, eating progressively less over the remaining 3hours. As illustrated in Figure 
2F, when exposed to sweetened high-fat food (dessert) during the last hour, both groups 
increased their caloric intake to a similar degree suggesting that STAT3 in DA neurons does not 
modulate hedonic feeding. 
 
Leptin supresses the rewarding effects of running via Stat3 signaling in DA neurons  
Endurance running or exercise can promote a lasting sense of well-being that includes feelings of 
euphoria and pleasantness (Janal et al., 1984) and reduced anxiety and stress (Morgan, 1985; 
Rosch, 1985), commonly referred to as the runner’s high (Boecker et al., 2008; Morgan, 1985; 
Partin, 1983; Wagemaker and Goldstein, 1980). Running also has natural rewarding properties in 
rodents: rats will work to have access to a running wheel (Belke, 1997; Pierce et al., 1986)  and 
spend more time in a place previously associated with the aftereffects of wheel running (Belke 
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and Wagner, 2005; Lett et al., 2000). Addictive and compulsive-like behavior directed at 
reinstating or maintaining high levels of physical activity are reported in humans (Berczik et al., 
2012; Davis et al., 1995) and rodents (Lattanzio and Eikelboom, 2003; Werme et al., 1999), and 
the rewarding effects of running can substitute for other rewards such as food (Routtenberg and 
Kuznesof, 1967; Satvat and Eikelboom, 2006) and drugs of abuse (Cosgrove et al., 2002; 
Kanarek et al., 1995). Running engages opioid (Lett et al., 2002; Vargas-Perez et al., 2004), DA 
(de Castro and Hill, 1988; Greenwood et al., 2011; Mathes et al., 2010; Vargas-Perez et al., 
2004) and endocannabinoid systems (Chaouloff et al., 2011; Raichlen et al., 2012). The euphoric 
effects of running have been associated with increased opioid signaling in corticolimbic brain 
areas (Boecker et al., 2008), however, very little is known about the neural pathways and 
signaling molecules that give rise to the rewarding impact of running. We next set out to 
determine if running reward is increased in STAT3DAT KO mice and if leptin modulates the 
rewarding effects of running via the VTA in a manner that relies on STAT3 signaling in DA 
neurons. Using the conditioned place preference (CPP) test (Fig. 3A), a behavioral tool for 
examining changes in conditioned reward, our data demonstrate that the rewarding effect of 
running is increased in STAT3DAT KO mice as compared to controls (Fig. 3B,C). STAT3DAT KO 
mice spend more time in the paired side of the chamber previously associated with wheel 
running (Fig. 3C). Next, a separate cohort of mice with intra-VTA bilateral cannulae went 
through the conditioning procedure and then received an intra-VTA injection of leptin, at a dose 
shown to inhibit feeding (Fig. 2A) (Hommel et al., 2006), or vehicle prior to the CPP post-test. 
Once again, STAT3DAT KO mice treated with vehicle showed increased conditioned rewarding 
effects associated with wheel running as compared to controls (Fig. 3D). Confirming our 
hypothesis that the increased running reward observed in STAT3DAT KO mice is mediated by 
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LepR-STAT3 signaling in VTA DA neurons, VTA leptin completely suppressed the rewarding 
effects of running in control mice yet was unable to block running reward in STAT3DAT KO mice 
(Fig. 3E). In agreement with previous studies suggesting a role for mesolimbic DA signaling in 
wheel running performance (Dubreucq et al., 2013; Mathes et al., 2010), here we identify the 
influence of leptin to inhibit running reward via the VTA in a manner that is contingent on 
STAT3 in DA neurons. 
 
Lack of Stat3 in dopamine neuron reduces dopamine overflow and expression of TH and 
D1R in the nucleus accumbens  
The NAc is a critical efferent target of VTA DA neurons strongly implicated in motivation, 
appetitive responses and reward learning (Salamone and Correa, 2012; Schultz, 2013). As DA 
signaling in the NAc is important for sustaining reward-related operant responding (Salamone 
and Correa, 2012), our finding that operant performance for food is impaired in STAT3DAT KO 
mice (Fig. 2C,D) are suggestive of perturbations in NAc DA signaling. Correspondingly, 
complete leptin-deficiency was previously reported to supress DA overflow in the NAc and to 
diminish the expression of TH, the rate-limiting enzyme for DA biosynthesis (Fulton et al., 
2006). To determine if lack of STAT3 modulates evoked DA overflow in the NAc we used fast 
scan cyclic voltammetry, an electrochemical method that permits real-time, quantal measurement 
of DA exocytosis. Axonal DA overflow in the NAc core of acute slice preparations was evoked 
with a stimulating electrode and recorded with a carbon fibre electrode (Fig. 4A). The NAc core 
was selected based on evidence linking this NAc sub-compartment to the regulation of wheel 
running (Greenwood et al., 2011; Vargas-Perez et al., 2003). As shown in Figure 4B and C, the 
amplitude of evoked DA overflow was significantly reduced in STAT3DAT KO mice relative to 
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controls. To determine if lower evoked DA overflow is coupled to changes in DA-relevant 
protein expression, we next carried out immunoblotting experiments. Protein levels of TH and 
D1 receptor were decreased in the NAc of STAT3DAT KO mice relative to controls (Fig. 4D). 
Similar reductions in D1R and TH expression in the NAc are reported in mice selectively bred 
for their high-running capacity (Knab et al., 2009). Collectively, these results identify a role for 
NAc DA signaling in running, physical endurance and the rewarding properties of running.  
 
Lack of Stat3 in DA neurons impairs amphetamine-induced locomotor sensitization  
To corroborate the electrochemical data showing attenuated DA overflow in the NAc we studied 
behavioral sensitization in response to the psychostimulant drug amphetamine (AMPH). The 
acute locomotor-activating effects of AMPH rely on its actions to increase extracellular DA in 
the mesoaccumbens pathway by blocking DA reuptake and eliciting reverse transport via DAT. 
Mice received systemic leptin or vehicle via subcutaneous osmotic mini-pumps for the 10-day 
sensitization protocol as reported previously (Fulton et al., 2006). As illustrated in Figure 4E, 
there was no difference in locomotor activity in response to low-dose AMPH between vehicle 
and leptin-treated mice of either genotype. As expected, locomotion was increased following 
repeat AMPH administration in control mice (sensitization effect - Figure 4F & G). However, 
vehicle-treated STAT3DAT KO mice failed to sensitize to AMPH as shown by similar locomotor 
responses to AMPH following the two injections (Fig. 4H). Despite the absence of AMPH 
sensitization in STAT3DAT KO mice, chronic leptin treatment restored AMPH locomotor 
sensitization in these mice, although not quite to levels observed in controls (Fig. 4H). These 
results suggest that STAT3 signaling in DA neurons is important but not necessary for leptin 
modulation of DA-dependent, AMPH-induced locomotor sensitization. In agreement with these 
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results, Leinninger et al. found that deletion of LepR in neurotensin neurons of the lateral 
hypothalamus (LH) that project to VTA DA neurons supresses the locomotor effects of AMPH 
and inhibit NAc DA overflow (Leinninger et al., 2011). Thus, leptin acts directly on DA neurons 
to modulate mesolimbic DA signaling and function, in part via STAT3 signaling, while also 
having important indirect actions via LH inputs to these neurons. 
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General Discussion 
The present findings uncover a new function for leptin in the control of the rewarding 
effects of running and identify the key contribution of LepR-STAT3 signaling in DA neurons to 
this process. STAT3 loss-of-function elicited substantial increases in spontaneous locomotor 
activity and voluntary endurance running capacity without affecting the anorectic actions of 
leptin or hedonic feeding, results that highlight the involvement of DA-specific STAT3 in the 
central control of physical activity. By tying behavioral changes to decreased NAc DA overflow 
and a dampening of mesolimbic DA function our findings also reveal STAT3 as an important 
regulator of mesoaccumbens DA tone and highlight the contribution of midbrain DA signaling in 
the rewarding impact of running.  
The present data suggest that reduced LepR-Stat3 signaling in midbrain DA neurons 
could be an important element mediating restriction-induced hyperactivity and the coinciding fall 
in leptin levels. Furthermore, as chronic (but not acute) exercise by itself has been shown to 
suppress leptin levels in men (Perusse et al., 1997), endurance training may be inherently 
reinforcing by inhibiting LepR-STAT3 signaling in DA neurons. Although energetically costly, 
the capacity for endurance running in cursorial mammals is considered to enable food acquisition 
when food is at a distance or requires pursuit (see examples of distance hunters in Carrier; 
(Bramble and Lieberman, 2004; Carrier, 1984). Correspondingly, the rewarding effects of 
running or the runner’s high may have evolved to encourage stamina and therefore increase the 
probability of return on this energetic investment. The motivational effects of physical activity 
would accordingly rise during conditions when food is scarce (or costly) to promote activity-
based behaviors such as hunting, scavenging or food hoarding (accumulation) then decrease as a 
function of food availability and increasing leptin. Interestingly, food hoarding increases with 
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food restriction and weight loss (Cabanac and Swiergiel, 1989), is inhibited by leptin (Buckley 
and Schneider, 2003; Keen-Rhinehart and Bartness, 2008) and was previously speculated as the 
underlying behavioral function of a brain reward circuit inhibited by leptin (Fulton et al., 2000). 
Otherwise, the rewarding effects of running could presumably encourage physical activity and 
thus help to counter overweight, obesity and associated health risks. Conversely, in some 
individuals the rewarding properties of physical activity can foster excessive and compulsive 
patterns of exercise that are characteristic of an addiction (Berczik et al., 2012). Consistent with 
findings here, an intriguing new report shows that exercise addiction in men is associated with 
low, fat-adjusted leptin levels (Lichtenstein et al., 2014). This finding may also have relevance to 
the issue of hyperactivity associated with hypoleptinemia in anorexia since individuals with 
anorexia exhibit heightened sensitivity to rewards (Jappe et al., 2011). It is not known if there are 
genetic or physiological factors that contribute to a larger drop in leptin levels in response to 
food restriction or exercise in normal or pathological states that could increase the propensity for 
physical activity and sensitivity to its rewarding effects  
In view of its well-established role in reward-relevant behaviour, motivation and 
addiction, the contribution of DA in leptin control of running reward is not surprising. Previous 
studies implicated opioids in frontolimbic circuitry in the euphoric effects of running in humans 
(Boecker et al., 2008) and endocannabinoid signaling via CB1 receptors in the VTA that 
modulate DA neurotransmission in the running performance of mice (Dubreucq et al., 2013). 
Endocannabinoid, DA and opioid systems converge in basal ganglia circuitry and several studies 
highlight their interaction in the control and drug and food reward.  CB1 signaling in the VTA 
fine-tunes phasic DA release and thereby contributes to appetitive behaviors and reward-relevant 
learning. Striatal DA can modulate the release of opioid peptides that have been connected to the 
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hedonic effects of rewarding stimuli. Parceling out the precise contribution of each these 
substrates, the manner in which they cooperate and the corticolimbic neuronal populations 
involved in the rewarding effects of running requires further investigation. 
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Supplemental Information 
Leptin modulates locomotor activity and running reward via STAT3 signaling in midbrain 
dopamine neurons 
Fernandes, MF; Sharma, S; Mogra, S.; Fulton, S. 
 
Supplemental Experimental Procedures 
Cre-mediated recombination 
Genomic DNA (200ng) was isolated using from brain tissue punches and peripheral tissue 
dissections using Trizol and subjected to PCR to detect recombination (“∆STAT3”) (Takeda et 
al., 1998) using the following primers: a- 5’-CAC ACA AGC CAT CAA ACT CTG GTC TCC-
3’ (specific for exon 23 of the STAT3 gene) b- 5’-GAT TTG AGT CAG GGA TCC ATA ACT 
TCG -3’ (specific for loxP site upstream of the targeting construct). 
Immunohistochemistry 
STAT3DAT KO mice and controls were injected IP with either leptin (5 mg/kg body weight) or 
PBS following an overnight fast. Recombinant leptin was obtained from Dr. A.F. Parlow 
(National Hormone and Peptide Program, National Institute of Diabetes and Digestive Kidney 
Diseases, Torrance, California). Two hours after treatment, mice were anesthetised with sodium 
pentobarbital (50mg/kg, IP) and perfused transcardially with 0.9% ice-cold saline followed by 
10% neutral buffered formalin. Tissue preparation for pSTAT3 staining was as described (Fulton 
et al., 2006). Following pSTAT3 primary antibody labeling, sections were rinsed and incubated 
with a secondary biotinylated anti-rabbit antibody (1:1000; Vector Laboratories), labeled with 
avidin-biotin complex, and then stained with nickel-enhanced diaminobenzidine (DAB). Floating 
sections were blocked in avidin/biotin solution followed by 3% goat serum, and then incubated 
in anti-TH antibody (1:1000, mouse, Millipore, EMD Millipore Corporation, Billerica, MA, 
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USA) overnight at 4°C. Sections were rinsed and incubated with a secondary biotinylated anti-
mouse antibody (1:300; Vector Laboratories), labeled with avidin-biotin complex, and then 
stained with Vector-VIP substrate. In a separate series of slices (n=4/group) stained for pSTAT3 
alone as above, the number of pSTAT3+ cells were counted using ImageJ software in slices at 
coronal levels corresponding to plates 59 to 61 of the mouse brain atlas (Paxinos and Franklin, 
2004). 
Elevated plus maze test (EPM) 
The EPM apparatus consists of two closed arms that oppose two open arms in a plus design 
(Med Associates, Inc., St Albans, VT, USA). Decreased time spent in the open, exposed arm is 
an indicator of increased anxiety-like behavior. The apparatus is placed 60 cm above the floor 
and has a video camera fixed overhead. Each mouse was placed in the middle of the maze facing 
the open arm opposing the experimenter. Movement in the maze was recorded and tracked for 5 
min by an overhead video camera connected to a PC with Ethovision XT software (Med 
Associates, Inc., St Albans, VT, USA). 
Open field test 
As an additional test of anxiety-like behavior, STAT3
DAT KO
 mice and controls were tested in the 
open field test. The open field consists of a Plexiglas box (50 x 50 x 30 cm) in a lit room. Each 
mouse was placed in the middle of the arena and allowed to explore the field for 5 min. 
Movement in the field was recorded and tracked by an overhead video camera connected to a PC 
with Ethovision XT software (Med Associates, Inc., St Albans, VT, USA). 
.
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Figure Legends 
Figure 1. STAT3 in DA neurons regulates body weight, locomotor activity and voluntary 
wheel running. (A) Body weights of control (n=7) and STAT3DAT KO mice (n= 8). Inset: 
Weaning weight (n=20/group) (B) Total lean and fat mass of control (n=7) and STAT3DAT KO 
(n=8) mice at 23 weeks of age. (C) Caloric intake (chow) normalized by body weight in control 
(n=7) and STAT3DAT KO (n=8) mice (D) Metabolic efficiency (total intake divided by weight 
gain) of control (n=7) and STAT3DAT KO (n=8) mice. (E) 24h ambulatory activity in control and 
STAT3DAT KO mice (n=9/group). (F) Dark phase locomotor activity is elevated in STAT3DAT KO 
mice relative to controls (n=9/group) (G) Ad libitum voluntary wheel running is increased in 
STAT3DAT KO (n=12) as compared to controls (n=7) (H) STAT3DAT KO (n=12) mice run much 
longer distances each day relative to controls (n=7). Mean±SEM; *p<0.05; ** p<.001; 
***p<0.001 
 
Figure 2. STAT3 in dopamine neurons does not mediate the anorectic effects of central 
leptin and hedonic feeding but impairs food-motivated operant learning (A) Food intake of 
control and STAT3DAT KO mice receiving an intra-VTA injection of leptin (200ng/500μl/side) or 
vehicle (n=7-11/group) (B) Food intake of control and STAT3DAT KO mice receiving an ICV 
injection of leptin (1μg/1μl) or vehicle (n=4/group) (C) Lever press responses on a fixed-ratio 
(FR)-1 operant conditioning task in control and STAT3DAT KO mice (n= 9/group; main effect of 
genotype). (D) Percentage of correct and incorrect responses by Day 8 of testing (n= 9/group) 
(E) Layout of the hedonic feeding test where mice learn to consume their daily chow ration in a 
4-h time window (F) Test day intake of chow and sweetened high-fat diet (“dessert”) in control 
and STAT3DAT KO mice (n= 7/group). Mean±SEM; *p<.05; ** p<.01; ***p<0.001 
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Figure 3. The rewarding effects of running are increased in STAT3DAT KO mice and are 
inhibited by leptin in the VTA. (A) Schema demonstrating the conditioned-place preference 
(CPP) task used to measure running reward. Alternating conditioning trials  (paired one day, 
unpaired next) lasted 14 days (B) Control (n=16) and STAT3DAT KO (n=12) mice show significant 
preference for the “paired” side of the chamber associated with wheel running. (C). Preference 
for the paired side of the chamber is enhanced in STAT3DAT KO mice (n=12) relative to controls 
(n=16). (D) In a separate cohort, running CPP was assessed 1 hour after intra-VTA injection of 
vehicle in control (n=9) and STAT3DAT KO (n=8) mice. As in B, STAT3DAT KO mice show 
increases running CPP relative to controls (E) Intra-VTA leptin blocked the rewarding effects of 
running in control mice (n=14) but not in STAT3DAT KO (n=16) mice. Running CPP was tested 
one hour after intra-VTA leptin (200ng, 500μl/side) injection. Mean±SEM; *p<0.05; ** p<0.01; 
***p<0.001 
 
Figure 4. Lack of STAT3 in DA neurons decreases DA overflow in the NAc core and blocks 
amphetamine locomotor sensitization. (A) Illustration of brain slice preparation with 
placement of carbon fibre recording and stimulating electrodes for measurement of DA overflow 
using fast-scan cyclic voltammetry. (B) Representative current-time plot showing subsecond 
stimulation-evoked DA release and reuptake in a control and STAT3DAT KO mouse. Background 
current waveforms obtained immediately before the stimulation were subtracted from current 
waveforms obtained after stimulation to generate DA cyclic voltammograms. Oxidation current 
peaks for DA were obtained at potentials of -300 to -500 mV (versus Ag/AgCl) corresponding to 
3.5–4.5 ms in the voltage waveform. The peak oxidation currents derived from voltammograms 
86 
 
 
were converted to concentration by electrode calibration and used to generate current-time plots 
(C) DA overflow (mean of peak values from current-time plots) is reduced in STAT3DAT KO mice 
(n=6;3) relative to controls (n=6;3). (D) TH and D1 receptor protein expression is lower in in the 
NAc of STAT3DAT KO mice as compared to controls (n=5-10/group). Protein quantifications were 
normalized to GAPDH values. (E) AMPH locomotor sensitization: Locomotor activity over time 
following the first dose of AMPH. (F). Locomotor activity over time following the second dose 
of AMPH. (G). Area under the curve (AUC) locomotor activity data for control mice treated 
with leptin (n=9) or vehicle (n=9). Locomotor activity was increased following the second 
injection of AMPH in both groups of control mice, indicative of sensitization. (H) Area under the 
curve (AUC) locomotor activity data for STAT3DAT KO mice treated with leptin (n=6) or vehicle 
(n=7). STAT3DAT KO mice treated with vehicle failed to sensitize to repeat AMPH whereas leptin 
treatment to these mice restored AMPH sensitization. Mean±SEM; *p<0.05; ** p<0.01. 
 
Supplementary Figures 
Supplementary Figure S1. Cre mediated STAT3 recombination. (A) PCR detection of STAT3 
gene recombination. The recombined STAT3 gene (∆STAT3) was observed only in 
tissues/nuclei of STAT3DAT KO mice in which DAT is expressed. (B) Double 
immunohistochemistry for TH (VIP, purple) and pSTAT3(tyr705) (ni-DAB, black) from leptin 
treated STAT3DAT KO mice (n=4/group) reveals the absence of pSTAT3 from TH+ 
(dopamine) neurons (open arrows) and the presence of pSTAT3 in TH- cells (closed arrows) of 
the VTA, SN and MBH of STAT3DAT KO mice. CX: cortex; HPC: hippocampus; Liv: liver; 
MBH: mediobasal hypothalamus; Pan: pancreas; OB: olfactory bulb; VTA: ventral tegmental 
area; SN: substantia nigra 
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Supplementary Figure S2, related to Figure 1. Similar wheel running activity between 
DAT::Cre and wildtype littermates. (n=4-5/group). 
 
Supplementary Figure S3, related to Figure 1. Comparable anxiety-like behavior in 
STAT3DAT KO mice and controls. (A) Heat maps showing locomotor activity in the EPM in a 
STAT3
DAT KO 
mouse and control. (B,C) Anxiety-like behavior as measured in the EPM was 
similar between STAT3
DAT KO 
mice and controls (n=11-12/group). Percentage of open arm and 
open arm time were not different between genotypes (C) No differences were observed in 
anxiety-like behavior in the open field test. Exploratory activity (distance travelled) was 
comparable between STAT3
DAT KO 
mice and controls (n= 5-6/group). 
.
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Abstract 
The adipocyte-derived hormone leptin targets the long form of its receptor in the central nervous 
system to produce several behavioral actions compatible with the maintenance of energy 
balance. Leptin activates a number of signaling pathways including JAK2-STAT3, MAPK, PI3-
K and AMPK. JAK2-STAT3 constitutes a key pathway by which leptin modulates gene 
expression and energy balance. Leptin has anxiolytic effects which have been tied to LepRb 
signaling on mesolimbic dopamine neurons that project to the central nucleus of the amygdala, 
however, it remains to be resolved which leptin signaling pathways are involved. To assess the 
contribution of STAT3 signaling in dopaminergic neurons on anxiety-related behavior we 
generated a dopamine-specific STAT3 knockout (STAT3DAT-KO) by crossing dopamine 
transporter DATCre mice with STAT3lox/lox mice. STAT3DAT-KO female mice exhibited normal 
feeding, locomotion, body weight and behavioral despair relative to littermate controls. 
However, STAT3DAT-KO mice showed increased anxiety-like behavior in both the elevated plus 
maze and open field tests, as well as increased plasma corticosterone levels. Blocking dopamine 
D1-receptors in the central nucleus of the amygdala by local microinjection of the D1-receptor 
antagonist SCH23390 reversed the anxiogenic phenotype of STAT3DAT-KO mice. These results 
suggest that activation of STAT3 in midbrain dopamine neurons that project to the central 
amygdala mediates the anxiolytic effects of leptin. 
 
 
 
Keywords: leptin, dopamine, central amygdala, anxiety 
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Introduction 
The ob gene product leptin is a well described satiety factor which acts via the long form of its 
receptor (LepRb) to inform the hypothalamic centres about the status of body fat stores (Inui, 
1999; Zhang et al, 1994). Leptin's actions in the hypothalamus as an "anti-obesity" hormone 
have been exhaustively studied. However, LepRb is distributed throughout the brain, including 
mesolimbic regions involved in emotional behavior (Elmquist et al, 1998; Leshan et al, 2006; 
Mercer et al, 1996; Scott et al, 2009). Via the LepRb, leptin targets the ventral tegmental area 
(VTA) to inhibit feeding-related behaviors (Davis et al, 2011; Hommel et al, 2006), locomotion 
(Hommel et al, 2006; Verhagen et al, 2011), and anxiety (Liu et al, 2011). 
Of note, the therapeutic targets for obesity and mood disorders, such as anxiety, are the same 
(Zheng et al, 2006) and a strong relationship between feeding and anxiolytic behavior has 
already been described (Pallister and Waller, 2008; Swinbourne and Touyz, 2007). Consistent 
with this idea, previous studies pointed out to the anxiolytic effects of leptin in rodents and 
humans. There is data showing that plasma leptin levels in women is strictly related to symptoms 
of anxiety, independent of body fat composition (Lawson et al, 2012). Peripheral administration 
of leptin was previously demonstrated to decrease anxiety-like behaviors in mice (Finger et al, 
2010; Liu et al, 2010; Lu et al, 2006). Moreover, leptin-deficient ob/ob mice display an 
anxiogenic phenotype, which can be reversed by systemic leptin administration (Asakawa et al, 
2003; Finger et al, 2010). Although the specific signaling mechanisms by which leptin 
modulates anxiety-like behavior needs further clarification, Liu and coworkers demonstrated that 
inhibition of dopaminergic transmission via dopamine D1-receptor (D1R) may be involved (Liu 
et al, 2011). 
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Estrogen acts downstream of the LepRb to directly activate signal transducer and activator of 
transcription-3 (STAT3) pathway in a leptin-independent manner and thus, to influence gene 
transcription (Gao and Horvath, 2008). Similarly to the leptin receptor, estrogen receptors (ER) 
are also expressed in both dopaminergic and non-dopaminergic neurons in the midbrain. More 
specifically, ERs were detected in and around the A8, A9, and A10 dopaminergic cell groups in 
rodents (Creutz and Kritzer, 2002). Moreover, both leptin and estrogens significantly contribute 
to the incidence and intensity of mood disorders, including anxiety and depression, with females 
being at higher risk than males (Lund et al, 2005; Walf and Frye, 2006; Williams, 2010). Based 
on these findings, it can be speculated that estrogens and leptin may act synergistically to 
modulate STAT3 signaling in DA neurons. However, further experiments are required to test this 
hypothesis. 
Given that STAT3 constitutes a predominant signal whereby leptin regulates gene expression 
(Bates et al, 2003); leptin induces STAT3 phosphorylation in dopamine (DA) and GABA 
neurons of the VTA (Fulton et al, 2006); and that both leptin and estrogen activates STAT3 
signaling pathway, we hypothesized that this transcription factor might be a strong potential 
candidate molecule to mediate the anxiolytic effects of leptin in female mice. Using Cre-LoxP 
cell-specific gene targeting to abolish STAT3 activation in DA neurons, our goal was to 
determine whether LepRb-STAT3 could mediate the role of leptin in the midbrain to affect 
emotional processes. 
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Materials and methods 
Animals 
DA-specific STAT3 KO mice ("STAT3DAT-KO") were generated as described (Fernandes et al, 
2014, submitted to Cell Metabolism). Briefly, STAT3DAT-KO mice have been generated by 
crossing the DATCre mice with STAT3lox/lox mice, which have the main activation site of STAT3 
gene (tyr705) flanked by loxP sites. STAT3DAT-KO mice and littermate controls were housed in 
groups of five at 22-24°C on a 12:12 h light–dark cycle (lights on at 10:00 am) with ad libitum 
access to food and water. Mice were genotyped using PCR-based procedures. Estrous cycle was 
not monitored during these studies. Therefore, the effects of inactivation of STAT3 in DAT 
expressing cells on anxiety- and depression-like behaviors were determined in randomly cycling 
females. All animal procedures were approved by the CRCHUM Animal Care Committee. 
 
Long term food intake and body weight 
Mice were individually housed with free access to standard chow and water. Food intake and 
body weight was measured 3 times per week. 
 
Ambulatory activity 
Following two days of habituation to cages, spontaneous locomotor activity was measured for 24 
hours in automated Accuscan metabolic cages (Accuscan Instruments Inc., Columbus, OH, 
USA) consisting of 16 light beam arrays in x, y and z axes. Distance travelled (horizontal 
activity) was measured by computer-controlled software. 
 
Open field test (OFT) 
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To assess anxiety-like behavior, STAT3DAT-KO mice and controls were tested in both the OFT 
and elevated plus maze (below). The open field consisted of a Plexiglas box (50 x 50 x 30 cm) in 
a brightly lit room. Each mouse was placed in the middle of the arena and allowed to explore the 
field for 5 min. Movement in the field was recorded and tracked by an overhead video camera 
connected to a PC with Ethovision XT software (Med Associates, Inc., St Albans, VT, USA). 
 
Elevated plus maze test (EPM)  
The EPM test served as an additional measure of anxiety-like behavior. The EPM apparatus 
consists of two closed arms that oppose two open arms in a plus design (Med Associates, Inc., St 
Albans, VT, USA). Decreased time spent in the open, exposed arm is an indicator of increased 
anxiety-like behavior. The apparatus is placed 60 cm above the floor and has a video camera 
fixed overhead. Each mouse was placed in the middle of the maze facing the open arm opposing 
the experimenter. Movement in the maze was recorded and tracked for 5 min by an overhead 
video camera connected to a PC with Ethovision XT software (Med Associates, Inc., St Albans, 
VT, USA). 
 
Forced swim test (FST) 
The FST was used to screen depressive-like behavior in STAT3DAT-KO and littermate controls. In 
this test, animals display "behavioral despair" as indicated by increased immobility and less 
escape-oriented behaviors. When forced to swim in a glass cylinder filled with water in which 
they are confined mice eventually cease escape attempts and become immobile. The increasing 
immobility time reflects a state of despair. For this experiment, all mice were forced to swim in a 
glass cylinder (height, 15 cm; diameter, 12 cm) containing water (23oC) at a 10-cm depth. A 
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video camera located above the apparatus recorded each test. The duration of immobility during 
the last 4 min of the 6-min testing period (2 min habituation) was calculated. 
 
Tail suspension test (TST) 
The TST test served as an additional measure of depressive-like behavior. In this test, mice first 
struggle in an attempt to escape and over time animals become immobile, which is believed to 
reflect a state of "behavioral despair". Mice were suspended by the tail to a movement-sensitive 
hook for 10 min. Movement of the mouse during the procedure is automatically recorded via the 
transmission of electrical signals to a central unit. When movement was lower than a pre-
established threshold, the mouse was considered immobile. 
 
Surgical procedures 
For intra-CeA cannula implantation, animals were anesthetized with Isoflurane (1.5%+oxygen) 
and placed in a stereotaxic frame (Kopf; Tujunga, CA, USA). Unilateral guide cannulae (26 
gauge; Plastics One, Roanoke, VA, USA) were lowered into both sides of the CeA, using the 
following coordinates: AP, –1.25 mm; ML, ± 2.70 mm; DV, −4.2 mm (Crock et al, 2012). 
Cannulae were anchored to the skull surface with dental cement and occluded with metal 
obturators of the same length. Following cannula implantation mice were individually housed 
and body weights monitored daily to ensure appropriate post-surgical weight recovery. Mice 
recovered for at least 7 days before testing. At the end of the experiment, the cannulae placement 
was confirmed by the administration of methylene blue dye (0.3ul/side). Mice without staining 
restricted to the CeA (n=3) were excluded from subsequent analysis. 
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D1 dopamine receptor antagonist (SCH23390) injections in the CeA 
For this experiment all mice were subjected to repeated handling to allow habituation and 
remained in their respective home cages until the infusion of the D1R antagonist SCH23390 
(Sigma-Aldrich, St Louis, MO, USA) or vehicle (isotonic sterile saline) bilaterally into the 
central nucleus of the amygdala (CeA) (0.1ug/ul; 0.3ul/side delivered over two minutes). 
Following injection, all mice returned to their home cages and were tested in the EPM 30 
minutes following the injections, as previously described (Liu et al, 2011). 
 
Basal and stress-induced corticosterone measures 
Both basal and stress-potentiated plasma corticosterone levels were measured. To measure basal 
corticosterone, blood samples were obtained via cardiac puncture at the time of sacrifice. For 
restraint stress experiments, mice were restrained in decapicones (Braintree Scientific 
Inc.,Braintree, MA, USA) for 30 min, and blood samples were obtained immediately after via 
cardiac puncture. All animals were sacrificed during the light cycle, at 6 am, when corticosterone 
levels are lower, according to the circadian pattern of corticosterone secretion. Plasma was 
separated by centrifugation and measured by an ELISA corticosterone kit according to 
manufacture instructions (Enzo Life Sciences, Farmingdale, NY, USA). Each sample was 
measured in triplicates. Inter assay variability was less than 10%. 
 
Western immunoblotting 
Mice were decapitated under Isoflurane anaesthesia and brains rapidly dissected and stored at -
80oC. Frozen brains were sliced into 0.5mm coronal sections using a brain matrix. Coronal 
sections were mounted onto slides maintained on dry ice. Bilateral punches were obtained from 
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NAc (figure 18, Mouse Brain Atlas), DLS (figure 21, Mouse Brain Atlas) and CeA (figure 39, 
Mouse Brain Atlas) (Franklin and Paxinos 2008) using brain tissue punches (Stoelting Inc., 
Wood Dale, IL). Microdissected tissues were homogenized on ice in 100 ml of cell lysis buffer 
(100mM Tris, pH 7.5; 750mM NaCl; 5mM Na2EDTA; 5mM EGTA, pH 7.5; 5% Triton x-100; 
12.5mM sodium pyrophosphate; 5mM beta-glycerophosphate; 1mM, 5mM Na3VO4; 5µg/ml 
leupeptin) with added protease (PMSF 1mM) and phosphotase inhibitors (Sigma phosphatase 
inhibitor cocktails I and II) in 1.5 ml aliquots using a motorized pestle. Aliquots were centrifuged 
for 15 min at 14000 g. Protein concentrations were measured using BCA protein assay (Pierce 
Biotechnology, IL, USA). Protein samples were separated by electrophoresis on a 12-10% 
polyacrylamide gel and electro transferred to a nitrocellulose membrane (EMD Millipore 
Corporation, Billerica, MA, USA). Non-specific binding sites were blocked in TBS 5% low-fat 
milk and 0.1% Tween-20 or 5% BSA. Membranes were rinsed in buffer (0.1% Tween-20 in 
TBS) and then incubated with anti-DAT (1:1000; Millipore, EMD Millipore Corporation, 
Billerica, MA, USA), anti-D2 receptor (1:1000; Millipore, EMD Millipore Corporation, 
Billerica, MA, USA), anti-TH (1:500; Millipore, EMD Millipore Corporation, Billerica, MA, 
USA), anti- pDARPP-32 (Thr 34) (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA) 
followed by anti-rabbit, anti-rat or anti-mouse IgG horseradish peroxidase-conjugate (1:5000). 
After rinsing with buffer, immunocomplexes were visualized by chemiluminescence using the 
western lighting plus ECL kit (PerkinElmer, Waltham, MA, USA). Protein size was assessed 
with a precision plus protein ladder (Bio-Rad, Bedford, MA, USA). The film signals were 
digitally scanned; density quantified using ImageJ software. GAPDH (1:10000, Cell Signaling 
Technology, Inc., Danvers, MA, USA) was used as an internal control, such that data were 
standardized according to GAPDH values. 
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Statistical analyses 
Data were analyzed using GraphPad 5 and presented as means and respective standard errors of 
the mean (SEM). Unpaired t-tests were used to compare control and STAT3DAT-KO  mice in all 
studies, except for 24h-ambulatory activity and food intake studies, which were analysed using 
2-way ANOVA with Bonferoni post-hoc tests. Criterion for significance was set to p≤0.05 in all 
comparisons. 
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Results 
Absence of STAT3 signaling in dopamine neurons enhances CORT levels and anxiety-like 
behavior. Basal plasma corticosterone (CORT) levels were elevated in female STAT3DAT-KO 
mice as compared to respective controls at the middle of the light cycle (6am) (***p< 0.001, 
Figure 1A). Consistent with these findings, 30-minutes of restraint increased corticosterone 
levels in both groups, however, stress-induced elevations of CORT were more pronounced in 
STAT3DAT-KO mice (***p< 0.001, Figure 1B). To determine the role of STAT3 signaling in DA 
neurons in anxiety-like behavior, STAT3DAT-KO and control mice were tested in an OFT and 
EPM - two well-validated behavioral tests of anxiety (Archer, 1973; Carobrez and Bertoglio, 
2005; Rodgers and Dalvi, 1997; Stanford, 2007). Our results demonstrated that STAT3DAT-KO 
mice avoid the center of the open field arena and spend more time in the periphery as compared 
to controls (***p < 0.001, Figure 1C and 1D). In addition, as shown in, Figure 1E both 
percentage of time spent into the open arm and percentage of entries made into the open arm of 
an EPM is lower in STAT3DAT-KO mice as compared to controls (**p<0.01. Figure 2E). Taken 
together, our results reveal an anxiogenic phenotype in STAT3DAT-KO female mice. 
STAT3DAT-KO  mice display normal locomotor activity, body weight and food intake 
To determine if the increased anxiety-like behavior was a result of changes in locomotor activity 
we examined 24 hours locomotor activity in STAT3DAT-KO mice and respective controls (Figure 
2A and 2B). STAT3DAT-KO mice and littermate controls exhibited similar locomotor activity 
during 24 hours (Figure 2A) and similar locomotor activity during the dark (active) phase 
(Figure 2B). Moreover, we assessed the effects of loss of STAT3 in DA neurons on long-term 
chow intake and body weight regulation. There is no difference in body weight and food 
consumption between genotypes (Figure 2C). 
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Lack of STAT3 in dopamine neurons does not affect depressive-like behavior 
To determine if the absence of STAT3 signaling in DA neurons impacts depressive-like 
behavior, mice were tested in the FST and TST, two well-validated tests of behavioral despair in 
mice (Castagne et al, 2010, 2011). As shown in Figure 3A and 3B, there were no differences in 
immobility time, an index of "behavioral despair", in either the FST and TST between 
genotypes, demonstrating that loss of pSTAT3 in DA neurons does not influence depressive-like 
behaviors . 
Lack of STAT3 in DA neurons alters the expression of DA-related proteins in the CeA 
To determine if changes in the expression of DA-related proteins could be involved in the 
heightened anxiety of STAT3DAT-KO mice we studied the expression of TH, DAT and phospho-
DARPP32(thr34) protein in the CeA. As shown in Figure 4, TH and DAT expression is 
significantly decreased in the CeA of STAT3DAT-KO female mice as compared to controls 
(***p<0.001, Figure 4) whereas phospho-DARPP32 (thr34), a marker of D1R activation, was 
increased in the CeA of STAT3DAT-KO mice relative to controls (*p<0.05). The increases in 
pDARPP32(thr34) observed are suggestive of increased CeA D1R signaling in STAT3 DAT-KO 
female mice. 
D1R antagonist (SCH23390) administration in the CeA reverses the anxiogenic phenotype 
of STAT3DAT KO mice  
As we obtained biochemical evidence to suggest that D1R signaling is increased in the CeA of 
STAT3DAT-KO mice, we next set out to determine if blocking D1R in the CeA could reverse the 
increased anxiety-like behavior of STAT3DAT-KO mice. Mice received a bilateral injection of the 
D1 receptor antagonist SCH23390 (0.3 µg per mouse) or vehicle into the CeA and were then 
screened for anxiety-like behavior 30 minutes later. Supporting our earlier results, saline-treated 
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STAT3DAT KO mice spent less time (*p<0.05, Figure 5A) and made less entries (*p<0.05, Figure 
5B) into the open arm as compared to controls. There were no differences in either the 
percentage of time spent in the open arm (Figure 5A) or percentage of entries made into the open 
arm (Figure 5B) of the EPM between SCH23390-treated STAT3DAT-KO and control mice. In 
addition, the percentage of time spent in the open arm (Figure 5A) or percentage of entries made 
to this arm (Figure 5B) was similar between vehicle- and SCH23390-treated control mice. 
However, we observed that SCH23390-treated STAT3DAT-KO mice increased the percentage of 
time spent in the open arms (**p<0.01, Figure 5A) as well as the percentage of entries made into 
this arm (*p<0.05, Figure 5B), as compared to vehicle-treated STAT3DAT-KO mice. Thus, D1 
blockade in the CeA reversed the increased anxiety-like behavior of STAT3DAT KO  mice. 
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Discussion  
Leptin has been shown to have anxiolytic actions mediated by LepRb signaling on mesolimbic 
dopamine (DA) neurons that project to the central nucleus of the amygdala (CeA) (Liu et al, 
2011). Here we find that absence of STAT3 signaling, an important signaling molecule 
downstream of LepRb, specifically in DA neurons induces anxiety in female mice by increasing 
DA signaling in the CeA. However, depressive-like behavior is similar between STAT3DAT-KO 
mice and respective controls, suggesting that STAT3 signaling in dopaminergic neurons 
specifically modulates anxiety in female mice. 
Besides its well-described role in controlling food intake and body weight, the adipocyte-derived 
hormone leptin also plays an important role in the modulation of mood (Leshan et al, 2006; Liu 
et al, 2010; Scott et al, 2009). Leptin's anxiolytic properties has already been described (Liu et 
al, 2010). Furthermore, systemic leptin ameliorates anxiety-like behavior in ob/ob mice 
(Asakawa et al, 2003) and reduced depressive-like behavior in rodents (Lu et al, 2006). 
However, the specific functional role of LepRb signaling in midbrain DA neurons in the 
regulation of emotional behavior as well as the signaling molecules involved remained elusive 
until now. Our findings that lack of STAT3 signaling in DA neurons of female mice results in 
increased anxiety-like behavior (OFT and EPM) and elevated basal and stress-induced 
corticosterone levels without changes in behavioral despair are consistent with those of Liu and 
coworkers, showing that LepRb KO in DA neurons increase anxiety but not despair in male mice 
(Liu et al, 2011). Alternatively, the anti-depressant effects of leptin appear to be more associated 
with hippocampal leptin signaling (Guo et al, 2013; Harvey, 2007). In contrast with Liu and 
coworkers, we failed to observe an anxiogenic phenotype in STAT3DAT-KO male mice. The 
difference between our results and those from Liu and collaborators as well as the sexual 
110 
 
 
dimorphism observed in anxiety-like behavior in STAT3DAT-KO mice can be explained from a 
few speculative perspectives. First, the authors do not mention the reason why they chose to 
include only male mice in their study, given that there is literature showing that females are 
much more prone to be affected by mood disorders than males (Bekker and van Mens-Verhulst, 
2007; Kessler et al, 2005). Furthermore, a dense population of estrogen-expressing neurons was 
observed in the CeA of female rats (Pfaff and Keiner, 1973) and estrogen increases extracellular 
DA levels by inhibiting the dopamine transporter (DAT) (Watson et al, 2006). Of note, estrogen 
modulation of DAT seems to occur either via an interaction between estrogen receptors (ERs) 
and DAT, or between ERs and a variety of signaling mediators responsible for second 
messengers and response cascades affecting DAT (Alyea et al, 2008). Thus, with regards to the 
gender differences observed between male and female STAT3DAT-KO mice, a possible 
explanation could be related to the previously suggested gender differences in estrogen's effect 
on dopaminergic function (Alyea et al, 2008). One hypothesis is that estrogen may be 
contributing to increase extracellular DA concentrations in the CeA of STAT3DAT-KO female 
mice by inhibiting DA reuptake. Moreover, given the growing literature suggesting marked 
sexual dimorphisms in brain wiring, morphology and chemistry (Cosgrove et al, 2007; De Vries 
and Boyle, 1998), one can speculate that the gender differences observed in our studies may be 
related to a difference in the number of ERs in the CeA of males versus females; an altered 
sensitivity to the anxiolytic actions of estrogen or even due to a different effect of estrogen in 
male and female brain. However, more research is necessary to test these hypotheses. 
In agreement with the anxiogenic phenotype observed in STAT3DAT-KO female mice, our results 
showed an increased basal and restraint stress-induced plasma corticosterone levels in mutant 
mice as compared to littermate controls. These findings are consistent with previous in vivo and 
111 
 
 
in vitro studies suggesting that leptin inhibits corticosterone secretion by the adrenal gland 
(Ahima et al, 1996; Nowak et al, 2002; Pralong et al, 1998; Szucs et al, 2001). On the other 
hand, other studies reported that central leptin increases the activity in the hypothalamic-
pituitary-adrenal axis (HPA) axis which in turn activates corticotropin-releasing hormone (CRH) 
neurons to drive corticosterone secretion in male rats (Morimoto et al, 2000; van Dijk et al, 
1997). The apparent discrepancy between these findings can be due to the metabolic status of the 
animal, gender and/or species differences. 
To try to identify potential signaling molecules underlying the anxiogenic behavior of 
STAT3DAT-KO mice, our immunoblotting studies found that absence of STAT3 signaling in DA 
neurons reduces DAT and increases phospho-DARPP32 (Thr34) protein levels in the CeA of 
STAT3DAT-KO female mice. Of note, DARPP-32 is a critical downstream target of D1R: D1R 
signaling increases cAMP levels and PKA activity via the stimulation of adenylyl cyclase by 
stimulatory G-proteins. PKA-catalyzed phosphorylation will then activate DARPP-32 (Beaulieu 
and Gainetdinov 2011) Thus, increased pDARPP32(thr34) is suggestive of enhanced D1R 
activation, which our findings suggest could be due to increased extracellular DA concentrations 
elicited by reduced DAT function. A very speculative hypothesis on the link between STAT3 
and DA reuptake would be that STAT3 binds to the DAT promoter to regulate its function. This 
hypothesis needs to be tested in future studies. 
Taken into consideration previous data demonstrating that absence of LepRb in DA neurons 
potentiates anxiogenic behavior and D1R signaling in the CeA (Liu et al. 2011), we next 
investigated whether increased D1R in the CeA was contributing to anxiety-like behavior in 
STAT3DAT-KO mice. By blocking DA transmission specifically in the CeA via an intra-CeA 
administration of a D1R antagonist (SCH23390) we observed that the anxiogenic phenotype of 
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STAT3DAT-KO female mice normalized. This finding is consistent with observations in DA-
specific LepRb KO mice (Liu et al, 2011). Of note, the effect of D1R antagonist could include a 
mixture of postsynaptic and presynaptic mechanisms, blocking the activity of D1R localized at 
postsynaptic elements of CeA neurons as well as at presynaptic nerve terminals. 
Importantly, the results of this study unravel the specific signaling pathway by which leptin acts 
on dopaminergic neurons to modulate anxiogenic behavior. Taken together, our findings suggest 
that the anxiolytic actions of leptin in female mice are mediated by increased LepRb-STAT3 
signaling in midbrain DA neurons that target the CeA to decrease D1R signaling, perhaps via 
increased DA reuptake. 
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Figure Legends 
Figure 1: Absence of STAT3 signaling in dopamine neurons enhances CORT levels and 
anxiety-like behavior. (A) Basal plasma corticosterone levels (ng/ml, ± SEM) is increased in 
STAT3DAT-KO mice (n=4) as compared to controls (n=4). ***p< 0.001. (B) 30’ restraint stress-
induced plasma corticosterone levels (ng/ml, ± SEM)  is significantly increased in STAT3DAT-KO 
mice (n=6) as compared to littermate controls (n=6). ***p< 0.001 (C) Significant decrease in 
percentage of time spent in the centre of an open field arena in STAT3DAT-KO mice (n=10) as 
compared with the control group (n=8). ***p < 0.001. (D) Percentage time spent  in the 
periphery of an open field arena is increased in STAT3DAT-KO mice (n=10) as compared to 
littermate controls (n=8). ***p < 0.001. (E) Percentage of open arm time and open arm entries is 
decreased in STAT3DAT-KO mice (n=7) as compared to littermate controls (n=8). **p<0.01, 
percentage open arm time; **p<0.01. 
 
Figure 2. STAT3DAT-KO  mice display normal locomotor activity, body weight and food 
intake. (A) 24h-locomotor activity, expressed as total distance travelled during the test in 
STAT3DAT-KO mice and respective controls (n=7-9). (B) Dark (active) phase locomotor activity 
in STAT3DAT-KO mice and respective controls (n=7-9). (C) Average caloric intake normalized by 
body weight of STAT3DAT-KO female mice and littermate controls on a regular chow diet (n=8-
9).  
 
Figure 3: Lack of STAT3 in dopamine neurons does not affect depressive-like behavior. (A) 
Total immobility time in the forced swim test is similar between STAT3DAT KO (n=6) and control 
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mice (n=4). (B) Immobility time of STAT3DAT KO (n=4) mice was comparable to controls (n=4) 
in the tail suspension test.  
 
Figure 4: Lack of STAT3 in DA neurons alters the expression of DA-related proteins in the 
CeA. TH and DAT protein levels in CeA of STAT3DAT KO mice (n=5-7) were reduced as 
compared to controls (n=4). ***p< 0.001. Phosphorylation of DARPP32 at Thr 34 was increased 
in STAT3DAT KO mice (n=4) relative to controls (n=4). *p<0.05. 
 
Figure 5: D1R antagonist (SCH23390) administration in the CeA reverses the anxiogenic 
phenotype of STAT3DAT KO mice. (A) Schema illustrating the placement of cannulae in the CeA 
(B) Percentage of time spent in the open arm of an EPM is comparable between STAT3DAT KO 
(n=5) and control mice (n=5) treated with SCH23390 (0.3 µg per mouse). Percentage of time 
spent in the open arm of an EPM is decreased in saline-treated STAT3DAT KO mice (n=5) as 
compared to saline-treated controls (n=5). *p<0.05. Similar proportion of time spent in the open 
arm time in saline- (n=5) versus SCH23390-treated (n=5) control mice.  Increased percentage of 
time spent in open arm in SCH23390-treated STAT3DAT KO mice (n=5) as compared to saline-
treated STAT3DAT KO mice (n=5). **p<0.01. (C) Percentage of entries made to the open arm of 
an EPM is similar between STAT3DAT KO (n=5) and control mice (n=5) treated with SCH23390.  
Percentage of entries to the open arm of an EPM is decreased in saline-treated STAT3DAT KO 
mice (n=5) as compared to saline-treated controls (n=5). *p<0.05. Comparable percentage of 
open arm entries in saline- (n=5) and SCH23390-treated (n=5) control mice.  Increased 
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percentage of open arm entries in SCH23390-treated STAT3DAT KO mice (n=5) as compared to 
saline-treated STAT3DAT KO mice (n=5). *p<0.05. 
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9. General Discussion 
The studies described in this thesis hone in on the LepRb signaling mechanisms by which leptin 
affects mesolimbic DA signaling previously described by Fulton et al, Hommel et al and 
Domingos et al. (Fulton et al. 2000, Fulton et al. 2006, Hommel et al. 2006, Domingos et al. 
2011). The objective of the present work was to further define the specific cells and signaling 
mechanisms by which leptin impacts the mesolimbic DA system. More specifically, this thesis 
tested the hypothesis that leptin acts in the midbrain to modulate multiple behaviors via STAT3 
signaling in DA neurons. Thus, to isolate the STAT3 gene and study its role in the brain DA 
system, we generated a line of conditional KO mice lacking the main activation site of STAT3 
gene (tyr705) selectively on DA neurons, as described in General Methods. It is important to 
highlight that STAT3 ablation was observed in DA neurons within the VTA/SN. No significant 
Cre-mediated STAT3 recombination was observed in other regions (Article#1, supplemental fig. 
1). Of note, we are the first to identify a role for DA-specific STAT3 signaling in the modulation 
of locomotion, running reward, anxiety-like behavior and DA tone. 
 
9.1. Role for STAT3 signaling in DA neurons in locomotion and running reward 
The first study described in this thesis shows for the first time that STAT3 signaling in DA 
neurons mediates the action of leptin in the VTA to decrease spontaneous and voluntary 
locomotor activity and running reward, and to decrease DA overflow in the NAc of male mice. 
Moreover, our findings provide firm evidence that the influence of leptin in the midbrain to 
decrease food intake does not require STAT3 signaling in DA neurons. 
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Previous reports demonstrated that a direct intra-VTA leptin injection induces short-term 
decreases in food consumption in rats (Hommel et al. 2006, Bruijnzeel et al. 2011), while viral-
mediated LepRb knockdown in the VTA has an opposite effect by increasing food intake without 
affecting body weight (Hommel et al. 2006). Thus, we sought to determine the contribution of 
STAT3 signaling in DA neurons on the previously described anorectic effects of leptin in the 
midbrain. We observed that either a single ICV or intra-VTA leptin injection reduced food intake 
to a similar extent in both control and STAT3DAT-KO mice. Our results are the first to show that 
leptin acts in the VTA to decrease food intake in mice, and imply that pSTAT3 in DA neurons 
does not mediate the acute anorectic effect of leptin. Alternatively, Hommel and coworkers 
found that adeno-associated virus (AAV)-mediated LepRb knockdown in the VTA, targeting 
both dopaminergic and non-dopaminergic neurons in this region, increases food intake (Hommel 
et al. 2006). This raises the possibility that either non-dopaminergic neurons (i.e.: GABA 
neurons) or other LepRb signaling pathway modulates the effect of leptin in the midbrain to 
decrease food consumption. Consistent with this hypothesis, Trinko and coworkers demonstrated 
that the anorexigenic effects of an intra-VTA leptin injection are probably mediated by ERK1/2 
pathway, and STAT3 (tyr705) activation is not sufficient for the effects of leptin in the VTA to 
reduce food intake (Trinko et al. 2011). Alternatively, JAK2 signaling pathway has also been 
suggested as a possible mediator of the anorectic effects of leptin in the VTA (Morton et al. 
2009). 
We next checked long-term food intake and body weight of control and STAT3DAT-KO mice fed a 
chow diet and we observed that STAT3DAT-KO male mice exhibited reduced body weight and 
reduced adiposity in spite of no changes in caloric intake, when normalized by the body weight, 
suggesting that STAT3 signaling in DA neurons are not involved in long-term food intake. Our 
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findings are in agreement with previous studies by Davis and coworkers showing that 
knockdown of LepRb in the midbrain does not affect feeding (Davis et al. 2011), and suggest 
that signaling pathways other than STAT3 mediates the effects of leptin in the VTA to reduce 
feeding. To determine whether the observed reduced body weight/body fat mass in STAT3DAT-KO 
mice is due to increased energy expenditure, we assessed metabolic efficiency in these mice. 
Metabolic efficiency, defined as the ratio of calories consumed divided by body weight gain over 
a specific time interval, constitutes a initial method from which we can infer change in energy 
expenditure (Butler and Kozak 2010, Ellacott et al. 2010). Our data show that metabolic 
efficiency, was enhanced in STAT3DAT-KO mice fed a standard chow diet, as compared to 
littermate controls. Given that normalized chow intake is not different between genotypes, we 
hypothesized that the decreased body fat mass and increased metabolic efficiency observed in 
STAT3DAT-KO mice might be due to increased locomotion. To address this question, we 
examined ambulatory activity in STAT3DAT-KO and littermate controls. We found a significant 
increase in dark-phase (active cycle) locomotor activity in STAT3DAT-KO male mice relative to 
controls. This is in agreement with a previous report that viral-mediated VTA LepRb knockdown 
stimulates locomotor activity in male rats (Hommel et al. 2006), and thereby suggests that DA-
specific STAT3 signaling mediates this effect. Furthermore, increased ambulatory activity in 
STAT3DAT-KO male mice may contribute to the observed enhanced metabolic efficiency. Of note, 
there's growing evidence of a link between metabolic signals and DA function, indicating a 
potential role for this neurotransmitter in energy balance. It has been suggested that the DA 
system acts to optimize the utilization of body energy resources, as DA favors energy 
expenditure (Beeler et al. 2012). In fact, dopamine can shift obese animals from a state of 
behavioral energy conservation to a state of behavioral energy expenditure (Beeler et al. 2012). 
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Consistent with this idea, dopamine was shown to increase resting energy expenditure in 
humans(Ruttimann et al. 1991, Nakagawa et al. 1994) As previously mentioned in this thesis, 
LepRb are also expressed on midbrain DA neurons and activation of these receptors on 
dopaminergic cells decreases dopamine function (Hommel et al. 2006, Figlewicz and Benoit 
2009) , enhances locomotor activity and energy expenditure (Ribeiro et al. 2011). 
VTA DA neurons also projects to the caudal brainstem, and VTA-SNc DA neurons modulate 
locomotor behaviors via projections to the basal ganglia which projects down to the brainstem 
mesencephalic locomotor region (Kravitz et al. 2010, Stephenson-Jones et al. 2011). Therefore, 
it could be possible that inactivation of STAT3 in midbrain DA neurons that project to the 
brainstem mediates the increases in locomotion observed in STAT3DAT-KO mice and thus, 
contributes to increased energy expenditure. 
Food intake is regulated by an interaction between homeostatic and hedonic pathways. 
Moreover, leptin is involved in the signaling of food reward (Fulton et al. 2000, Fulton et al. 
2004), and reduces the hedonic response to palatable foods (Rangel 2013). Thus, we assessed 
hedonic-based feeding behavior in control and STAT3DAT-KO mice using the "Dessert-Effect" 
test. In this test paradigm, the intake of a palatable food (“dessert”) is assessed in calorically-
sated mice (Davis et al. 2012). Our results demonstrated that there are no differences in the 
hedonic responses to palatable food between genotypes, suggesting that STAT3 signaling in DA 
neurons does not modulate either the incentive motivational properties of food or food hedonics. 
Likewise, we did not observe differences in other aspects of feeding behavior, including food 
anticipatory activity (FAA), restriction-induced feeding and food preference between STAT3DAT-
KO and control mice (Figures 7, 8, 9, respectively Appendix I). Thus, taken together, these 
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results strongly suggest that STAT3 signaling in DA neurons does not modulate any aspect of 
feeding behavior in mice. 
As discussed in previous sections, leptin also affects energy balance by influencing the 
rewarding effects of food as well as goal-oriented behaviors that contribute to obtaining food 
(Rangel 2013). Accordingly, LepRb knockdown in the midbrain increases the motivation to 
obtain food (Davis et al. 2011). To test our hypothesis that STAT3 signaling in DA neurons 
mediates leptin's effect in food reward, we assessed food-motivated learning in STAT3DAT-KO 
and control mice. Interestingly, STAT3DAT-KO male mice show impaired food-motivated learning 
in a Fixed Ratio 1 (FR1) schedule of reinforcement. During appetitive instrumental learning 
tasks, animals are expected to learn to emit a behavior (lever press) to obtain a reinforcer (i.e.: 
sucrose pellet) (Robinson et al. 2007). A number of reports suggested that DA signaling (mainly 
in the NAc) is greatly involved in instrumental (i.e.: operant conditioning) and Pavlovian or 
classical conditioning (i.e.: CPP) learning, invoked during acquisition of behaviors associated 
with food reward (Wise et al. 1978, Smith and Schneider 1988, Beninger and Miller 1998, Di 
Chiara 2002, Wise 2004). Instrumental conditioning is a form of associative learning in which a 
voluntary response is strengthened or diminished by its consequences (i.e.: reward, punishment, 
etc.) (Thorndike 1911, Skinner 1966). In this kind of conditioning, the animal has to perform an 
operant response and learn the relationship between the response and the response-associated 
reward (Domjan 2005). Pavlovian or classical conditioning is another form of associative 
learning in which a stimulus initially incapable of evoking a response acquire the ability to do so, 
through repeated pairing with another stimulus (Pavlov 1927). Notably, the neurocircuitry 
underlying the classical conditioning processes are distinct from those underlying the 
instrumental learning (Bardo and Bevins 2000). Moreover, DA has been implicated in the 
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association between actions and outcomes in instrumental learning tasks (Schultz 1998, Dayan 
and Balleine 2002, Robinson et al. 2006), while in classical conditioning tests DA has been 
implicated in associations between neutral stimuli and rewards (Wilkinson et al. 1998, Dickinson 
et al. 2000, Di Ciano et al. 2001, Dalley et al. 2005). However, the role of DA in the distinct 
learning processes is not completely clear. For example, slightly hyperdopaminergic mice (DA 
levels elevated 70% above controls) display normal instrumental learning (Yin et al. 2006), and 
DA-depleted mice can acquire CPP for morphine reward (Hnasko et al. 2005), although they do 
not perform tasks that require intentional movement (Szczypka et al. 1999, Hnasko et al. 2006), 
such as operant responding. A recent report demonstrated that DA projections to the NAc 
(mediated by D1R) are critical for operant conditioning (Steinberg et al. 2014). Moreover, 
impaired D1R signaling in the NAc decreases lever pressing for food reinforcers (Nakajima 
1989, Smith-Roe and Kelley 2000, Gore and Zweifel 2013). Likewise, reducing DA in the NAc 
using intra-NAc injections of either 6-OHDA or D1R antagonist, substantially decreased lever 
pressing for palatable food, without causing a general reduction in food motivation, as rats 
remained directed toward the acquisition and consumption of food when it is freely available 
(Salamone et al. 1991, Nowend et al. 2001). These findings suggest that diminishing DA in the 
NAc may impair the ability of animals to overcome work-related response costs in order to 
obtain food in a instrumental responding task (Nowend et al. 2001). Consistent with this idea, we 
observed decreased D1R protein expression and decreased DA release in the NAc of STAT3DAT-
KO male mice, as compared to controls. Based on this result, we speculate that the significant 
impairment in food-motivated learning in a FR1 schedule of reinforcement observed in our 
model might be due to an impaired D1R transmission within the NAc of STAT3DAT-KO mice. 
Notably, in spite of their poor performance in a food-motivated learning task, STAT3DAT-KO male 
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mice acquired CPP for running reward, suggesting that their learning impairment is specific to 
the appetitive-operant conditioning task. The ability of STAT3DAT-KO mice to demonstrate 
associative learning in a CPP task but not in a simple operant conditioning task (FR1) 
underscores the point that there are multiple subtypes of reward-related learning, which are 
differently affected by LepRb-STAT3 signaling in DA neurons. 
In view of the well-described role of mesolimbic DA system in physical activity and the 
reinforcing effects of running exercise, we measured voluntary wheel running in a separate 
cohort of mice. Voluntary running wheel exercise was shown to reduce the preference of rodents 
for palatable food, in addition to influence STAT3 activation selectively in the VTA (Scarpace et 
al. 2010, Shapiro et al. 2011). Furthermore, a single leptin injection into the VTA suppresses 
voluntary running exercise (Verhagen et al. 2011). Our results demonstrated that STAT3DAT-KO 
male mice exercise significantly more than their respective controls, suggesting that the ability of 
leptin in the VTA to suppress voluntary wheel running rely on STAT3 activation in DA neurons. 
Similarly to food, voluntary exercise can also be rewarding. As previously mentioned in this 
thesis, regular physical exercise can produce a rewarding effect in humans often referred to as 
"runner’s high" (Panksepp et al. 2002, Dietrich and McDaniel 2004), and rats will work to have 
access to a running wheel (Belke 2006, Belke 2006, Belke and Christie-Fougere 2006) and spend 
more time in a place previously associated with the aftereffects of wheel running (Lett et al. 
2000, Lett et al. 2001). To test the hypothesis whether the enhanced voluntary exercise in 
STAT3DAT-KO mice reflects an increase in the rewarding aftereffects of wheel running, we 
assessed the reward value of running in STAT3DAT-KO and control mice using a CPP paradigm. 
In the CPP paradigm, the reinforcing effects of objects and/or behaviors are evaluated by 
measuring the amount of time the animal spends in an environment previously associated with 
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that object/behavior (Tzschentke 2007). As the most striking finding of this study, we observed 
that STAT3DAT-KO mice spend more time in a place previously associated with the aftereffects of 
wheel running, relative to controls. Moreover, a single intra-VTA leptin injection one hour prior 
to the CPP test impaired running CPP acquisition to a greater extent in the control group, firstly 
suggesting that STAT3DAT-KO mice exercise more because the rewarding value of wheel running 
is much higher in these mice as compared to controls. Most importantly, the increased running 
reward observed in our model is modulated by LepRb-STAT3 signaling in DA neurons, and not 
by other activators for STAT3 such as CNTF or IL-6. In fact, given that LepRb-deficient db/db 
mice does not show STAT3 activation in the VTA after leptin administration (Fulton et al. 
2006), and intra-VTA leptin decreases running reward in control mice but not in STAT3DAT-KO, it 
is very unlikely that other STAT3 activator is involved in mediating the phenotypic 
characteristics of STAT3DAT-KO mice. Very little is known about the neural controls of voluntary 
running and its rewarding effect, and we are the first to show that leptin modulates the rewarding 
aftereffects of running via LepRb-STAT3 signaling in DA neurons. 
Besides the above-mentioned reduced D1R protein expression in NAc of STAT3DAT-KO mice, the 
observed behavioral changes are accompanied by decreases in DA biosynthesis (decreased TH 
protein expression) in the NAc, which is consistent with the effects of central leptin to increase 
TH expression (Fulton et al. 2006, Leinninger et al. 2009), and suggests that STAT3 signaling in 
DA neurons is involved. Interestingly, our findings matches with those by Knab and coworkers, 
demonstrating that both D1R and TH expression were significantly downregulated in the NAc of 
mice bred for high wheel running exercise (Knab et al. 2009), and thus suggest that D1R as well 
as TH may be associated with the regulation of physical activity in STAT3DAT-KO male mice. 
Moreover, we measured evoked DA release in the NAc core using fast scan cyclic voltammetry 
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in acute brain slice preparations and found that electrically stimulated DA release was reduced in 
STAT3DAT-KO male mice. This is in agreement with a previous report from Fulton and coworkers 
demonstrating that electrically evoked release of DA in the NAc is drastically reduced in ob/ob 
mice (Fulton et al. 2006), and suggest that diminished evoked DA release in STAT3DAT-KO male 
mice is induced by loss of DA-specific STAT3 signaling and could be partially related to a 
reduction in DA available for release, potentially due to diminished synthesis reflected by the 
observed reduced TH protein expression. Of note, there are no differences in DAT and D2R 
protein expression in the VTA, NAc, DLS and CeA. 
As an alternative means to assess mesoaccumbens DA function, we investigated AMPH-induced 
locomotor sensitization in STAT3DAT-KO and control mice. Of note, one of the primary actions of 
AMPH is to increase dopaminergic concentration in the synaptic cleft by inhibiting DA reuptake 
and promoting reverse transport, resulting in efflux of DA via the DAT (Besson et al. 1971, Von 
Voigtlander and Moore 1973, Hoebel et al. 1983, Sulzer et al. 2005) - the resultant dramatic 
increase in extracellular DA has been suggested to be of major importance for AMPH-induced 
psychomotor activation (Kelly et al. 1975, Pijnenburg et al. 1975, Sulzer et al. 2005). Consistent 
with previous reports showing that leptin increases AMPH-induced locomotion in rodents (Hao 
et al. 2004, Fulton et al. 2006), a sensitized locomotor response was observed in control mice 
receiving continuous treatment with leptin or vehicle delivered via a 14-days subcutaneous mini-
osmotic pump implants. Interestingly however, subcutaneous infusion of leptin also enhances the 
locomotor responses to AMPH in STAT3DAT-KO mice suggesting that LepRb-STAT3 signaling is 
important but not necessary for the actions of leptin to increase AMPH sensitization. 
Accordingly, Leinninger and coworkers reported that there is a population of LepRb neurons in 
the LHA expressing the neuropeptide NT, which is activated by leptin and modulates the 
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mesolimbic DA system (Leinninger et al. 2011). Most importantly, these authors observed that 
leptin signaling in NT neurons participates in the action of AMPH to stimulate locomotor 
activity (Leinninger et al. 2011). Thus, the fact that STAT3DAT-KO male mice show increased 
AMPH-induced locomotor response when treated with leptin, could well be related to leptin's 
action via an alternative signaling mechanism, such as the NT neurons in the LHA, to decrease 
DAT activity and consequently increase AMPH sensitization. Experiments needs to be 
conducted to test this hypothesis. 
Taken together, our findings suggest an important role for leptin in attenuating ambulatory 
activity, voluntary exercise and running reward in male mice, that are mediated via LepRb-
STAT3 signaling in midbrain DA neurons and changes in DA tone. We posit that leptin acts in 
mesolimbic brain reward circuitry as a signal of plenty to dampen the motivational and 
rewarding effects of several behaviors that serve to replenish energy stores. Consistent with this 
idea, our findings further suggest that LepRb-STAT3 signaling in DA neurons constitute a 
potential mechanism involved in hypoleptinemia-induced hyperactivity. Based on the fact that 
STAT3DAT-KO male mice show reduced food intake and reduced body fat mass due to increased 
locomotion and wheel running hyperactivity, these transgenic mice could potentially serve as a 
useful model for the study of activity-based anorexia (ABA). 
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9.2. Loss of STAT3 signaling in DA neurons induces an anxiogenic phenotype in female 
mice 
It is well known that DA signaling in the VTA is implicated in anxiety-like behavior. Previous 
studies demonstrated that electrical stimulation of VTA neurons induces anxiogenic responses, 
while lesions of the VTA or inhibition of DA signaling within this region by stimulation of the 
inhibitory D2R have anxiolytic effects (Borowski and Kokkinidis 1996, Munro and Kokkinidis 
1997, Gifkins et al. 2002). As mentioned previously, the VTA is known to project to the 
amygdala, among other areas. The amygdala is a subcortical structure in the limbic system which 
has long been highlighted as a major constituent of the neural circuits processing emotional 
behavior (Weiskrantz 1956, Aggleton 1993, LeDoux 2000). In regards to its anatomical 
organization, the amygdala consists of a group of anatomically and functionally distinct nuclei 
(Amaral and Insausti 1992, Saygin et al. 2011). Among these nuclei, the CeA is strongly 
modulated by DA and, most importantly, it is located in a strategic position to mediate many 
aspects of anxiety-like behavior, given that CeA neurons project to sites involved in mediating 
different aspects of mood and emotion (Amaral and Insausti 1992, Davis 1992). Consistent with 
these observations, DA signaling within the CeA is enhanced in response to a variety of 
emotional stimuli (Inglis and Moghaddam 1999, Torres et al. 2002) and D1R signaling in the 
CeA has been highly associated with anxiety behavior (Guarraci et al. 1999, de la Mora et al. 
2005). In addition, leptin modulates DA signaling within the CeA via D1R (Liu et al. 2011) and 
play an important role in emotional behavior (Leshan et al. 2006, Scott et al. 2009, Liu et al. 
2010). The anxiolytic and antidepressant properties of leptin were already described (Asakawa et 
al. 2003, Lu et al. 2006, Liu et al. 2010), however, the specific LepRb signaling pathway and 
brain sites has, until now, remained poorly understood. 
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As the most striking finding of this study, we observed that STAT3DAT-KO female mice exhibited 
an anxiogenic phenotype, which was consistently observed in two widely used tests of anxiety: 
the open field test (OFT) and the elevated-plus maze (EPM). Of note, both OFT and EPM tests 
have proven to be efficient to detect anxiety-like behavior in studies other than those testing 
anxiolytic drugs (Teegarden and Bale 2007, Liu et al. 2011, Sharma et al. 2013). 
Importantly, the anxiogenic behavior is not the result of general hypolocomotion or 
abnormalities in feeding activity as STAT3DAT-KO female mice showed normal feeding behavior 
and locomotion when compared to littermate controls (Figures 10 and 11 respectively, 
Appendix II). Given that symptoms of anxiety and depression often co-occur (Sartorius et al. 
1996), we assessed depressive-like behavior in STAT3DAT-KO mice by determining immobility 
time in the forced-swim and tail suspension tests. In agreement with findings that LepRb 
signaling in DA neurons does not modulate behavioral despair in mice (Liu et al. 2011), 
depressive-like behavior is similar between genotypes. These findings suggest that leptin acts via 
distinct neural pathways to modulate anxiety and depression in mice. In fact, there is literature 
strongly supporting the involvement of LepRb signaling in the hippocampus in the modulation of 
depression-like behavior (Lu et al. 2006, Yamada et al. 2011, Garza et al. 2012, Guo et al. 
2013). Taken together, our results points to the conclusion that STAT3 signaling in DA neurons 
does not affect DA signaling in brain structures involved in depression-like behavior (i.e.: 
hippocampus) or, alternatively, leptin's antidepressant-like effects is not mediated by STAT3 
signaling in DA neurons. 
Evidence from our immunoblotting studies on brain nuclei of STAT3DAT-KO female mice 
demonstrates that DAT protein expression is reduced, while threonine-34 phosphorylation of 
DARPP32 is increased in the CeA of STAT3DAT-KO as compared to controls. Briefly, D1R 
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signaling activates cAMP-dependent protein kinase (PKA), which will, in turn, directly stimulate 
DARPP32-Thr 34 phosphorylation (Nishi et al. 2000). These results suggest an increased DA 
signaling via D1R due to reduced DA reuptake, elicited by reduced DAT function, in midbrain 
DA neurons that projects to the CeA. Moreover, it represents a potential mechanism by which 
increased D1R signaling within the CeA mediates the anxiogenic-like behavior in STAT3DAT-KO 
female mice. Consistent with this hypothesis and observations in DA-specific LepRb KO mice 
(Liu et al. 2011), we found that pharmacological blockage of D1R signaling in the CeA 
normalized anxiogenic behavior in STAT3DAT-KO mice, suggesting that lack of STAT3 activation 
in DA neurons results in increased anxiety by somehow increasing D1R signaling. 
As discussed in Article 2, our studies complement those of Liu and collaborators (Liu et al. 
2011) and indicate that selective inactivation of STAT3 (tyr705) in DA neurons results in an 
anxiogenic phenotype, mediated by increased D1R signaling in the CeA of female but not male 
mice. Furthermore, STAT3 signaling in DA neurons does not affect despair-like behavior, 
suggesting that leptin's antidepressant-like action is mediated by other brain circuits or even 
other neurotransmitters (Harvey 2007, Guo et al. 2013). Intriguingly, in contrast to a previous 
study suggesting that lack of LepRb signaling in DA neurons increases anxiety in male mice (Liu 
et al. 2011), we found that loss of STAT3 activation in DA neurons did not affect anxiety-like 
behavior in STAT3DAT-KO male mice. There are a few hypothesis to explain the sexual 
dimorphism observed in our mice model. First of all, there is literature showing that females are 
much more prone to be afflicted by mood disorders than males (Kessler et al. 2005, Bekker and 
van Mens-Verhulst 2007), suggesting that gonadal hormones, such as estrogen and testosterone, 
may play an essential role in the etiology of anxiety and depression. Likewise, an important role 
for estrogen in augmenting both pre- and postsynaptic dopaminergic function was already 
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described (Morissette et al. 1990, Levesque and Di Paolo 1991, Hu et al. 2006, Becker and Hu 
2008). Moreover, estrogens are known to regulate circulating leptin levels and leptin sensitivity 
(Rosenbaum et al. 1996, Shimizu et al. 1997, Clegg et al. 2006) and to improve mood (Joffe and 
Cohen 1998); while testosterone or androgens suppress leptin concentration (Hislop et al. 1999) 
and have anxiolytic and antidepressant benefits (Wang et al. 1996, Hermans et al. 2006, 
DiBlasio et al. 2008). It was already reported that there are differences in estrogen levels 
between males and females, with females showing higher levels than males (Clegg et al. 2006). 
In addition, leptinemia also varies between males and females (Maffei et al. 1995, Castracane et 
al. 1998), and female rats exhibits increased sensitivity to the central effects of leptin as 
compared to males (Clegg et al. 2003). Most importantly, estrogen receptors (ERs) colocalize 
with TH positive cells in mesolimbic regions (Kritzer 1997, Creutz and Kritzer 2002), including 
the amygdala (Asmus and Newman 1993, Cavanaugh and Lonstein 2010, Cavanaugh and 
Lonstein 2010), suggesting a potential role for estrogens on TH cell activity. In agreement with 
these findings, circulating levels of both estrogen receptors (ERα and ERβ) are correlated with 
DA hyperactivity within the mesolimbic system (Thompson and Moss 1997). Of note, estrogen 
modulates STAT3 in the hypothalamus (Gao and Horvath 2008) and targets ERβ in the VTA 
(Creutz and Kritzer 2002). Furthermore, a dense population of estrogen-expressing neurons has 
already been described in limbic regions, such as the CeA, in female rats (Pfaff and Keiner 
1973). Given the growing literature suggesting marked sexual dimorphisms in brain wiring, 
morphology and chemistry (De Vries and Boyle 1998, Cosgrove et al. 2007), we speculate that 
sex differences observed in our studies may involve a difference in the number of ERs in the 
CeA of males versus females; an altered sensitivity to the anxiolytic actions of estrogen; a 
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different effect of estrogen in male and female brain or even due to estrogen action to increase 
DA reuptake within the CeA. However, these hypotheses awaits further experimentation. 
Besides suggesting that leptin regulates feeding or emotion-related behavior by distinct neuronal 
targets and in a sex-specific fashion, the results presented on this study unravel the signaling 
pathway by which leptin acts on DA neurons to modulate anxiety-like behavior. Importantly our 
studies contribute to the mechanistic understanding of the role of leptin in anxiogenic behavior 
and provide insights into novel therapeutic approaches for the treatment of anxiety disorders 
(For a graphic representation of our main conclusion, see Figure 5). 
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Figure 5: The anxiolytic actions of leptin in female mice are mediated by increased LepRb-
STAT3 signaling in midbrain DA neurons that target the CeA to decrease D1R signaling, 
perhaps via increased DA reuptake. 
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10. General limitations 
Limitations of this study include: 
 we cannot totally exclude the possibility of developmental compensation that might 
have occurred in STAT3DAT-KO mice; 
 
 we cannot affirm that all the phenotype of STAT3DAT-KO mice was caused by lack of 
LepRb-STAT3 signaling in DA neurons, as not all experiments were performed in leptin-
treated mice; 
 
 we did not assess DA release in the CeA of STAT3DAT-KO mice, in order to better 
understand the mechanisms underlying the observed anxiogenic phenotype in our model; 
 
 we did not investigate whether estrogen and leptin signaling interact in the VTA. 
 
 the estrous cycle was not monitored or controlled in our study. Thus, the contribution of 
the hormonal milieu to the gender differences reported cannot be determined. 
143 
 
 
11. Perspectives 
The identification of a major role for STAT3 signaling in DA neurons in the modulation of 
locomotion, running reward, operant learning, DA tone and anxiety-like behavior in addition to 
the sexual dimorphic phenotype observed in STAT3DAT-KO mice will undoubtedly lead to a great 
amount of future research. The following are a select few studies that may shed further insight on 
STAT3 signaling in midbrain DA neurons. 
 
 Which DA-relevant genes are directly modulated by STAT3? 
To address this question, future studies can evaluate the direct binding of STAT3 to promoters 
using pSTAT3 chromatin immunoprecipitation. 
 
 Which are the LepRb signaling pathways mediating the effects of leptin in feeding behavior? 
As mentioned in previous sections, leptin's effect in eating behavior is well described (Fulton 
2010, Narayanan et al. 2010, Fernandes et al. 2013). However, we found that DA specific 
STAT3 activation does not mediate the effects of leptin on any aspect of feeding behavior, 
suggesting that either GABA neurons or other LepRb signaling pathway is involved. To further 
our understanding of the LepRb signaling pathways mediating the effects of leptin in feeding 
behavior, it would be interesting to perform experiments involving the use of viral-mediated 
knockdown of STAT3 in the VTA by administering AAV delivery of Cre-recombinase directly 
into the VTA of STAT3lox/lox mice, targeting both DA and GABA neurons. Alternatively, if this 
KO model also does not show any effect on feeding behavior, it would be relevant to use 
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pharmacological manipulations to modulate the activity of LepRb relevant signaling pathways 
(i.e.: PI3-K, MAPK and AMPK) in the VTA. These experiments will allow a better 
understanding of the contribution of specific LepRb signaling pathways in the actions of leptin in 
the midbrain to impact feeding behavior. 
 
 Which signaling molecules are involved in leptin-induced increased AMPH sensitization in 
STAT3 DAT-KO mice? 
Leptin has been shown to play important roles in the control of the mesolimbic DA system, 
including in the behavioral responses to AMPH (Sulzer et al. 1995, Figlewicz et al. 1998, Kahlig 
et al. 2005, Fulton et al. 2006). Our data demonstrated that leptin peripheral administration 
induced locomotor sensitization to AMPH in STAT3DAT-KO mice. This is suggestive that leptin's 
effect to enhance AMPH sensitization (Fulton et al. 2006) does not only involve STAT3 
signaling in DA neurons. It was already reported that:  
1) VTA NT signaling contributes to AMPH psychomotor activation (Panayi et al. 2005); 
2) leptin action via NT neurons modulates the locomotor stimulating effects of AMPH 
(Leinninger et al. 2011); 
3) LepRb neurons expressing NT projects to the VTA (Leinninger et al. 2011) 
Thus, we hypothesize that leptin may be acting via NT neurons to induce AMPH sensitization in 
STAT3DAT-KO mice. As a means to test this hypothesis, I propose to determine whether an intra-
VTA injection of the NT receptor antagonist (SR142948A) would prevent leptin-induced AMPH 
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sensitization in STAT3DAT-KO mice. This experiment will determine whether LepRb-NT 
signaling mediates leptin action to promote AMPH sensitization. 
 
 What is the contribution of estrogen signaling for the sexual dimorphism observed in this 
study? 
The answer to this question could be found by determining whether central estradiol 
administration activates STAT3 in DA neurons. If it is the case, it would be very interesting and 
informative to investigate whether ovariectomized STAT3DAT-KO mice results in a behavioral 
phenotype similar to that observed in STAT3DAT-KO male mice. These studies could open up a 
compelling line of research on the crosstalk between leptin and estrogen signaling in DA 
neurons. 
146 
 
 
12. Conclusion 
The salient findings of this thesis are: 
I. Our studies with STAT3DAT-KO mice suggest that the influence of leptin in the midbrain 
to decrease free-feeding intake does not require STAT3 activation in DA neurons. 
Alternatively, previous data suggest that JAK2 (Morton et al. 2009)or ERK1/2-MAPK 
signaling (Trinko et al. 2011) is likely involved in the anorectic responses of leptin in the 
VTA. Beyond that, we found that LepRb-STAT3 signaling in DA neurons does not 
modulate feeding behavior. 
 
II. Based on our findings that LepRb-STAT3 signaling in DA neurons mediates the effect 
of leptin in the midbrain to decrease locomotor activity, voluntary exercise and running 
reward in male mice, we hypothesize that leptin acts in mesolimbic brain reward circuitry 
as a satiety signal to reduce the motivational and rewarding value of behaviors that 
contribute to replenish energy stores. Consistent with this idea, lack of STAT3 activation 
in midbrain DA neurons reduced both DA biosynthesis and NAc evoked DA release. 
 
III. Loss of STAT3 signaling in DA neurons increases anxiety in female mice without 
affecting depressive-like behavior. Furthermore, the anxiolytic action of leptin in female 
mice is mediated by increased LepRb-STAT3 signaling in midbrain DA neurons that 
target the CeA to decrease D1R signaling, perhaps via increased DA reuptake. 
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Appendices 
 
The aim of this section is to describe relevant unpublished data obtained from STAT3DAT-KO mice 
which will hopefully contribute for a broader understanding of the function of STAT3 signaling 
in DA neurons. 
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13. Appendices 
13.1. Appendix I 
Unpublished results on the role for STAT3 signaling in DA neurons in the modulation of 
feeding behavior in male mice 
In addition to the chow intake studies described in Article 1, we also conducted experiments to 
check long-term HF intake and body weight of control and in STAT3DAT-KO mice. In agreement 
with what was observed in the chow-fed groups, there are no differences in HF consumption 
and/or body weight between genotypes (Figure 6A-B, Appendix I). Notably, besides the 
hypothalamus, the VTA has been suggested as another susceptible site for leptin resistance 
(Matheny et al. 2011, Bruijnzeel et al. 2013), given the observations that leptin-induced STAT3 
phosphorylation is impaired in this region in long-term HF-fed animals (Matheny et al. 2011). 
Thus, a possible hypothesis to explain why food intake and body weights are not different 
between HF-fed STAT3DAT-KO and control mice could be that the long term exposure to this 
palatable food triggers leptin resistance in the VTA of control mice, by increasing SOCS 3 
expression. This way, VTA leptin-resistant control mice would resemble the phenotype of 
STAT3DAT-KO mice in which concerns to HF intake and body weight. In another words, we 
hypothesize that in a HF condition LepRb-STAT3 signaling is also disrupted in the VTA of 
control mice, so that both STAT3DAT-KO and control would exhibit a similar phenotype. This is a 
very speculative explanation, which would require further experimentation. 
In regards to other aspects of feeding behavior, we also failed to observe differences between 
genotypes in FAA (Figure 7A-B, Appendix I) restriction-induced feeding (Figure 8, Appendix 
I) and food preference (Figure 9, Appendix I) tests. FAA is defined as a behavior which 
includes increased locomotion prior to receiving a daily scheduled meal (Merkestein et al. 2012). 
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As shown in Figure 7, STAT3 signaling in midbrain dopaminergic neurons does not affect FAA 
in mice, when using a food-restriction protocol. Similarly, lack of leptin in ob/ob mice failed to 
affect critically the expression of FAA (Gunapala et al. 2011). On the other hand Ribeiro and 
coworkers observed that leptin administration abolishes FAA in ob/ob mice (Ribeiro et al. 2011). 
Moreover, leptin receptor-deficient Zucker rats exhibited enhanced FAA after 22 days of food 
restriction (Mistlberger and Marchant 1999). The apparent inconsistency regarding leptin's effect 
on the expression of FAA is likely related to different experimental conditions, including the 
duration of the food restriction protocol (long versus short duration) and also to the type of 
restriction used (caloric restriction versus food intake restriction). To access restriction-induced 
feeding in STAT3DAT-KO mice, we used a relatively short-term food restriction protocol (12 days) 
during which the animals were habituated to have a limited access to standard chow daily (4h 
only), while most of the studies suggesting that leptin reduces FAA used a long-term restriction 
protocol (22-28 days). Furthermore, our findings suggest that locomotor behavior and FAA are 
regulated independently by LepRb-STAT3 signaling in DA neurons. 
We also failed to observe differences in chow consumption between STAT3DAT-KO and control 
mice, following a 3-days food restriction-induced feeding, which is consistent with our previous 
observation that there are no differences in regular chow consumption between genotypes. Given 
food-restriction is known to induce stress (Ilott et al. 2014), and leptin has been suggested to 
affect stress-induced eating (Appelhans 2010, Tomiyama et al. 2012), a possible explanation for 
the lack of difference in restriction-induced feeding between groups could be that leptin does not 
modulate this behavior via LepRb-STAT3 signaling in midbrain DA neurons. Alternatively, 
Tomiyama and coworkers reported that the influence of leptin in stress-induced eating in humans 
is specific for sweetened HF diet, as they failed to find a relationship between leptin and stress-
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induced feeding in other food category (Tomiyama et al. 2012). Consistent with these findings, 
other studies in rodents and humans suggested that stress affects sweet food intake to a much 
greater extent than it affects the intake of regular chow or salty foods (Kawai et al. 2000, Epel et 
al. 2001, Dallman et al. 2003, Habhab et al. 2009). Therefore, the inconsistency between our 
results and these findings could be due to the use of different protocols and also to the fact that 
we used standard chow in our experiments, instead of opting for a more palatable diet. 
A role for DA in the modulation of food choice was previously described (Cooper and Al-Naser 
2006). In addition, leptin has been suggested to modulate food preference in humans and rodents 
(Wetzler et al. 2004, Licinio et al. 2007, Tomiyama et al. 2012), although the molecular 
mechanisms and cell types involved remain unknown. Moreover, to our knowledge, the effects 
of STAT3 signaling in DA neurons have not been previously reported in any form of food-
preference situation. Thus, we assessed food choice (high-fat versus low-fat diet) in control and 
STAT3DAT-KO mice and we failed to observe differences between genotypes, further suggesting 
that leptin's modulation of food preference does not involve STAT3 signaling in DA neurons. 
Along with the findings presented on Article 1, these results strengthen our conclusion that 
STAT3 signaling in DA neurons does not influence any aspect of feeding behavior. 
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Methods 
Long-term HF intake and body weight 
STAT3DAT-KO and control mice were housed individually and had free access to a HF diet 
(D12231; Research Diets, Inc., New Brunswick, NJ, USA) containing 58% kcal from fat; 16.4% 
kcal from protein and 25.5% kcal from carbohydrates and tap water throughout the experiment 
(8 to 23 weeks of age). The animal room was kept at 22–24°C in a 12:12 h light–dark cycle. 
Body weight and HF intake were assessed three times a week at 10am (onset of the dark period). 
In addition to the amount of food consumption, weekly HF caloric intake for each mouse was 
normalized by its respective body weight. 
 
Food anticipatory activity 
Mice were habituated to have a 4 hour-limited access to standard chow (Teklad Global 18% 
Protein Rodent Diet, Harlan Laboratories, Indianapolis, Indiana, USA) daily (12-4pm) during 19 
days in a novel entrainment cage (CLAMS metabolic chambers). On day 20, mice were placed in 
their entrainment cage 4h prior to food access (8am) and locomotor activity was measured using 
an automated comprehensive laboratory animal monitoring system (CLAMS, Columbus 
Instruments, Columbus, OH, USA). Locomotor activity was defined as successive linear infrared 
beam breaks recorded in 20min bins (breaks/20min). 
 
Food restriction-induced feeding 
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All mice were housed individually with free access to standard chow and water. Food intake was 
measured for 3 consecutive days. After that (on the following 3 days) STAT3DAT-KO and control 
mice were 50% food restricted. On day 4 all mice were given free access to standard chow and 
food consumption was measured after 2, 6, 12 and 24h. 
 
Food preference test 
Food choice was assessed in a food preference test for the HF diet (D12231; Research Diets, 
Inc., New Brunswick, NJ) containing 58% Kcal from fat; 16.4% Kcal from protein and 25.5% 
Kcal from carbohydrates, or ingredient-matched LF diet (D12328; Research Diets, Inc., New 
Brunswick, NJ), containing 10.5% Kcal from fat; 16.4% Kcal from protein and 73.1% Kcal from 
carbohydrates. All mice were single housed with free access to tap water. In each cage two cups 
were provided in opposite corners one filled with HF diet and the other filled with LF diet. The 
location of the cups was switched every 24 hour and food choice was assessed for 3 consecutive 
days by measuring the amount of diets consumed. The results were presented as a ratio of HF 
preference. 
 
Statistical analyses 
Data were analyzed using GraphPad 5 and presented as means and respective standard errors. A 
two-way ANOVA with Bonferoni post-hoc tests was used to compare STAT3DAT-KO and control 
mice body weight, HF caloric intake, chow intake in a food restriction-induced feeding test, FAA 
and food preference. Criterion for significance was set to p≤0.05 in all comparisons. 
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Figure legends 
Figure 6. Long-term high-fat(HF) diet intake and body weight is not different between 
STAT3DAT-KO and control mice. (A) Cumulative HF caloric intake of STAT3DAT-KO and control 
mice. n= 8-11/group. (B) Long-term body weight in STAT3DAT-KO and control mice. n= 8-
11/group.  
 
Figure 7. Food anticipatory activity (FAA) is not different between STAT3DAT-KO male mice 
and littermate controls. (A) 4h-locomotor activity prior to food access is not different in control 
and STAT3DAT-KO mice. n= 5/group. (B) Locomotor activity is not different between control and 
STAT3DAT-KO mice 60 minutes prior to access of food (n=5/group). 
 
Figure 8. Food restriction-induced feeding is not different between STAT3DAT-KO male mice 
and littermate controls. (A) Protocol schematics. (B) Free-access to food after three days of 50% 
food restriction did not alter significantly regular chow consumption between 
genotypes.n=7/group.  
 
Figure 9: Food preference in STAT3DAT-KO mice. HF- versus LF-diet preference is similar 
between STAT3DAT-KO and littermate controls. n=10-14/group.  
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13.2. Appendix II 
Unpublished results on the role for STAT3 signaling in DA neurons in the modulation of 
feeding behavior and learning in female mice 
In agreement with our findings in STAT3DAT-KO male mice, our studies in female mice also 
demonstrated that STAT3 signaling in DA neurons does not influence food intake and body 
weight in chow-fed animals (Figure 10A, Appendix II). Likewise, food preference (HF versus 
LF diet) as well as HF diet intake was also unaltered in STAT3DAT-KO female mice (Figure 10B-
C, Appendix II). However, we found that gender significantly affects general locomotion in 
STAT3DAT-KO mice as, opposed to what was observed in males, ambulatory activity and 
voluntary wheel running exercise is similar between STAT3DAT-KO and control female mice 
(Figure 11A-B, Appendix II). The reason for the gender difference in locomotor behavior is not 
known although, we hypothesize that estrogen signaling in DA neurons could be involved, as it 
is well described that there are sex differences in dopaminergic function in the brain (Kuhn et al. 
2010). Furthermore, circulating leptin levels are modulated by different cytokines and hormones 
(including estrogen) that are also under the influence of gender (Considine 2001, Janeckova 
2001). Of note, leptin levels are higher in females than in males (Frederich et al. 1995, Considine 
2001, Janeckova 2001), also suggestive of a possible sexual dimorphism of LepRb signaling. 
Similar to what was observed in STAT3DAT-KO male mice, lack of STAT3 signaling in DA 
neurons also suppresses lever pressing for food in females - STAT3DAT-KO female mice showed 
severe impairment in learning a FR1 schedule of reinforcement in an appetitive operant 
conditioning task (Figure 12A-B, Appendix II). There is data implicating DA signaling in the 
dorsolateral striatum (DLS) in the modulation of learning, including operant learning (Frank et 
al. 2004, Yin et al. 2006, Balleine et al. 2007, Balleine and O'Doherty 2010). Consistent with 
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this idea, we found that D1R protein expression is downregulated in the DLS of STAT3DAT-KO 
female mice as compared to controls, which we hypothesize may be related to the severe 
impairment in learning a FR1 schedule of reinforcement for food pellet reward (Figure 12C, 
Appendix II). Furthermore, STAT3DAT-KO female mice exhibited normal performance in a CPP 
for palatable food (sweetened HF pellets), strengthening our hypothesis that loss of STAT3 in 
DA neurons mediates leptin's effect in appetitive operant learning, but not in a classical 
conditioning task (Figure 13, Appendix II). Of note, the learning impairment observed in 
STAT3DAT-KO mice is not related to locomotor deficits or loss of appetite, as these mice exhibited 
normal ambulatory activity and feeding behavior as compared to controls. Although our findings 
suggest that STAT3 signaling in DA neurons is critical for operant learning, more experiments 
needs to be conducted to shed light on the detailed mechanisms underlying the effects of leptin 
signaling in different forms learning. 
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Methods 
Long-term food intake and body weight 
STAT3DAT-KO and control mice were housed individually with free access to standard chow 
(Teklad Global 18% Protein Rodent Diet, Harlan Laboratories, Indianapolis, Indiana, USA) and 
tap water throughout the experiment (8 to 23 weeks of age). The animal room was kept at 22–
24°C in a 12:12 h light–dark cycle. Body weight and food intake were assessed three times a 
week at the onset of the dark period. 
 
Food preference test 
Food choice was assessed in a food preference test for the HF diet (D12231; Research Diets, 
Inc., New Brunswick, NJ) containing 58% Kcal from fat; 16.4% Kcal from protein and 25.5% 
Kcal from carbohydrates, or ingredient-matched LF diet (D12328; Research Diets, Inc., New 
Brunswick, NJ), containing 10.5% Kcal from fat; 16.4% Kcal from protein and 73.1% Kcal from 
carbohydrates. All mice were single housed with free access to tap water. In each cage two cups 
were provided in opposite corners one filled with HF diet and the other filled with LF diet. The 
location of the cups was switched every 24 hour and food choice was assessed for 3 consecutive 
days by measuring the amount of diets consumed. The results were presented as a ratio of HF 
preference. 
 
Long-term HF intake 
STAT3DAT-KO and control mice were housed individually and had free access to a HF diet 
(D12231; Research Diets, Inc., New Brunswick, NJ, USA) containing 58% kcal from fat; 16.4% 
kcal from protein and 25.5% kcal from carbohydrates and tap water throughout the experiment 
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(8 to 23 weeks of age). The animal room was kept at 22–24°C in a 12:12 h light–dark cycle. 
Food intake was assessed three times a week at the onset of the dark period. 
 
Ambulatory activity 
To access 24-hour spontaneous locomotor activity STAT3DAT-KO and littermate controls were 
individually placed into metabolic cages (Accuscan Instruments Inc., Columbus, OH, USA) 
consisting of 16 light beams arrays in x, y and z axes. Distance travelled (horizontal activity) was 
measured by nearby computer-controlled software. 
 
Voluntary wheel running activity 
To record daily running wheel behavior, animals were single housed into standard rat cages 
(26,03cm width x 48,26cm depth x 20,32cm height) containing plastic wireless running wheels 
(one wheel revolution=36.9 cm, Med Associates Inc., St. Albans, VT, USA). Wheel running 
activity was continuously monitored through wireless transmitters and recorded using the 
Wireless Running Wheel Manager Data Acquisition Software (Med Associates Inc., St. Albans, 
VT, USA). Data were exported from the wheel manager database for further analysis. The 
parameter evaluated was the total wheel running activity (revolutions per 24 h). 
 
Appetitive food-motivated operant learning 
Fixed ratio 1 (1:1) schedule of reinforcement 
We used mouse operant chambers (Med Associates Inc., St. Albans, VT, USA) equipped with 
two levers and a pellet dispenser delivering 20mg of sucrose pellets (Bio-Serv, Frenchtown, NJ, 
USA). During the operant conditioning sessions, the mouse is expected to press the designated 
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active lever (triggering food reward) to get a reinforcer. The allocation of right and left levers 
were counterbalanced between mice. All mice were trained in 60 min sessions to press the active 
lever on a continuous reinforcement schedule (FR1), in which every lever press is reinforced 
with a 20 mg sucrose pellet. All training was conducted in the dark cycle and the animals were 
50% food restricted during the operant training. Operant training was carried out over 10 days. 
 
Conditioned Place Preference for sweetened HF food 
The place preference apparatus (Med Associates Inc., St. Albans, VT, USA) consisted of three 
chambers with overall inside dimensions of: 46.5cm length x 12.7cm width x 12.5cm height. The 
two choice compartments consist of a black compartment with a stainless steel grid rod floor and 
a white compartment with a spaced stainless steel mesh floor. These two chambers are separated 
by a small center compartment that is 11.7 cm long with a neutral gray finish and a PVC floor. 
Preference test: On day 0 each experimental mouse was confined to both the black and white 
compartment of the CPP apparatus for 5 minutes to allow habituation to each chamber. On this 
same day, animals were allowed to move freely within the apparatus for 15 minutes, during 
which the amount of time spent in each compartment was recorded. Conditioning training: In the 
following 14 days, mice were randomly assigned to a pairing compartment (black or white) 
associated with palatable food (sweetened HF pellets, containing 48.9% Kcal as fat, Bio-Serv, 
Frenchtown, NJ, USA) on even days or no food on even days. Mice were confined to the 
appropriate compartment for 30 min during the 14-days conditioning period. CPP test: On day 
15, each mouse was placed back in the CPP apparatus and allowed to move freely across 
compartments for 15 min. The amount of time spent in each compartment was recorded and the 
proportion of time spent on the paired side was compared to that obtained during the pre-test. 
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Western immunoblotting 
Mice were decapitated under Isoflurane anaesthesia. Brains were rapidly dissected and stored at -
80oC. Frozen brains were sliced into 0.5mm coronal sections using a brain matrix. Coronal 
sections were mounted onto slides and maintained on dry ice. Nuclei were microdissected using 
brain tissue punches (Stoelting Inc., Wood Dale, IL). Bilateral punches of 1.0mm diameter were 
obtained from the DLS. Microdissected tissues were homogenized on ice in 100 ml of cell lysis 
buffer (100mM Tris, pH 7.5; 750mM NaCl; 5mM Na2EDTA; 5mM EGTA, pH 7.5; 5% Triton x-
100; 12.5mM sodium pyrophosphate; 5mM beta-glycerophosphate; 1mM, 5mM Na3VO4; 
5µg/ml leupeptin) with added protease (PMSF 1mM) and phosphotase inhibitors (Sigma 
phosphatase inhibitor cocktails I and II) in 1.5 ml tubes using a motorized pestle, and after that 
centrifuged for 15 min at 14000 g. Protein concentrations were measured using BCA protein 
assay (Pierce Biotechnology, IL, USA). Protein samples were separated by electrophoresis on a 
10% polyacrylamide gel and electrotransferred to a nitrocellulose membrane (EMD Millipore 
Corporation, Billerica, MA, USA). Non-specific binding sites were blocked in TBS 5% low-fat 
milk and 0.1% Tween-20 or 5% BSA. Membranes were rinsed in buffer (0.1% Tween-20 in 
TBS) and then incubated with anti-D1R (1:1000; Millipore, EMD Millipore Corporation, 
Billerica, MA, USA) followed by anti-rabbit IgG horseradish peroxidase-conjugate (1:5000). 
After rinsing with buffer, immunocomplexes were visualized by chemiluminescence using the 
western lighting plus ECL kit (PerkinElmer, Waltham, MA, USA). Protein size was compared 
by using precision plus protein ladder (Bio-Rad, Bedford, MA, USA). The film signals were 
digitally scanned and then density quantified using ImageJ software. GAPDH (1:10000, Cell 
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Signaling, Cell Signaling Technology, Inc., Danvers, MA, USA) was used as an internal control, 
such that data were standardized according to GAPDH values. 
 
Statistical analyses 
Data were analyzed using GraphPad 5 and presented as means and respective standard errors. A 
two-way ANOVA with Bonferoni post-hoc tests was used to compare control and STAT3DAT-KO 
mice body weight, food intake (chow and HF diet), food preference, food motivation and 
voluntary exercise. Unpaired t-tests were used to compare control and STAT3DAT-KO mice 
locomotor activity, food CPP and D1R protein expression. Criterion for significance was set to 
p≤0.05 in all comparisons. 
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Figure legends 
Figure 10. Caloric intake, body weight, and food preference is not different in STAT3DAT-KO 
female mice as compared to controls. (A) Average long-term caloric intake and body weight of 
STAT3DAT-KO female mice and littermate controls on regular chow diet. n=8-9/group (B) Food-
preference test in STAT3DAT-KO and control mice. n=11-12/group.  (C) Average long-term high-
fat caloric intake of STAT3DAT-KO female mice and littermate controls. n=12-13/group.  
 
Figure 11. Locomotor activity and voluntary exercise is not different in STAT3DAT-KO female 
mice as compared to controls. (A) Dark (active) phase locomotor activity expressed as total 
distance travelled during the test in STAT3DAT-KO female mice as compared to controls. n=7-
9/group. (B) Voluntary wheel running exercise in female mice, expressed as average number of 
wheel revolutions per week. n=10 mice/group.  
 
Figure 12. Operant conditioning task and D1R protein expression in STAT3DAT-KO and control 
mice. (A) Total lever press. n= 8-10/group ***p<0.001 (B) Percentage of correct over incorrect 
responses by day 10. n= 8-10/group. **p<0.01 (C) Significant decrease in D1R protein levels in 
the dorsolateral striatum (DLS) of STAT3DAT-KO mice as compared to controls. n=4-7/group. 
**p<0.01. 
 
Figure 13. STAT3DAT-KO female mice acquired CPP for a sweetened high-fat food. (A) CPP 
protocol schematics (B) Preference for the food-paired side of the CPP apparatus after minus 
before the CPP test. n=11/group. 
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